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ABSTRACT 
 DNA has recently emerged as an extremely promising material to organize 
molecules on nanoscale. The reliability of base recognition, self-assembling behavior, 
and attractive structural properties of DNA are of unparalleled value in systems of this 
size. DNA scaffolds have already been used to organize a variety of molecules including 
nanoparticles and proteins. New protein-DNA bio-conjugation chemistries make it 
possible to precisely position proteins and other biomolecules on underlying DNA 
scaffolds, generating multi-biomolecule pathways with the ability to modulate inter-
molecular interactions and the local environment. This dissertation focuses on studying 
the application of using DNA nanostructure to direct the self-assembly of other 
biomolecular networks to translate biochemical pathways to non-cellular environments. 
 Presented here are a series of studies toward this application. First, a novel 
strategy utilized DNA origami as a scaffold to arrange spherical virus capsids into one-
dimensional arrays with precise nanoscale positioning. This hierarchical self-assembly 
allows us to position the virus particles with unprecedented control and allows the future 
construction of integrated multi-component systems from biological scaffolds using the 
power of rationally engineered DNA nanostructures. Next, discrete glucose oxidase 
(GOx)/ horseradish peroxidase (HRP) enzyme pairs were organized on DNA origami 
tiles with controlled interenzyme spacing and position. This study revealed two different 
distance-dependent kinetic processes associated with the assembled enzyme pairs. 
Finally, a tweezer-like DNA nanodevice was designed and constructed to actuate the 
activity of an enzyme/cofactor pair. Using this approach, several cycles of externally 
controlled enzyme inhibition and activation were successfully demonstrated. This 
ii 
 
principle of responsive enzyme nanodevices may be used to regulate other types of 
enzymes and to introduce feedback or feed-forward control loops. 
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Chapter 1 
DNA Nanotechnology and DNA Organized Biomolecular Networks 
Adapted with permission from Fu, J.; Liu, M.; Liu, Y.; Yan, H., Spatially-Interactive 
Biomolecular Networks Organized by Nucleic Acid Nanostructures. Acc. Chem. Res. 
2012, 45, 1215-1226.  Copyright 2012 American Chemical Society. 
1.1. Abstract 
Living systems have evolved a variety of nanostructures to control the molecular 
interactions that mediate many functions including the recognition of targets by 
receptors, the binding of enzymes to substrates, and the regulation of enzymatic activity. 
Mimicking these structures outside of the cell requires methods that offer nanoscale 
control over the organization of individual network components. Advances in DNA 
nanotechnology have enabled the design and fabrication of sophisticated one-, two- and 
three-dimensional (1D, 2D, and 3D) nanostructures that utilize spontaneous and 
sequence-specific DNA hybridization. Compared with other self-assembling 
biopolymers, DNA nanostructures offer predictable and programmable interactions and 
surface features to which other nanoparticles and biomolecules can be precisely 
positioned. The ability to control the spatial arrangement of the components while 
constructing highly organized interactive networks will lead to various applications of 
these systems. In this chapter, we introduce the principle of structural DNA 
nanotechnology, summarize the most advances in the DNA nanostructure directed 
assembly of biomolecular networks and explore the possibility of applying this 
technology to other fields of study.  
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1.2. Introduction  
Biological systems use complex macromolecular nanostructure networks to 
mediate a range of cellular functions such as biomolecular synthesis, signal transduction, 
and gene expression and regulation, all with high efficiency and specificity. Many of 
these macromolecular systems have evolved through the spontaneous self-assembly of 
components into highly organized spatial structures, where the position and orientation of 
molecules are precisely controlled to facilitate functionality. For example, the 
multienzyme cascades
1
 found in biochemical synthesis pathways and the light harvesting 
system in photosynthetic reaction centers
2
 both rely on very specific arrangements of 
components. Over the past few decades, molecular self-assembly processes have been 
exploited to construct various nanostructures including vesicles, nanofibers, and 
nanotubes from self-assembling lipids, peptides, nucleic acids, and polysaccharides.
3
 
However, current methods to assemble multienzyme pathways, including genetic fusion, 
chemical crosslinking, liposome compartmentalization, and surface co-immobilization, 
all lack the ability to precisely control inter-component distance and overall spatial 
organization without compromising functionality. Additional challenges include the 
development of novel assembly algorithms to increase structural complexity and improve 
the fidelity and yield of the assembly process.  
Deoxyribonucleic acid (DNA) is among the most promising biomolecules for the 
construction of complex biomolecular networks.
4
 As illustrated in Figure 1.1, DNA is a 
self-assembling biopolymer that is directed by canonical Watson-Crick base pairing
5
 to 
form predictable, double helical secondary structures, which are stabilized by hydrogen-
bonding, π-π stacking, and hydrophobic interactions. B-form DNA double helices have 
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well-defined structural characteristics, including a helical repeat of ∼3.4 nm, helical 
diameter of ∼2.0 nm, and ∼34.3° twist angle between base pairs in solution.  
 
Figure 1.1. Introduction to structural DNA nanotechnology. (A) Self-assembly of 
nanostructures based on DNA base pairing. (B) Examples of DNA helix bundles (left), 
2D arrays (middle) and small 3D cages (right).  
In the early 1980's, Nadrian Seeman constructed artificial DNA tiles, where four 
rationally designed DNA strands self-assembled into an immobile four-way branched 
junction
6
. The creation of these junctions led nanotechnology to a new era with the 
engineering of double helical DNA molecules. Double-crossover (DX) DNA tiles,
7
 with 
increased structural rigidity, were developed later and were suitable for assembling more 
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complex periodic nanostructures through sticky end interactions.
8
 Tile-based DNA 
assembly has been demonstrated through the construction of a number of unique 
nanostructures, ranging from multi-helix bundles, nanotubes
9 
and 2D lattice arrays
10 
to 
3D geometric cube,
11
 tetrahedron,
12
 and buckyball.
13
  
 
Figure 1.2. Introduction to DNA origami: arbitrary shapes can be created by folding 
DNA, such as (A) 2D DNA origami nanostrcutures, and (B) 3D DNA origami 
nanostructures. 
An important milestone in structural DNA nanotechnology was the creation of 
aperiodic patterns using a scaffolding strategy. In 2006, Paul Rothemund made a 
breakthrough in scaffold-directed DNA nanostructure assembly; in the method he 
developed, referred to as DNA origami, a long single-stranded DNA scaffold (e.g., 7429-
nt M13 bacteriophage genome DNA) is folded into arbitrary 2D shapes by following 
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predetermined folding paths that are specified by a collection of short oligonucleotide 
“staple” strands complementary to two or more regions of the scaffold that are not 
adjacent. (Figure 1.2A).
14
 Many 2D origami examples including a square, rectangle, 
smiley face, triangle, and star have been demonstrated using the DNA origami method. 
One of the most attractive properties of DNA origami structures is the addressability of 
the surface, a result of the unique sequence at each oligonucleotide staple position. Thus, 
various patterns can be displayed by selectively modifying staple strands at desired 
locations with single-stranded probe extensions. The DNA-origami method has several 
advantages over “tile-based” assembly approaches: (1) scaffolded DNA can be folded 
into nearly any symmetric or asymmetric structure; (2) well-formed nanostructures are 
generated with high yield using unpurified staple strands, because the scaffold imposes 
the correct stoichiometry between strands; (3) spatially addressable assembly is achieved 
with a resolution of ∼6 nm. The DNA origami approach was further developed for the 
construction of 3D nanostructures (Figure 1.2B). The Gothelf group assembled a hollow 
DNA box by joining six distinct (though connected by the scaffold) origami sheets 
through the action of staple strands bridging the edges.
15
 The Shih group introduced a 
method to construct solid 3D shapes by packing scaffolded DNA double helices into 
pleated layers, constrained to a honeycomb or square lattice.
16-18
 Twisted and curved 3D 
objects were further developed through insertion or deletion of base pairs at selected 
positions within the helical layers.
19
 Our group also developed a strategy to construct 
DNA nanostructures with complex curvatures by nesting a collection of concentric DNA 
rings of decreasing circumference to generate the rounded contours of various 3D 
objects.
20
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In conclusion, as an information-encoding polymer, DNA can be programmed to 
assume a particular nanoscale shape. Cohesive, intermolecular interactions (sticky ends) 
can be used to link individual elements together and thus, it is possible to assemble 
intricate DNA networks in all three dimensions. They are reliable directors in the 
organization of heterogeneous nanoscale entities such as peptide, proteins, and 
nanoparticles. Molecular networks that are scaffolded by DNA nanostructures exhibit 
well-controlled inter-component distances and well-defined numbers. This characteristic 
presents exciting opportunities for fundamental studies of distance-dependent molecular 
interactions and for practical applications including biocatalysis and responsive 
nanodevices. 
1.3. DNA-Directed Self Assembly 
 
Figure 1.3. Seeman’s proposal to organize macromolecules within a DNA nanoscaffold. 
As shown in Figure 1.3, Seeman's original proposal suggested that a DNA nano-
lattice could be used as a framework to organize proteins into 3D crystals, where the 
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position and orientation of each protein could be controlled by elements of the DNA 
lattice.
6  
 
Figure 1.4. DNA origami directed assembly of macromolecules: streptavidin (top),
23
 
virus capsid (middle),
24
 and orthogonal protein decoration (bottom).
25
 
Since 1982, the sequence specificity of DNA hybridization has been exploited to 
assemble external biomolecules at specific positions on addressable DNA nanostructures. 
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Sequence-specific hybridization between the DNA functionalized biomolecules and 
single-stranded probe extensions of the DNA nanostructures generate networks of 
molecules with controlled intermolecular distances and ratios. This approach was 
demonstrated by organizing smaller biomolecules, including aptamers
21
 and peptide,
22
 as 
well as larger macromolecules, including proteins
23
 and virus capsids,
24
 on DNA 
nanostructures (Figure 1.4). DNA-directed assembly of virus capsids is described in 
chapter 2.  
To guarantee highly efficient DNA-directed assembly yield, people have 
developed many oligonucleotide-biomolecule coupling methods. One of the attractive 
features of DNA scaffolds is that the constituent oligonucleotides can be modified with a 
variety of different functional groups for subsequent crosslinking reactions with other 
biomolecules;
26
 amino and thiol modifications are among the most common. A widely 
used conjugation method is to use a bivalent coupling reagent, Succinimidyl-4-[N-
maleimidomethyl] cyclohexane-1-carboxylate (SMCC) to attach to a lysine residue on a 
protein surface, for subsequence linkage to a thiol-modified oligonucleotide.
27
 Figure 1.5 
illustrates an alternative approach which is to modify a protein with an N-succinimidyl 3-
(2-pyridyldithio) propionate (SPDP) crosslinker, followed by the activation of the pyridyl 
disulfide group to facilitate a disulfide bond exchange reaction with thiol-modified DNA. 
The leaving group pyridine 2-thione has specific absorbance at 343nm (extinction 
coefficient: 8.08×10
3
 M
-1
cm
-1
) and thus the coupling yield can be determined by 
measuring the absorbance change at this wavelength.   
9 
 
 
Figure 1.5. Chemistry of SPDP crosslinker reaction between amine and thiol functional 
groups.
28
 
Despite their versatility, one of the drawbacks of conventional crosslinking 
methods is a lack of control over the conjugation site and stoichiometry of coupling. The 
presence of multiple lysine and cysteine residues on the surface of most proteins makes it 
difficult to generate a site-specific protein conjugation, which is required for certain 
applications.
29
 Genetic modification of proteins with reactive tags (His-tag and ybbR-
tags, for example) and the use of fusion domains (such as streptavidin, intein, SNAP, and 
HALO) are alternative approaches to achieve site-specific protein-oligo conjugation with 
very high efficiency.
29
 In addition to covalent coupling approaches, noncovalent binding 
between proteins and specific ligands such as biotin-streptavidin interaction
 
and can also 
be used for assembling protein nanoarrays.
30
 It should be possible to achieve more 
precise control over the orientation of biomolecules by combining site-specific 
10 
 
conjugation strategies with 3D DNA nanostructures that have specifically tailored 
cavities or cages to constrain the guest molecule through steric interactions. 
1.4. Organization of Multienzyme Reaction Pathways 
The metabolism of living systems involves complex synthetic pathways with 
numerous multistep reactions that possess extraordinary yields and specificities. Many of 
the enzyme systems carrying out these reaction pathways are highly organized complexes 
with precisely controlled enzyme positions and orientations, facilitating efficient 
diffusion of substrates between the enzymes.
1
 Artificial synthesis of these multienzyme 
systems is generally achieved by genetic fusion,
31
 chemical cross-linking, and co-
immobilization;
32
 however, precise control over spatial organization of components is 
lacking for these methods. 
With DNA nanostructures as assembly scaffolds, it has become feasible to 
organize multiple enzymes with controlled spacing in linear as well as 2D or 3D 
geometric patterns, which enables the study of cascade activity.
33
 One of the first 
demonstrations was the assembly of a bioenzymatic NAD(P)H:FMN oxidoreductase and 
luciferase cascade on a double-stranded DNA scaffold with an observed ∼3-fold increase 
in activity compared with the unassembled enzyme pair.
34
 This strategy was later applied 
to probing the distance-dependent activity of multidomain complexes of cytochrome 
P450 BM3 by varying the length of spacing scaffolds between the BMR reductase 
domain and the BMP porphyrin domain.
35
 2D DNA nanostructures provide an even 
greater opportunity to organize multienzyme systems into more complicated geometric 
patterns. There was a report in 2009 of the self-assembly of a glucose oxidase (GOx) and 
horseradish peroxidase (HRP) enzyme cascade on 2D hexagonal DNA strips, with the 
11 
 
distance between the two enzymes controlled by the underlying nanostructure.
36
 A 
greater than 10-fold activity enhancement was observed compared with the 
corresponding unstructured enzymes.  
 
Figure 1.6. DNA nanostructures for engineering multienzyme systems. A linear double-
stranded DNA scaffold for the assembly of (A) an enzyme cascade, 
NAD(P)H:FMN(NFOR) oxidoreductase and luciferase (Luc),
34
 and (B) evaluating the 
distance-dependent activity of cytochrome P450 BM3 by varying the spacing between 
the BMR reductase domain and the BMP porphyrin domain.
35
 (C) 2D DNA strip for 
12 
 
organizing GOx/HRP cascades.
36
 (D) Organization of a GOx/HRP cascade on DNA 
origami tiles with controlled spatial positions, and a protein bridge for facilitating 
surface-limiting intermediate diffusion between enzymes.
37
 
Recently, a GOx/HRP cascade was organized on DNA origami tiles with 
precisely controlled spatial positions, which was applied to investigating the distance 
dependent interenzyme substrate diffusion.
37 
The study revealed that substrate transfer 
between enzymes might occur at the connected hydration shells for closely paced 
enzymes and demonstrated this idea by constructing a protein bridge to facilitate the 
intermediate transfer across protein surfaces. This work is described in chapter 3.      
1.5. Responsive Nanodevice 
  It has been a dream for many years to create molecular level robots that mimic 
functional macromolecules and are capable of traveling through the human body. The 
enormous potential of DNA nanotechnology is bringing us closer to this dream. 
Autonomous DNA walkers are early demonstrations of functional nanorobots, where the 
motion of the legs is coordinated and driven by either strand displacement
38
 or 
deoxyribozyme (DNAzyme) substrate binding and cleavage.
39
 Recent advances in DNA 
origami make it possible to construct integrated nanosystems that combine walkers, 
cargo, tracks, and drive mechanisms to achieve complex motions on 2D or 3D surfaces. 
There was a report of an integrated system that executed cargo loading, transportation, 
and destination control functions.
40
  
13 
 
 
Figure 1.7. Responsive DNA nanowalkers: (A) a cargo transportation system consisting 
of an assembly template, cargo loading apparatus, and DNA walker,
40 
and (B) walker 
movement along a 2D deoxyribonucleotide substrate surface.
41
 
14 
 
In Figure 1.7A, the hands of the DNA walker bound to specific nanoparticle cargo 
when the cassette was switched from an “OFF” to “ON” state. Fuel strands were 
employed to initiate the walker's stepwise movement, with a 120°rotation for each step.  
The cargo-transportation system was programmed to reach eight different destinations by 
controlling the states of the three loading cassettes and the movement along the tracks. In 
parallel, a spider-like molecular walker was developed with the ability to travel along a 
2D oligonucleotide substrate track assembled on a DNA origami tile.
41
 The walker was 
composed of an inert streptavidin protein body with three catalytic DNAzyme legs and a 
single capture leg for loading the molecular spider on the surface of the origami (Figure 
1.7B). For movement along a predetermined path, the molecular walker was first loaded 
at the START position via hybridization of the capture leg to a partially complementary 
probe extended from the DNA origami surface. The walker was subsequently released by 
the addition of a 27-nt single-stranded DNA trigger that was fully complementary to the 
START probe, displacing the capture leg and allowing the walker to move to the 
substrate track. The catalytic action of the DNAzyme legs, binding to and cleaving the 
underlying DNA substrate track, drove the spider toward uncleaved substrate until it 
reached a STOP site, where further movement was inhibited by strong binding between a 
noncleavable probe and the DNAzyme legs.    
In addition to walkers, other responsive DNA nanodevices such as tweezers,
42, 43
 
I-motif switches,
44
 and hybridization-chain-reaction systems
45
 have been developed.   
These devices are capable of sensing the presence of specific DNA or non-covalent 
interactions, changes in pH, and mRNA expression.  An example of DNA tweezer based 
enzyme nanoreactor is described in chapter 4. 
15 
 
       
Figure 1.8.  DNA tweezer-like nanodevices: (A) DNA origami based tweezers that are 
regulated by metal ion-nucleotide, biotin-streptavidin and antigen-antibody binding 
interactions. 
42 
(B) Functionalized DNA nanoreactors that can reversibly regulate enzyme 
activities by DNA fuel/set strands. 
43
      
1.6. Projects 
1.6.1. DNA Directed Self Assembly of Virus Capsids with Nanoscale 
Precision. In this project, we reported a strategy of using DNA origami as a scaffold to 
arrange spherical virus capsids into one-dimensional arrays with precise nanoscale 
positioning. To do this, we first modified the interior surface of bacteriophage MS2 
capsids with fluorescent dyes as a model cargo. An unnatural amino acid on the external 
surface was then coupled to DNA strands that were complementary to those extending 
from origami tiles. Two different geometries of DNA tiles (rectangular and triangular) 
were used. The capsids associated with tiles of both geometries with virtually 100% 
efficiency under mild annealing conditions, and the location of capsid immobilization on 
the tile could be controlled by the position of the probe strands. The rectangular tiles and 
16 
 
capsids could then be arranged into one-dimensional arrays by adding DNA strands 
linking the corners of the tiles. The resulting structures consisted of multiple capsids with 
even spacing (∼100 nm). We also used a second set of tiles that had probe strands at both 
ends, resulting in a one-dimensional array of alternating capsids and tiles. This 
hierarchical self-assembly allows us to position the virus particles with unprecedented 
control and allows the future construction of integrated multicomponent systems from 
biological scaffolds using the power of rationally engineered DNA nanostructures. 
1.6.2. Organization of GOx/HRP Cascade Using DNA Origami and the Study 
of Interenzyme Substrate Diffusion. In this project we organized discrete glucose 
oxidase (GOx)/ horseradish peroxidase (HRP) enzyme pairs on DNA origami tiles with 
controlled interenzyme spacing and position. The distance between enzymes was 
systematically varied from 10 to 65 nm, and the corresponding activities were evaluated. 
The study revealed two different distance-dependent kinetic processes associated with the 
assembled enzyme pairs. Strongly enhanced activity was observed for those assemblies 
in which the enzymes were closely spaced, while the activity dropped dramatically for 
enzymes as little as 20 nm apart. Increasing the spacing further resulted in a much weaker 
activity dependence on distance. Combined with diffusion modeling, the results suggest 
that Brownian diffusion of intermediates in solution governed the variations in activity 
for more distant enzyme pairs, while dimensionally limited diffusion of intermediates 
across connected protein surfaces contributed to the enhancement in activity for closely 
spaced GOx/HRP assemblies. To further test the role of limited dimensional diffusion 
along protein surfaces, a noncatalytic protein bridge was inserted between GOx and HRP 
17 
 
to connect their hydration shells. This resulted in substantially enhanced activity of the 
enzyme pair. 
1.6.3. A DNA Tweezer-like Responsive Enzyme Nanoreactor. In this project, a 
tweezer-like DNA nanodevice was designed and constructed to actuate the activity of an 
enzyme/cofactor pair. A dehydrogenase and the corresponding NAD
+
 cofactor were 
attached to different arms of the DNA tweezer structure and actuation of enzymatic 
function was achieved by switching the tweezers between open and closed states. The 
enzyme/cofactor pair is spatially separated in the open state which leads to inhibition of 
enzyme function, while in the closed state the activity of the enzyme is enhanced by the 
close proximity of the two molecules. The conformational state of the DNA tweezers is 
controlled by the addition of specific oligonucleotides that served as the thermodynamic 
driver (fuel) to trigger the change. Using this approach, several cycles of externally 
controlled enzyme inhibition and activation were successfully demonstrated. This 
principle of responsive enzyme nanodevices may be used to regulate other types of 
enzymes and to introduce feedback or feed-forward control loops. 
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Chapter 2 
DNA-Directed Self Assembly: Immobilization and 1D Arrangement of Virus 
Capsids with Nanoscale Precision Using DNA Origami 
Adapted with permission from Stephanopoulos, N.; Liu, M.; Tong, G.; Li, Z.; Liu, Y.; 
Yan, H.; Francis, M. B. Immobilization and One-Dimensional Arrangement of Virus 
Capsids with Nanoscale Precision Using DNA Origami. Nano Lett. 2010, 10, 2714-2720. 
Copyright 2010 American Chemical Society.; and from Li, Z.; Liu, M.; Wang, L.; 
Nangreave, J.; Yan, H.; Liu, Y. Molecular Behavior of DNA Origami in Higher Order 
Self-assembly. J. Am. Chem. Soc. 2010, 138, 13545-13552. Copyright 2010 American 
Chemical Society. 
2.1. Abstract 
In this chapter, we report a strategy of using DNA origami as a scaffold to arrange 
spherical virus capsids into one-dimensional arrays with precise nanoscale positioning. 
To do this, we first modified the interior surface of bacteriophage MS2 capsids with 
fluorescent dyes as a model cargo. An unnatural amino acid on the external surface was 
then coupled to DNA strands that were complementary to those extending from origami 
tiles. Two different geometries of DNA tiles (rectangular and triangular) were used. The 
capsids associated with tiles of both geometries with virtually 100% efficiency under 
mild annealing conditions, and the location of capsid immobilization on the tile could be 
controlled by the position of the probe strands. The rectangular tiles and capsids could 
then be arranged into one-dimensional arrays by adding DNA strands linking the corners 
of the tiles. The resulting structures consisted of multiple capsids with even spacing 
(∼100 nm). We also used a second set of tiles that had probe strands at both ends, 
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resulting in a one-dimensional array of alternating capsids and tiles. This hierarchical 
self-assembly allows us to position the virus particles with unprecedented control and 
allows the future construction of integrated multicomponent systems from biological 
scaffolds using the power of rationally engineered DNA nanostructures. 
2.2. Introduction 
Self-assembly has proven to be one of the most effective ways to arrange matter 
at the nanometer level. Biology, in particular, makes extensive use of self-assembly to 
position molecules over several length scales with a high degree of spatial control over 
structure. In recent years, one promising approach that takes advantage of biological self-
assembly in order to build synthetic materials employs virus capsids, the protein shells 
that encapsulate the genetic material of viruses.
1, 2
 Capsids are composed of multiple 
protein subunits that can assemble (either spontaneously or under an external stimulus) 
into a monodisperse structure with different geometries depending on the virus. By 
appropriately functionalizing the proteins that comprise the capsid, multiple copies of a 
molecule or other entity can be positioned with a predictable arrangement. A wide variety 
of components have been attached to and arranged by virus capsids, including 
chromophores,
3-8
 catalysts,
9, 10
 nanoparticles and quantum dots,
11-15
 polymers,
16-18
 drug 
molecules,
19-22
 and imaging agents.
23-25
  
Integrating virus capsid-based materials into higher-order structures, however, 
remains a challenge and a limitation to their use in many materials applications. A 
number of groups have investigated various techniques for patterning capsids on larger 
length scales, including cysteine conjugation to gold surfaces to create a monolayer of 
capsids,
26
 DNA-based aggregation of functionalized capsids,
27
 and dip-pen 
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nanolithography
28
 or nanografting
29
 to introduce patterns of reactive handles on surfaces 
for virus immobilization. It is difficult to use these methods, however, to control the 
inter-capsid spacing and position individual capsids with nanoscale precision. 
2.3. Experimental Design 
In order to achieve nanoscale precise control, we sought a scaffold that could 
selectively and efficiently immobilize virus capsids and order them into hierarchical 
structures, and we chose DNA origami
30
 for this purpose. In this method, a long single-
stranded piece of DNA (usually the bacteriophage M13 genome) is folded into an 
arbitrary two-dimensional shape using a large number of short “staple” strands. The 
predictable and programmable properties of DNA hybridization allow for a high degree 
of control and the design of virtually any geometry desired. Furthermore, it is possible to 
synthesize staple strands that contain an extra single-stranded “probe” sequence that 
extends from the origami structure. The addition of components functionalized with 
DNA complementary to the probes allows for their immobilization on the origami tile 
with a high degree of spatial control. It should also be possible to create higher order 
structures by adding linker strands to connect the origami tiles together. As a final 
consideration, the size scale of DNA origami (∼100 nm) is compatible with that of many 
virus capsids, facilitating the integration of the two components, unlike other DNA-based 
scaffolds that are too small to effectively order such large objects.  
DNA origami has been used effectively to direct the self-assembly of nanoscale 
objects such as gold
31, 32
 and silver
33
nanoparticles, RNA molecules,
34
 or carbon 
nanotubes
35
 with exquisite precision. In addition, several groups have immobilized small 
proteins on origami tiles using a variety of approaches, including aptamer binding,
36,37
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His6 tags,
38
 or biotin-streptavidin.
39
 Our work represents the first attempt, to our 
knowledge, to attach a large, multiprotein entity like a virus onto an origami tile. For the 
capsid, we chose bacteriophage MS2, an icosahedral E. coli virus comprised of 180 
identical protein subunits that spontaneously assemble into spherical particles 27 nm in 
diameter.
40-42
 The coat protein can be expressed recombinantly, allowing for site-directed 
mutagenesis, and is purified as a fully assembled capsid devoid of genetic material. 
Access to the interior is afforded by 32 holes with 2 nm in diameter allowing for 
orthogonal functionalization of the interior and exterior surfaces by modifying the 
appropriate amino acid residues. 
43, 9
 As a result, these capsids are attractive targets as 
molecular containers or scaffolds for multiple copies of different components.  
People have reported a method to modify the inside of the capsid with maleimide 
reagents (at a mutagenically introduced cysteine) and the exterior of the capsid with 
single-stranded DNA using an oxidative coupling reaction that targets an unnatural amino 
acid introduced via amber codon suppression (Figure 2.1.A).
43,44
 By functionalizing the 
exterior of the capsid with DNA complementary to single-stranded probes extending 
from the DNA origami construct, the capsids should be able to bind the origami tile via 
Watson-Crick base pairing. For this work, we modified the interior of MS2 with a 
fluorescent dye (Oregon Green maleimide, as previously reported
9
) to approximately 
100% modification, installing 180 copies of the molecule. In these experiments, the dye 
serves as a model cargo; in principle, however, any maleimide reagent that can fit 
through the 2 nm holes can be introduced. We next modified the exterior of the capsids 
with a 20-nt poly-T sequence to ∼11% modification, installing approximately 20 copies 
per capsid. The capsids remained intact, hollow, and 27 nm in diameter after both interior 
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and exterior modification (see APPENDIX A for characterization of the dual-surface 
modified MS2 conjugate). 
For the DNA origami tile, to improve the one-dimensional array, we utilized a 
new design for the rectangular-shaped DNA origami that was intended to relieve the 
deformation present in Rothemund’s original design (see APPENDIX A for design of the 
zigzag DNA origami). Here we explored two different geometries: (1) rectangles, 90 nm 
in length by 60 nm in width, and (2) equilateral triangles, 120 nm on a side with a 40 nm 
triangular hole in the center. For the rectangles, we placed probes on either the edge (E) 
or middle (M) of the tile in order to demonstrate control over the exact location of the 
immobilized capsid on the tile. Similarly, for the triangles, we added probes either to one 
side (Tri1) or to all three sides (Tri3). The probes consisted of a 40-nt poly-A sequence, 
allowing the capsids with the 20-nt poly-T sequence to bind via cDNA pairing. We 
selected a 40-nt sequence in order to also provide a spacer between the negatively 
charged tile and the negatively charged capsid-DNA conjugate in order to reduce 
electrostatic and steric repulsion as much as possible. The multiple probe strands on each 
tile (3 for E tiles, 5 for Tri1 tiles, 6 for M tiles, and 15 for Tri3 tiles; see APPENDIX A 
for tile designs and probe locations), and the multiple complementary strands on the 
capsids allow for multivalent binding and thus stronger association of the two 
components. 
2.4. Materials and Methods 
See APPENDIX A 
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Figure 2.1. Summary of the components integrated in this work. (A) Bacteriophage MS2 
capsids were modified on the interior with fluorescent dyes and on the exterior surface 
with single-stranded DNA (ssDNA). (B) Several different DNA origami tiles were 
constructed with different geometries and probe locations. The ssDNA probes were 
complementary to the DNA strands on the capsids, directing the association of the two 
components.  
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2.5. Results and Discussion 
2.5.1. Association of Single Origami Tiles with MS2 Capsids Using DNA 
Based Hybridization. In order to attach the capsids to the tiles, we mixed the 
components in a 2:1 ratio and annealed the mixture from 37 to 4 °C at a rate of 1 °C/min 
to help facilitate binding. The DNA origami templated viral capsid structures were 
verified by atomic force microscopy (AFM), allowing us to distinguish the tile shape 
from the much taller spherical capsid. To determine the efficiency of tile association with 
capsids, a large number of AFM images were inspected to determine the fraction of tiles 
with capsids bound to them.  
 
Figure 2.2. Single rectangular tiles with MS2 attached. (A) E tiles + MS2 (left to right): 
zoom-out AFM image, zoom-in AFM image, height profile of zoom-in image, and 
characterization of association efficiency. (B) M tiles + MS2 (left to right): zoom-out 
AFM image, zoom-in AFM image, height profile of zoom-in image, and characterization 
of association efficiency. Zoom-out scale bars, 200nm. Zoom-in scale bars, 50nm. 
Figure 2.2 demonstrates that after annealing, the rectangular tiles showed virtually 
complete association of tiles with capsids, with 97.5% of E tiles and 98.1% of M tiles 
bearing an MS2 capsid. For the E tiles, the capsids were clearly attached to the edge of 
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the tile, where the probes were located. Similarly, for the M tiles the capsids were located 
in the middle of the tile, demonstrating the DNA-specific association and the ability to 
position the capsids precisely. Analyzing the height profile of a capsid on a tile 
demonstrated a spherical object around 35 nm in diameter (slightly larger than the 27 nm 
diameter of the capsid, due to lateral broadening by the AFM tip) attached on the origami 
tile 1.5-2 nm in height, as expected for the width of the DNA double helix. The height of 
the capsids was around 12 nm, resulting from the collapse and concomitant flattening of 
the hollow structure on the mica surface used for AFM. 
Because the capsids display approximately 20 copies of the single-stranded DNA 
(ssDNA), multiple tiles can, in principle, bind to a single capsid. Roughly 18% of the E 
tiles were associated with a capsid already bound to a tile, whereas about 10% of the M 
tiles showed similar aggregation. This disparity between the designs is not surprising 
given that there is less surface area exposed and thus less electrostatic repulsion when 
two tiles approach one another from the side, as is the case with the E tiles, compared to 
face-on, as with the M tiles. 
Using only 1 equivalent of MS2 (relative to the tile) resulted in around 89% of E 
tiles and only 70% of M tiles bearing a capsid. The higher efficiency of association for E 
tiles is again consistent with a lower amount of charge repulsion involved in an edge-on 
approach of the tile to the capsid. Because the origami tiles serve as the structural 
element to arrange the capsids, we wanted complete modification of the tiles with 
capsids, so we used 2 equivalent of MS2 for all further experiments. Current studies are 
under way to determine a method to purify MS2 not associated with a tile from the 
desired tile-capsid conjugates.  
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Control experiments with capsids without DNA showed no association with the 
tiles, indicating that the association was not due to some other nonspecific effect (see 
APPENDIX A). Similarly, mixing tiles bearing DNA that did not complement the 
sequences on the capsids also showed no significant association of the two components 
(see APPENDIX A). Furthermore, binding capsids to the tiles and then adding excess 40-
nt poly-T ssDNA (which should bind to the 40-nt polyA probe with greater affinity than 
the 20-nt sequence on the MS2) removed the capsids from the tile (see APPENDIX A). 
This experiment not only confirmed the specific DNA-based association but also 
indicates a potential mechanism for releasing the capsids from the tiles if desired. 
Figure 2.3 shows that the triangular tiles proved equally efficient at binding 
capsids as the rectangular tiles. Exposing the Tri1 tiles to 2 equivalent of MS2 and 
annealing as above resulted in virtually 100% association of capsids to the tiles. The 
capsids are bound to a single side of the triangular tile, and the hole in the center is 
clearly visible by AFM. The triangular shape of the tiles allowed facile visualization by 
transmission electron microscopy (TEM) as well, and the electron micrographs further 
confirm the association of the capsids to a single side of the triangular tile.  
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Figure 2.3. Single triangular tiles with MS2 attached. (A) Tri 1 tiles + MS2 (left to 
right): zoom-out AFM image, zoom-in AFM image, zoom-out TEM image, zoom-in 
TEM image. (B) Tri 3 tiles + MS2 (left to right): zoom-out AFM image, zoom-out TEM 
image, zoom-in TEM image. Zoom-out scale bars, 200nm. Zoom-in scale bars, 50nm. 
The Tri3 tiles showed a similarly high hybridization efficiency (∼100%), but in 
this design anywhere between one and three capsids can bind to each tile. The majority of 
samples visualized by AFM and TEM, however, showed a single capsid bound in the 
central hole of the tile (Figure 2.3B). We believe that once the capsid binds to one side of 
the triangular tile, the extra DNA strands on its surface quickly hybridize to the probes on 
the other two sides due to the increased local concentration effect. This hypothesis is 
supported by the fact that the sides of the Tri3 tiles appear to be contracted toward the 
center, suggesting that the capsid (which is smaller than the 40 nm hole in which it sits) 
pulls the sides inward by binding to all three. Some Tri3 tiles were observed bearing one 
capsid on a single side (instead of in the hole), one capsid on each of two sides, or one 
capsid on each of three sides (see APPENDIX A), but the majority of the tiles visualized 
showed a single capsid in the center. 
It is important to note that the polyA/T strategy used was necessary for obtaining 
the high efficiency of capsid association in these results. Similar experiments using a 
randomly chosen DNA sequence resulted in only around 50% association of capsids with 
E tiles (see APPENDIX A), and increasing the amount of MS2 added or the annealing 
time did not result in increased efficiency. We believe that the polyA/T strategy is 
particularly effective because the strands on the MS2 can bind only one or two bases of 
the probe initially and then “slide” along the probe to find the thermodynamically 
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optimum conformation. 
45
 Furthermore, different strands on the capsid can bind the probe 
strand with less than 20 base pairs, promoting multivalent binding without requiring 
complete hybridization. Although it would seem that the polyA/T strategy will only allow 
for one type of capsid to be immobilized, we believe that any short repeating sequence 
would allow for a similar “sliding” mechanism and thus efficient binding. This would 
allow multiple types of capsids, bearing different groups on the interior, for example, to 
be patterned. 
2.5.2. Formation and Distribution of One-Dimensional MS2 Arrays. Having 
successfully immobilized capsids on origami tiles with high efficiency, we next sought to 
use the DNA scaffold to organize the capsids on a larger length scale. As a proof of 
principle, we decided to create a one-dimensional array of capsids by linking the 
supporting origami tiles together. We designed two sets of strands, each of which partly 
binds to the M13 genome on opposite corners of the rectangular origami tile. These two 
sets contain complementary sequences, linking tiles at their corners and arranging them 
in a step-like array. We hypothesized that we could use this method with the E and M 
tiles to create a one-dimensional array of capsids with defined nanoscale separation. 
Mixing the tiles (E or M), capsids, and linkers together and annealing from 37 to 4 
°C at a rate of 1 °C/min resulted in the expected arrays of tiles while retaining the 
virtually 100% association efficiency of the capsids (Figure 2.4). The AFM images 
clearly show a one-dimensional arrangement of capsids either on the edge or in the 
middle of the tiles (for E and M tiles, respectively) separated by approximately 100 nm. 
About 50% of the tiles formed arrays of at least two tiles, and the percentage of tiles in a 
given array decreased with increasing length (see APPENDIX A for length distributions). 
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Figure 2.4. AFM images of MS2 arrays formed by origami tiles: one-pot annealing and 
step-wise annealing. (A) E tiles + MS2 + linkers (one-pot annealing) and E tiles + MS2, 
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followed by the addition of linkers in a second step. (B) M tiles + MS2 + linkers (one-pot 
annealing) and M tiles + MS2, followed by the addition of linkers in a second step. The 
top image of the three zoom-ins corresponds to the indicated area of the zoom-out; the 
other two zoom-in images come from different areas (see APPENDIX A for additional 
zoom-out images). Zoom-out scale bars, 500 nm. Zoom-in scale bars, 200 nm. 
However, we occasionally observed arrays of five or six tiles, all the while 
maintaining the spacing between the capsids. Doubling the linker concentration resulted 
in a higher proportion of tiles in arrays (∼60%). It was also possible to create the arrays 
in a hierarchical, rather than one-pot, procedure by annealing the capsids to the tiles first 
and then adding the linkers to form arrays in a second annealing step. Once again, arrays 
formed readily, though slightly fewer tiles (∼45%) were in arrays greater than two. This 
decrease is likely due to the increased steric or electrostatic demands of linking tiles with 
capsids already bound (see APPENDIX A for summaries of the percentage of tiles in 
arrays two tiles or greater). 
Because the E tiles experience less repulsion when two tiles bind a single capsid 
compared to the M tiles (Figure 2.2), we saw numerous instances of two E tile arrays that 
were linked by one set of capsids (see Figure 2.4A, top zoom-in). Also, once a single tile 
in an E-tile array binds a capsid on another array, the other tiles are perfectly positioned 
to bind adjacent capsids. The M tile arrays, by comparison, do not suffer as much from 
these drawbacks and result in structures with markedly less inter-array aggregation.  
We also formed arrays of E and M tiles without any MS2 in order to compare the 
efficiency of the process with and without the capsids present. We found that in both 
cases a higher proportion of tiles were incorporated into arrays (65-68% compared to 
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∼50% for arrays with MS2) and that the arrays tended to be longer, with a few instances 
of eight or nine tiles in a row (see APPENDIX A for AFM images of arrays without MS2 
and length distributions). We attribute this improvement to the decreased steric and 
electrostatic repulsion between tiles when capsids were not present. 
In light of these results, we sought to first form longer arrays with tiles alone, and 
then in a second step add capsids to bind to the probes on the arrays. With the E tiles, this 
strategy resulted in a great degree of inter-array aggregation, as multiple arrays were 
connected by a single set of capsids. As a result, very few single arrays were observed, 
and a majority of arrays clumped together into amorphous aggregates (data not shown). 
The M tiles, by contrast, proved much more effective for this strategy due to their 
lower propensity to form aggregates. In Figure 2.5A, long arrays of capsids, occasionally 
reaching nine or ten capsids in length, were observed. Furthermore, because the linkers 
were still present in solution during the second annealing step (to attach the capsids to the 
arrays), the arrays were able to grow yet longer and incorporate even more tiles into 
arrays of two tiles or longer (∼75% as shown in Figure 2.5A bottom). Unlike the one-pot 
annealing results, however, doubling the concentration of linkers did not result in 
increased array lengths or an increased percentage of tiles in arrays. 
The hierarchical self-assembly in forming the E and M tile arrays is a competition 
between productive assembly (the capsids associating with the tiles and the tiles forming 
arrays) and unproductive assembly (multiple tiles binding to a single capsid, resulting in 
aggregation). Annealing for a longer time (1 °C/2 min) resulted in a much higher degree 
of aggregation and significantly fewer well-formed arrays. 
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Figure 2.5. AFM images of MS2 arrays and distributions. (A) M tiles + linkers, then 
addition of MS2 in a second step. (B) DC tiles + MS2 + edge staples (to encourage tile 
edge stacking). The top image of the three zoom-ins corresponds to the indicated area of 
the zoom-out; the other two zoom-in images come from different areas (see APPENDIX 
A for additional zoom-out images). Zoom-out scale bars, 500 nm. Zoom-in scale bars, 
200 nm. 
Furthermore, although it was possible to create remarkably long arrays by 
annealing the tiles only (without MS2) for much greater lengths of time (45 to 4 °C at a 
rate of 1 °C/10 min), the resulting arrays were too flexible, and upon addition of MS2 
different sections of the arrays folded back on themselves and bound to a single capsid, 
again resulting in undesired and intractable aggregates. 
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The E tiles demonstrated the facility of binding multiple tiles to a single capsid 
when the probes are located at the edge of the tile. Although this was a liability in the 
linker based array formation, we decided to capitalize on this property by designing 
another rectangular tile with a set of five 40-nt poly-A probes on both short ends (see 
APPENDIX A). We envisioned that this design would allow for two tiles to be linked by 
a single capsid, creating a “daisy-chain” (DC) array of alternating capsids and tiles. In 
order to promote association of the tiles further via noncovalent base stacking 
interactions, we added the staple strands for the short edges of the tiles into the annealing 
mixture. We hypothesized that this stacking would pre-organize the tiles into short linear 
arrays, further facilitating the capsids in linking them.  
Annealing a mixture of DC tiles, capsids (again, 2 equivalent), and edge staples 
from 37 to 4 °C at a rate of 1 °C/min resulted in the expected formation of arrays of tiles 
linked by capsids, with approximately 90-100 nm spacing between capsids (Figure 2.5B). 
The efficiency was remarkably high, with only a small fraction of tile edges (∼6%) that 
were not associated with a capsid. The length distribution of arrays peaked at three 
capsids in a row (separated by two tiles) and decreased thereafter, but some arrays of 10 
or more capsids were observed (Figure 2.5B bottom). Occasionally, three or four tiles 
bound to a single capsid resulting in branching arrays; however, only a small fraction of 
capsids (∼5%) served as such branching points, and the vast majority bound only two 
tiles. The arrays usually formed in a linear fashion (most likely to minimize repulsion 
between tiles), but because the tiles could bind to any location on the capsid, occasionally 
the tiles bound the capsids with an angle less than 180°, resulting in kinks in the arrays. 
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Omitting the edge staples resulted in shorter arrays (data not shown), indicating the 
usefulness of these staples in promoting array formation.  
 
Figure 2.6. TEM images of DC tile arrays formed with MS2. The arrays most likely 
adsorb to the grid with the tiles sideways, making them appear as lines connecting the 
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capsids. In addition to illustrating the arrays, these images confirm that the capsids are 
intact, hollow, and 27 nm in diameter. Scale bars: 50 nm 
We note that the DC tile design represents a complementary approach to forming 
capsid arrays compared to the linker-based approach for the E and M tiles. In the latter 
case, an external stimulus (i.e., the addition of the linker strands) induces assembly into 
higher-order structures, whereas in the former case the actual capsid binding event is the 
stimulus for array growth through a condensation polymerization-like mechanism. 
Depending on the application at hand, one strategy or the other may prove more useful. 
(For additional AFM images of all experiments shown in Figure 2.4 and 2.5, see 
APPENDIX A.) 
In order to further characterize the conjugates, we obtained TEM images of both 
the M and DC tile arrays. Although the rectangular tiles are not easily visualized in TEM, 
we were able to obtain images that clearly showed the hollow capsids spaced 
approximately 100 nm apart. The arrays most often adsorbed to the TEM grid edge-on, 
so the tiles appeared as dark lines connecting the capsids. The tiles were often twisted 
when deposited on the TEM grid, but these results further confirm that the capsids 
remained intact during the array formation. 
2.6. Conclusion 
One of the great advantages of our approach lies in its versatility due to the 
modular nature of the capsid modification and the high degree of programmability 
intrinsic to DNA-based nanostructures. By choosing the appropriately designed tile, 
virtually any geometry is possible, and the capsids can be placed in any location on that 
tile. Furthermore, the interior of the capsid can be modified with a wide variety of 
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reagents, allowing for introduction of imaging agents, catalysts, or nucleation sites for 
nanoparticle growth. The one-dimensional arrays made possible by the origami tiles thus 
create the possibility of patterning arrays of nanoscale reactors, drug carriers (with 
programmed release by strand displacement) or metal particles for plasmonic arrays, all 
with high precision. 
Finally, we stress the size and complexity of the components involved in these 
experiments. The MS2 capsids are 2.5 MDa, spherical objects 27 nm in size, self-
assembled from 180 protein monomers, covered in ssDNA, and containing chromophores 
inside on each monomer at specified locations. The DNA origami tiles are 4.8 MDa 
objects with dimension around 100 nm, comprised of hundreds of individual DNA 
strands self-assembled into a well-defined geometry. Yet these two components come 
together in a predictable manner, with high efficiency and specificity, under mild 
conditions in only 30 min. Furthermore, the conjugates can then be used to build higher 
order structures approaching a micrometer in length (for arrays of ten tiles, for example). 
We believe that the programmability of origami scaffolds and the ability to modify large 
protein constructs with single-stranded DNA will allow for the construction of 
increasingly complex and integrated biomolecular systems in the future, and pave the 
way for a variety of interesting nanotechnology applications. 
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Chapter 3 
Organization of Multienzyme Reaction Pathways: Interenzyme Substrate Diffusion 
for an Enzyme Cascade Organized on Spatially Addressable DNA Nanostructures 
Adapted with permission from Fu, J.; Liu, M.; Liu, Y.; Woodbury, N. W.; Yan, H. 
Interenzyme Substrate Diffusion for an Enzyme Cascade Organized on Spatially 
Addressable DNA Nanostructures. J. Am. Chem. Soc. 2012, 134, 5516-5519. Copyright 
2012 American Chemical Society. 
3.1. Abstract 
Spatially addressable DNA nanostructures facilitate the self-assembly of 
heterogeneous elements with precisely controlled patterns. In this chapter we organized 
discrete glucose oxidase (GOx)/ horseradish peroxidase (HRP) enzyme pairs on specific 
DNA origami tiles with controlled interenzyme spacing and position. The distance 
between enzymes was systematically varied from 10 to 65 nm, and the corresponding 
activities were evaluated. The study revealed two different distance-dependent kinetic 
processes associated with the assembled enzyme pairs. Strongly enhanced activity was 
observed for those assemblies in which the enzymes were closely spaced, while the 
activity dropped dramatically for enzymes as little as 20 nm apart. Increasing the spacing 
further resulted in a much weaker distance dependence. Combined with diffusion 
modeling, the results suggest that Brownian diffusion of intermediates in solution 
governed the variations in activity for more distant enzyme pairs, while dimensionally 
limited diffusion of intermediates across connected protein surfaces contributed to the 
enhancement in activity for closely spaced GOx/HRP assemblies. To further test the role 
of limited dimensional diffusion along protein surfaces, a noncatalytic protein bridge was 
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inserted between GOx and HRP to connect their hydration shells. This resulted in 
substantially enhanced activity of the enzyme pair. 
3.2. Introduction 
Cellular activities are directed by complex, multienzyme synthetic pathways that 
exhibit extraordinary yield and specificity. Many of these enzyme systems are spatially 
organized to facilitate efficient diffusion of intermediates from one protein to another by 
substrate channeling
1, 2 
and enzyme encapsulation.
3, 4
 Understanding the effect of spatial 
organization on enzymatic activity in multienzyme systems is not only fundamentally 
interesting, but also important for translating biochemical pathways to noncellular 
environments. Despite the importance, there are very few methods available to 
systematically evaluate how spatial factors (e.g., position, orientation, enzyme ratio) 
influence enzymatic activity in multienzyme systems. 
DNA nanotechnology has emerged as a reliable way to organize nanoscale 
systems because of the programmability of DNA hybridization and versatility of DNA-
biomolecule conjugation strategies.
5-7
 The in vitro and in vivo assembly of several 
enzymatic networks organized on two-dimensional DNA and RNA arrays
8, 9
 or simple 
DNA double helices
10, 11
 has led to the enhancement of catalytic activities. Nevertheless, 
the nucleic acid scaffolds used in these studies are limited in their ability to study spatial 
parameters in multienzyme systems because of the lack of structural complexity. The 
development of the DNA origami method
12
 provides an addressable platform upon which 
to display nucleic acids or other ligands, permitting the precise patterning of multiple 
proteins or other elements.
13
 In this chapter we report a study of the distance-dependence 
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for the activity of glucose oxidase (GOx)/horseradish peroxidase (HRP) cascade by 
assembling a single GOx/HRP pair on a discrete, rectangular DNA origami tile. 
3.3. Materials and Methods 
3.3.1. Chemicals. See APPENDIX B  
3.3.2. Protein-DNA Conjugation. SPDP was used to crosslink GOx and HRP 
with DNA strands. GOx was linked to Poly(T)22 (5’-HS-
TTTTTTTTTTTTTTTTTTTTTT-3’) and HRP was linked to Poly(GGT)6 (5’-HS-
TTGGTGGTGGTGGTGGTGGT-3’).  
 
Figure 3.1. Protein-DNA conjugation using a SPDP crosslinker (GOx demonstrated). 
As shown in Figure 3.1, 100 μl of 40 μM enzyme solution was first reacted with a 
20-fold excess of SPDP in 1×PBS (pH 8) for two hours, allowing amine-reactive N-
hydroxysuccinimide (NHS) esters to react with the lysine residues on the protein surface. 
Excess SPDP was removed by washing, and filtered using Amicon 30 kD cutoff filters. 
Next, SPDP-modified protein was conjugated to thiolmodified DNA (10-fold excess) 
through a disulfide bond exchange of the activated pyridyldithiol group. The reaction 
mixture was incubated in 1×PBS (pH 8) for two hours. The coupling efficiency was 
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evaluated by monitoring the increase in absorbance at 343 nm due to the release of 
pyridine-2-thione (extinction coefficient: 8080 M
-1
 cm
-1
) as shown in Figure 3.2.  
 
Figure 3.2. Quantification of protein-DNA conjugation efficiency via absorbance 
spectra. (A) HRP-poly(GGT)6 conjugation: ∆A343 before and after poly(GGT)6 
conjugation is ~ 0.266 (extinction coefficient: 8080 M-1 cm-1), corresponding to 33 μM 
poly(GGT)6 coupled with 19 μM HRP (ε=100000 M
-1
 cm
-1
 at 403 nm for HRP). (B) 
GOx-poly(T)22 conjugation: ∆A343 before and after poly(T)22 conjugation is ~ 0.8352, 
corresponding to 100 μM poly(T)22 coupled with 18 μM GOx (ε=28200 M-1 cm-1 at 452 
nm for GOx). GOx has ~ 30 lysine residues, resulting in a higher ratio of DNA-protein 
conjugates. 
Finally, the excess DNA was removed by washing, and filtered using Amicon 30 
kD cutoff filters (see APPENDIX B). The enzymatic activities of DNA-modified GOx 
and HRP were ~ 75% of the activities of the unmodified enzymes (Figure 3.3). 
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Figure 3.3. Enzyme activity vs. concentration for both DNA-modified GOx/HRP 
cascades and unmodified enzymes. 
3.3.3. DNA Origami Preparation. Rectangular DNA origami tiles were prepared 
in 1×TAE-Mg
2+
 buffer (40 mM Tris, 20 mM acetic acid, 2 mM EDTA and 12.5 mM 
magnesium acetate, pH 8.0) using established protocols.
14
 For each sample, 20 nM 
single-stranded M13mp18 DNA (7249 nucleotides) was mixed with a 5-fold molar 
excess of staple stands and a 10-fold molar excess of probe strands. The mixture was 
annealed from 95 ºC to 4 ºC with the temperature gradient for ~ 10 hours. The excess 
staple strands were removed by repeated (3 times) washing in 1×TAE-Mg
2+
 buffer (pH 
7.5) and filtered using 100 kD 500 μL Amicon filters. The purity of the origami tiles was 
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analyzed by agarose gel electrophoresis. The concentration of the DNA origami tiles was 
quantified by absorbance at 260 nm, assuming an extinction coefficient of ~ 109119009 
M
-1
cm
-1
. For detailed sequence design, please see APPENDIX B.
 
3.3.4. GOx/HRP Co-assembly on DNA Origami Tiles. GOx-poly(T) and HRP-
poly(GGT) were mixed with DNA origami tiles in 1×TAE-Mg2
+
 buffer (pH 7.5) with a 
molar ratio of 3:1. The solution mixture was cooled from 37°C to 4°C with the following 
temperature gradient: 37°C for 5 min; 36-10°C, 2 min per degree; 4°C for storing the 
solution. 
3.3.5. Enzyme Assay. 10 nM GOx-HRP origami tiles were diluted to 1 nM for 
activity assays, which were performed on a SpectraMax M5 96 well plate reader 
(Molecular Device, Sunnyvale, CA). GOx-HRP cascade activity was measured in 1×TBS 
(tris buffered saline, pH 7.5) and 1 mM MgCl2 in presence of 1 mM Glucose and 2 mM 
ABTS by monitoring the increase in absorbance at 410 nm. At least three replicates of 
each sample were measured. 
3.4. Results and Discussion 
3.4.1. DNA Origami-directed Coassembly of GOx and HRP enzymes with 
Control over Interenzyme Distances. The DNA-directed co-assembly of GOx and HRP 
on DNA origami tiles is illustrated in Figure 3.4A. The DNA-conjugated rectangular 
DNA origami tiles (∼60 × 80 nm) by hybridizing with the corresponding complementary 
strands displayed on the surface of the origami scaffolds. Four different rectangular 
origami tiles were prepared with interenzyme probe distances (distance between two 
protein-binding sites) of 10 nm (S1), 20 nm (S2), 45 nm (S3), and 65 nm (S4). To 
achieve high coassembly yields of the GOx/HRP pairs, a 3-fold excess of enzymes were 
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incubated with the DNA tiles. The coassembly of the GOx/HRP cascade was visualized 
using AFM imaging of DNA nanostructures. The presence of a protein results in a higher 
region than the surrounding surface of the origami tile (see APPENDIX B for height 
profiles). Most origami tiles were deposited on the mica surface with the protein 
decorated side facing up, likely because of the strong interaction (charge or stacking) of 
the opposite flat side with the mica surface. 
 
Figure 3.4. DNA nanostructure-directed coassembly of GOx and HRP enzymes with 
control over interenzyme distances. (A) The assembly strategy and details of the 
GOx/HRP enzyme cascade. (B) Rectangular DNA origami tiles with assembled 
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Gox/HRP pairs spacing from 10 to 65 nm. GOx/HRP coassembly yields were determined 
from AFM images as shown in the bottom panel. Scale bar: 200 nm. 
As shown in Figure 3.4B, high coassembly yields of GOx/HRP pairs on DNA 
origami tiles were achieved for longer interenzyme distances, with ∼95% for S3 (45 nm) 
and ∼93% for S4 (65 nm). For shorter distances, the coassembly of GOx/HRP pairs was 
less efficient because of the steric hindrance between two nearby enzymes, with ∼45% 
for S1 (10 nm) and ∼77% for S2 (20 nm). To rule out any nonspecific absorption of the 
enzymes to the tile surfaces, a control experiment was performed where tiles without any 
nucleic acid probes (C1) were incubated with DNA modified GOx and HRP, and no 
binding of the enzymes to the tiles was observed. 
3.4.2. Spacing Distance-dependent Effect of Assembled GOx/HRP Pairs. The 
activities of the enzyme complexes, containing all components of GOx/HRP coassembled 
on DNA tiles, unbound enzymes and free DNA tiles were measured in the presence of 
substrates glucose and ABTS
2−
 by monitoring the increase in absorbance at 410 nm 
(Figure 3.5A). The S1 (10 nm) tile solution exhibited the highest enzyme activity, which 
was more than 2 times greater than the activity of the S2 (20 nm) tile solution (Figure 
3.5B), even though the coassembly yield of GOx/HRP pairs was significantly lower for 
S1 tiles. Increasing the distance between GOx and HRP from 20 to 65 nm resulted in a 
small decrease in the raw enzyme activity (∼10%). A similar distance-dependent trend in 
activity was also observed in additional interenzyme distance-dependence studies using a 
different attachment scheme (see APPENDIX B). All samples containing assembled 
GOx/HRP tiles exhibited higher activities than unassembled enzyme controls, 
demonstrating how arranging the enzymes in close proximity results in enhanced activity. 
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Further, the control solutions (with free enzymes and unbound DNA tiles) had similar 
activities as free enzymes without any DNA nanostructures, confirming that a DNA-
nanostructure environment does not affect enzyme activity under the conditions used.  
Both the raw activity (uncorrected for the yield of the completely assembled 
nanostructures) and yield-corrected activity are shown. The activity correction for 
assembly yields was performed using equation 1. 
                                             (1) 
Equation 1 above was used to adjust the activities to account for the differences in 
yields of coassembled enzymes. In eq 1, the raw activity (Araw) consists of contributions 
from both assembled GOx/HRP cascades (Aassem) and unassembled enzyme (Aunassem), 
where Yassem is the coassembly yield of GOx/HRP pairs on the origami tiles. Because a 
3:1 ratio of enzymes to origami tiles was used for the assembly, the percentage of 
assembled enzymes was ∼(Yassem/3), while the percentage of unassembled enzymes was 
∼((3 − Yassem)/3). The resulting calibrated activities are presented in Figure 3.5B. The 
largest enhancement in activity was observed for enzymes with 10 nm spacing, which 
was more than 15 times higher than the corresponding control. A sharp decrease in 
cascade activity occurred as the interenzyme distance was increased from 10 to 20 nm, 
followed by a slow and gradual decrease in activity as the distance was further increased 
to 65 nm. 
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Figure 3.5. Spacing distance-dependent effect of assembled GOx/HRP pairs as 
illustrated by (A) plots of product concentration vs time for various nanostructured and 
free enzyme samples and (B) enhancement of the activity of the enzyme pairs on DNA 
nanostructures compared to free enzyme in solution.  
3.4.3. Brownian Model of H2O2 Diffusion. For a GOx/HRP cascade, effective 
transfer of the intermediate H2O2 between the enzymes is essential to the cascade activity 
(Figure 3.6A).  
 
Figure 3.6. Model of H2O2 diffusion in a single GOx/HRP pair. (A) Simplified 
illustration of the distance-dependent (r) H2O2 concentration gradient resulting from 3D 
Brownian diffusion. (B) Simulated H2O2 concentration gradient as a function of distance 
between GOx and HRP using equation 3 with the following parameters: diffusion 
coefficient ∼1000 μm2/s; kcat (GOx) ∼300 s
−1
; and the integration time ∼1 s. Inset shows 
the enlarged distance-dependent H2O2 concentration gradient within 1 μm. 
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Here, we use Brownian motion to simulate the distance-dependent, three-
dimensional (3D) diffusion of H2O2 between enzymes as described by equation 2, where 
n(r,t) is the concentration of H2O2 at a distance r from the initial position, D is the 
diffusion coefficient, and t is the diffusion time.
15
 GOx is assumed to generate H2O2 at a 
constant rate, kcat. Equation 3 describes the convolution function of Brownian motion of 
H2O2 with a constant catalytic rate for a GOx/HRP pair in the given time t, where τ is the 
average time between GOx turnovers (1/ kcat). Figure 3.6B shows the simulation result 
using the following parameters: D = 1000 μm2/s for H2O2,
16,17
 kcat = 300 s
−1
 for GOx 
(Figure 3.7), and t = 1 s.  
Because of the rapid diffusion of H2O2 in water, the concentration of H2O2 drops 
off only slightly within a few hundred nanometers of GOx. If one assumes that the 
activity is linear with substrate concentration, this simulation result agrees with the 
observation that assembled GOx/HRP cascades exhibit only small variations in activity 
for interenzyme distances between 20 and 65 nm. For a 1 nM solution of unassembled 
enzymes, the average spacing between proteins is ∼1.2 μm, where the H2O2 
concentration is ∼60% of the initial position in the simulation. 
𝑛 𝒓, 𝑡 =
1
(4𝜋𝐷𝑡)
3
2
∗ exp −
𝑟2
4𝐷𝑡
                                                     (2) 
𝑛 𝒓, 𝑡 =  
1
(4𝜋𝐷(𝑡 − 𝑖 ∗ 𝜏))
3
2
∗ exp −
𝑟2
4𝐷 𝑡 − 𝑖 ∗ 𝜏 
           (3)
𝑖=
𝑡
𝜏−1
𝑖=0
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Figure 3.7. Michaelis constants of GOx and standard OD curve for ABTS
-
 (A) 
Determining the Michaelis constants of GOx using a cascade detection of 1 nM GOx and 
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100 nM HRP. Glucose concentration is varied from 40 uM to 5 mM and ABTS
2-
 is kept 
at 5 mM for the assay. In GOx/HRP cascade detection, one mole of glucose generates 
one mole of H2O2, oxidizing two mole ABTS
2-
 to ABTS
-
.
18
 (B) Standard OD curve 
versus ABTS
-
 concentration. 
This result is consistent with the limited activity enhancement (less than 2-fold) 
for distantly spaced GOx/HRP pairs (e.g., 45 or 65 nm) compared to unassembled 
enzymes in Figure 3.5. Further, if the intermediate transfer between distantly spaced 
enzymes is dominated by Brownian motion, diluting the sample will result in a decreased 
H2O2 concentration for free HRP, while the H2O2 concentration near HRP in the 
assembled complexes remains nearly constant. Thus greater activity enhancement will be 
observed for assembled GOx/HRP pairs relative to the free enzymes under these 
conditions. This concentration-dependent enhancement was confirmed by performing the 
assay at a range of GOx/HRP concentrations (Figure 3.8). 
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Figure 3.8. Concentration-dependent enhancement in activity for assembled GOx/HRP 
tiles with 45-nm inter-enzyme distance as compared to unscaffolded enzymes. The 
expected interenzyme distance in solution for unscaffolded enzymes is noted above with 
corresponding concentrations. For assembled GOx/HRP tiles, the inter-enzyme is 
independent of the concentration. The inter-enzyme distance for unassembled enzymes 
becomes larger as the concentration decreases. Therefore, a greater enhancement in the 
activity of assembled enzymes is observed at lower enzyme concentrations. 
3.4.4. Surface-limited H2O2 Diffusion Induced by a Protein Bridge. While the 
Brownian diffusion model is consistent with the interenzyme distance dependence of the 
activity at distances greater than 20 nm, the strong activity enhancement for GOx/HRP 
pairs spaced 10 nm apart cannot be explained by this model. Apparently, the transfer of 
H2O2 between closely spaced enzymes is governed by a different mechanism than that for 
more distantly spaced enzymes. Since both GOx and HRP are randomly oriented on the 
DNA origami tiles, it is unlikely that the active sites of GOx and HRP are perfectly 
aligned to allow the direct transfer of H2O2 between active sites. It seems more likely that 
when GOx and HRP are spaced in very close proximity, the two protein surfaces become 
essentially connected with one another, as demonstrated by AFM imaging of S1 tiles for 
10 nm interenzyme spacing (Figure 3.4B). One possibility is that under these 
circumstances, H2O2 does not generally escape into the bulk solution but instead transfers 
from GOx to HRP along their mutual, connected protein surface, providing a 
dimensionally limited diffusion mechanism that dominates over three-dimensional 
diffusion when the two enzymes are essentially in contact. In support of this concept, it is 
known that water molecules are translationally and rotationally constrained in the 
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hydration layer around a protein, relative to bulk solution, because of hydrogen bonding 
and Coulombic interactions with the protein.
19
 Some simulation results have suggested 
that H2O2 also has an affinity for protein surfaces resulting in an even longer residence 
time in the hydration layer near the protein than water.
20,21
 In addition, dimensionally 
limited diffusion has been observed in a number of biochemical systems, resulting in 
decreased times for diffusion of a substrate or ligand to its point of action.
1
 Examples 
include linear diffusion of nuclease or transcription factors along DNA
22,23
 and the 
surface-attached “lipoyl swing arm” in the pyruvate dehydrogenase complex.2  
If the enhancement seen in Figure 3.5 at 10 nm interenzyme distance is in fact due 
to dimensionally restricted diffusion along protein surfaces, it should be possible to 
enhance the activity observed at longer interenzyme distances by placing a protein bridge 
between the enzymes. To test this, we designed a ‘bridge-based’ cascade in which a 
noncatalytic protein was inserted between GOx and HRP, in order to connect the protein 
hydration shells and facilitate the surface-limit diffusion of H2O2.  
As shown in Figure 3.9A, a GOx/HRP pair was first assembled on a DNA 
origami tile with a 30 nm interenzyme distance. Next, a noncatalytic protein, either 
neutravidin (NTV) or streptavidin (STV)-conjugated β-galactosidase (β-Gal), was 
inserted between the enzymes. As shown in Figure 3.9B, assembled GOx/HRP pairs with 
a β-Gal bridge exhibited ∼42 ± 4% higher raw activity than control assemblies without 
the bridge. 
STV conjugated β-Gal and NTV in solution did not affect GOx/HRP activities 
(Figure 3.10).   
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Figure 3.9. Surface-limited H2O2 diffusion induced by a protein bridge. (A) The design 
of an assembled GOx/HRP pair with a protein bridge used to connect the hydration 
surfaces of GOx and HRP. (B) Enhancement in the activity of assembled GOx/HRP pairs 
with β-Gal and NTV bridges compared to unbridged GOx/HRP pairs. AFM images of 
GOx/HRP pairs with and without protein bridges were used to estimate the coassembly 
yield. Scale bar: 200 nm. 
 
Figure 3.10. Control experiments to evaluate the effect of free NTV and β-Gal on the 
assembly of GOx/HRP tiles. (black) 1 nM assembled GOx/HRP tiles with 30-nm inter-
enzyme distance; (blue ) 1 nM assembled GOx/HRP tiles + 3 nM free β-Gal streptavidin 
conjugate; (red) 1 nM assembled GOx/HRP tiles + 3 nM free NTV. Note, no biotin probe 
between the assembled GOx and HRP was present for these experiments. 
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With a larger protein diameter (∼16 nm), β-Gal can fill the space between GOx 
and HRP more completely than NTV (∼6 nm diameter), resulting in a more enhanced 
activity for the β-Gal bridge even with a lower coassembly yield (see APPENDIX B). 
This result supports the notion that surface-limited diffusion of H2O2 between closely 
spaced enzymes is responsible for the increase in cascade activity beyond what is 
possible by three-dimensional Brownian diffusion. 
3.5. Conclusion 
In conclusion, we have systematically studied the activity of a GOx/HRP cascade 
spatially organized on a DNA nanostructure as a function of interenzyme distance. The 
intermediate transfer of H2O2 between enzymes was found to follow the surface-limited 
diffusion for closely spaced enzymes, while 3D Brownian diffusion dominated H2O2 
transfer between enzymes with larger spacing distances. These studies imply that the 
strong activity enhancement observed for assembled enzyme cascades is not simply 
achieved by reducing the interenzyme distance to reach high local molecule 
concentration, but also results from restricting diffusion of intermediates to a two-
dimensional surface connecting the enzymes. While it is possible that some coassembled 
GOx/HRP pairs are aligned in such a way that their active sites are juxtaposed, 
facilitating H2O2 transfer between enzyme pockets, there was no specific attempt to 
orient the enzymes in this study. In the future, it will be important to study the effect of 
enzyme orientation on the activity of assembled enzyme complexes as well.
24
 With the 
further development of DNA-protein attachment chemistry through site-specific 
conjugation or ligand capture,
25,26
 it should be possible to start to direct the flow of 
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substrate molecules between active sites using some of the concepts and tools discussed 
above. 
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Chapter 4 
Build up Responsive Nanodevice: A DNA Tweezer-actuated Enzyme Nanoreactor 
Adapted with permission from Liu, M .; Fu, J.; Hejesen, C.; Yang, Y.; Woodbury, N.W.; 
Gothelf, K.; Liu, Y.; Yan, H., A DNA Tweezer-actuated Enzyme Nanoreactor. Submitted 
to Nature Communication. 
4.1. Abstract 
The functions of regulatory enzymes are essential to modulating biochemical 
cellular pathways. In this chapter, a tweezer-like DNA nanodevice was designed and 
constructed to actuate the activity of an enzyme/cofactor pair. A dehydrogenase and the 
corresponding NAD
+
 cofactor were attached to different arms of the DNA tweezer 
structure and actuation of enzymatic function was achieved by switching the tweezers 
between open and closed states. The enzyme/cofactor pair is spatially separated in the 
open state which leads to inhibition of enzyme function, while in the closed state the 
activity of the enzyme is enhanced by the close proximity of the two molecules. The 
conformational state of the DNA tweezers is controlled by the addition of specific 
oligonucleotides that served as the thermodynamic driver (fuel) to trigger the change. 
Using this approach, several cycles of externally controlled enzyme inhibition and 
activation were successfully demonstrated. This principle of responsive enzyme 
nanodevices may be used to regulate other types of enzymes and to introduce feedback or 
feed-forward control loops. 
4.2. Introduction 
Nature has evolved a myriad of enzymes to catalyze chemical reactions that are 
vital to the metabolism and reproduction of living systems.
1
 The ability to regulate those 
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enzyme activities in response to cellular environmental conditions (e.g. substrate levels, 
stimulants, etc.) is critical to many metabolic functions.
2,3
 Scientists are currently 
interested in finding ways to mimic enzyme regulatory circuitry outside of the cell,
4,5
 not 
only to increase our knowledge of cellular metabolism, but also so that we may create 
man-made nanoreactors that have potential utility in applications ranging from 
diagnostics to the production of high-value chemicals
6-8
 and smart materials.
9
 DNA 
nanostructures are promising scaffolds for use in the organization of molecules on the 
nanoscale because they can be engineered to site-specifically incorporate functional 
elements in precise geometries
10-12
 and to enable nanomechanical control capabilities. 
Examples of such structures include autonomous walkers,
13,14
 nanotweezers
15-18
 and 
nanocages for controlled encapsulation and payload release.
19,20
 New protein-DNA 
conjugation chemistries make it possible to precisely position proteins and other 
biomolecules on DNA scaffolds,
21
 generating multi-enzyme pathways with the ability to 
modulate inter-molecular interactions and the local environment.
22-25
 Taking advantage 
of these features, we exploited a DNA tweezer nanostructure to actuate the activity of a 
glucose-6-phosphate dehydrogenase (G6pDH)/NAD
+
 enzyme/cofactor pair. Here, the 
enzyme and cofactor are displayed from different arms and actuation of enzyme function 
is achieved by switching between open and closed states to spatially separate the 
enzyme/cofactor pair for inhibition, or bring the pair together for activation, respectively.   
4.3. Materials and Methods 
4.3.1. Chemicals. (see APPENDIX C). 
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4.3.2. Bioconjugation. The conjugation chemistry used to link the protein 
enzyme to single-stranded oligonucleotides is described in a previous study
22
 illustrated 
in Figure 4.1A.  
 
Figure 4.1. Protein-DNA conjugation using a SPDP cross linker. (A) A schematic 
illustration of the conjugation chemistry; (B) Quantification of protein-SPDP 
modification via absorbance spectra. G6pDH-SPDP conjugation: ΔA343 before and after 
67 
 
SPDP conjugation is ~ 0.16 (extinction coefficient: 8080 M
-1
 cm
-1
), corresponding to 20 
µM SPDP coupled with 13 µM G6pDH (ε=115200 M-1 cm-1 at 280 nm for G6pDH). (C) 
Calculation of DNA ratio to purified G6pDH-TTTTTCCCTCCCTCC: an A260/A80 
ratio of 0.84 corresponds to ~ 0.86 DNA per protein, with a protein-DNA concentration 
of ~ 5.1 µM. 
Briefly, SPDP was used to crosslink G6pDH with a 5’thiol-modified oligo (5’ 
HS-TTTTTCCCTCCCTCC). 100 µL of 40 µM enzyme solution was first reacted with a 
2-fold excess of SPDP in 10 mM sodium HEPES (pH 8-8.5) for one hour, allowing 
amine-reactive N-hydroxysuccinimide (NHS) esters to react with the lysine residues on 
the protein surface. Excess SPDP was removed by washing, and purified using Amicon, 
30 kD cutoff filters. Next, SPDP-modified protein was conjugated to a thiol-modified 
oligo (10-fold excess) through a disulfide bond exchange of the activated pyridyldithiol 
group. The reaction mixture was incubated in 1 × PBS (pH 8-8.5) for one hour. The 
coupling efficiency was evaluated by monitoring the increase in absorbance at 343 nm 
due to the release of pyridine-2-thione (extinction coefficient: 8080 M
-1
 cm
-1
) as shown in 
Figure 4.1B. Finally, the excess oligo was removed by washing with 1 M NaCl and 1 × 
PBS and filtered with Amicon 30 kD cutoff filters. The filtered protein-oligo solution 
was quantified by absorbance at 260 and 280 nm (Figure 4.1C). Figure 4.2 shows that the 
enzymatic activity of oligo-labeled G6pDH (label ratio ~ 1) was ~ 50% of the activity of 
the unmodified enzymes.  
Figure 4.3 shows the conjugation of 6AE-NAD
+
 to single-stranded 
oligonucleotide. 200 µL of 100 µM 5’amine-modified oligo was first immobilized onto 
200 µL anion-exchange DEAE-Sepharose resin by charge absorption. 
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Figure 4.2. Enzyme activity for both G6pDH-DNA and unmodified enzymes. 
The unbound oligo and water was removed by washing and filtering the resin 
with DMF in a Sigma Prep Spin column (7-30 µm). 200 µL of 150 mM DSS was 
prepared in DMF with 2 %( v/v) DIPEA. The oligo-bound resin was incubated with DSS 
for one hour. Excess DSS crosslinker was removed by washing the resin with DMF.  To 
couple NAD
+
 to an oligo, a 10- fold excess of 6AE-NAD
+
 was incubated with oligo-
bound resin in 1 M HEPES, pH8 for one hour. After the reaction, the oligo-bound resin 
was spun down at 3000 rpm to remove any unreacted 6AE-NAD
+
. The purification of 
6AE-NAD+ was performed using HPLC and characterized by MALDI-TOF Mass 
Spectrometry (see APPENDIX C).  The thermal stability of the NAD
+
-coupled oligo was 
measured as shown in Figure 4.4. NAD
+
 could maintain most of its activity after 
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incubation at temperatures less than 75˚C, while NAD+ activity quickly decreased after 
incubation at temperatures higher than 85˚C.   
 
Figure 4.3. Conjugation of an aminoethyl NAD to the 3’ end of DNA using resin-based 
DSS crosslinking chemistry. 
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Figure 4.4. Evaluation of the thermal stability of NAD
+
. Amino-modified NAD
+
 (AE-
NAD
+) was incubated at a series of temperatures ranging from 25 to 95 ˚C for 10 min 
(black), 30 min (blue) and 60 min (red), respectively. NAD
+
 activity was evaluated from 
the reduction of NAD
+
 to NADH by G6pDH, followed by a coupled PMA-catalyzed 
resazurin reaction as described in Figure 4.9. Assay condition: 50 nM G6pDH, 50 µM 
AE-NAD
+
, 1 mM glucose-6 phosphate, 200 µM PMS and 400 µM resazurin in 1×TBS 
with 1 mM MgCl2 at pH 7.5, room temperature. All the thermal activities were 
normalized to the sample incubated at 25 ˚C. The results show that after 10 minutes, AE-
NAD
+
 function is significantly reduced for temperatures higher than 70 ˚C. This indicates 
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that thermal annealing programs with very short incubation time at high temperature are 
required.    
4.3.3. DNA Tweezer Preparation. Oligonucleotides were purchased from IDT 
(Integrated DNA Technology, Inc) and purified using denaturing polyacrylamide gel 
electrophoresis or HPLC. The concentration of each strand was determined by measuring 
the OD260. Detailed sequences and locations of fluorescent labels are shown in Figure 
4.5.  
 
 
Name Sequence
TB1 TTTTCGACCGAGCGTGAATTAGTGATCCGGAACTCGCGCAATGAACCTTTT/3BioTEG/
TP2
TTTTTCAGCTGGCCTATCTAAGACTGAACTCGCACCGCCGGCATAAGCTATGCGCTCTGCCGCTTTG
GAGGGAGGG
T3 TTTTTTAGGAGATGGCACGTTAATGAATAGTCTCCACTTGCATCCGAGATCCGAACTGCTGCCTTTT
TB4 /5BioTEG/TTTTCGAGAGAAGGCTTGCCAGGTTACGTTCGTACATCGTCTGAGTTTTTT
T5 TTTTGGCAGCAGTTCAGGCCAGCTGATTTT
T6 TTTTGGTTCATTGCGGAGTTCAGTCTTAGATGGATCTCGGATGCAAGGCCTTCTCTCGTTTT
T7
GGTGCCGAGTTCCGGATCACTAATTCCATAGCTTATGCCGGCTTTGCGTAAGACCCACAATCGCTTT
ACTATTCATTAACGTGTGTACGAACGTAACCTGGCAATGGAG
TP8 TTTTGCGGCAGAGCGACGCTCGGTCGTTTGGAGGGAGGG
Set CGTGTGGTTGAAAGCGATTGTGGGTCTTACGCAAA
Fuel TTTGCGTAAGACCCACAATCGCTTTCAACCACACG
TP8-Cy5 Cy5-TTTTGCGGCAGAGCGACGCTCGGTCGTTTGGAGGGAGGG
T3-Cy3 Cy3-TTTTTAGGAGATGGCACGTTAATGAATAGTCTCCACTTGCATCCGAGATCCGAACTGCTGCC
T9-0T AACTCAGACGACCATCTCCTAA/3AmMO/
T9-3T AACTCAGACGACCATCTCCTAATTT/3AmMO/
T9-13T AACTCAGACGACCATCTCCTAATTTTTTTTTTTTT/3AmMO/
T9-20T AACTCAGACGACCATCTCCTAATTTTTTTTTTTTTTTTTTTT/3AmMO/
T9-30T AACTCAGACGACCATCTCCTAATTTTTTTTTTTTTTTTTTTTTTTTTTTTTT/3AmMO/
T9-40T AACTCAGACGACCATCTCCTAATTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT/3AmMO/
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Figure 4.5. Design and sequences of DNA tweezers. The 3’ or 5’ ends of strands are 
modified with 4T nucleotides to reduce stacking effects. Strands TB1 and TB4 are 
labeled with biotin. The probe sequence for G6pDH attachment is incorporated into the 
3’ ends of strands TP8 and TP2. The 3’ end of strand T9 is bound to the NAD+ molecule 
via 0 T to 40 T nt linkers. The T7 strand (shown in red) is used to regulate the opening 
and closing of the tweezers, which initially folds into a hairpin with a “GCG” stem loop. 
To open the tweezers, a 2-fold excess of set strands are incubated with the tweezers. To 
switch to a closed state, a 2-fold excess of fuel strands are added to displace the set 
strands and release the double helical regulatory strand complex. 
Core strands for the open state tweezers were mixed in 1×TAE/Mg
2+
 buffer (40 
mM Tris, 20 mM acetic acid, 2 mM EDTA and 12.5 mM magnesium acetate, pH 8.0) to 
reach a final concentration of 0.5 µM, except for the set and NAD
+
 conjugated strands 
which were prepared at 0.75 µM. All samples were annealed in an Eppendorf 
Mastercycler. The temperature steps in the annealing protocol are shown in APPENDIX 
C with gradually decrease from 90 ˚C to 72 ˚C over 10 min, decrease from 68 ˚C to 24 ˚C 
over 60 min then hold at 4 ˚C. 
Name Extinction coefficient (M
-1
cm
-1
) 
0T-open 4002998.8 
3T-open 4026906.7 
13T-open 4106599.8 
20T-open 4162384.9 
30T-open 4242077.9 
40T-open 4321771.0 
 
Table 4.1. Estimated extinction coefficient at 260nm of the tweezers linked to NAD
+
. 
The extinction coefficient of each tweezer structure was estimated by inputting sequences 
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into IDT Biophysics analyzer (http://biophysics.idtdna.com/UVSpectrum.html). These 
values can be used to roughly estimate tile concentration after biotin purification. 
3-fold molar excess of oligo-conjugated G6pDH was added to the pre-annealed 
tweezer structures and mixed well. Proteins were assembled by using a 1 hour annealing 
program: the temperature was decreased from 37 ˚C to 10 ˚C and held at 4 ˚C using an 
established protocol.
22
 Excess G6pDH-WN1 was removed using monomeric avidin resin 
(Pierce) and biotin-labeled tweezers; the protein was eluted out with 2mM biotin and the 
recovery yield was ~30%. Purified assembled enzyme nanoreactor sample was 
characterized using Native PAGE gel shown in Figure 4.6. The estimated extinction 
coefficient of the open tweezers at 260nm is shown in Table 4.1. 
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Figure 4.6. Removal of free proteins using biotin-affinity resin purification. The native 
polyacrylamide gel shown here was first stained with EB  (left) to detect the DNA 
tweezer structure and then rinsed with pure water; the same gel was later stained with 
silver stain (right) to detect the proteins.  Lane 1 is G6pDH-assembled tweezers after 
purification; no free proteins are observed in the silver stained image. Lane 2 is G6pDH-
assembled tweezers before purification; a large quantity of free proteins is visible in the 
silver stained image. Lane 3 is the tweezers without proteins. Note that the integrity of 
the tweezers structures is maintained before (Lane 2) and after purification (Lane 3). 
4.3.4. Enzyme Assay. 100 nM G6pDH/NAD
+
-assembled DNA tweezers were 
prepared with 100 µL of substrate for the activity assay, which was performed on a 
SpectraMax M5 96 well plate reader (Molecular Device, Sunnyvale, CA). G6pDH/NAD
+
 
activity was measured using a coupled assay of PMS (phenazine methosulfate) and 
resazurin in which PMS first oxidizes NADH to NAD
+
, then reduces resazurin to 
resorufin with the appearance of a fluorescent signal (excitation maxi. ~ 544 nm, 
emission maxi. ~ 590 nm) as shown in Figure 4.7.  
For a typical reaction, 100 nM G6pDH nanotweezers were incubated with 1 mM 
G6p, 1 mM PMS and 500 µM resazurin. Each addition of fuel or set strands utilized a 
50% to 100% excess compared to the previously added amount. Activity was 
continuously measured for 15 min after 15 min incubation time for each addition of fuel 
or set strands. Mg
2+
 was removed from the sample solution to avoid the formation of 
double-stranded DNA/Mg
2+
 complexes that quench resorufin fluorescence (see 
APPENDIX C).
26
  
75 
 
 
Figure 4.7. Detection of enzymatic activity in the G6pDH/NAD
+
-assembled tweezers 
using a PMS/resazurin coupled assay: NAD
+
 is first reduced to NADH by G6pDH. Next, 
PMS catalyzes electron transfer from NADH to resazurin producing a strongly 
fluorescent resorufin with an emission maximum ~ 590 nm.   
4.3.5. Real-time FRET Experiment. The Cy3 and Cy5 labeled actuator structure 
is illustrated in Figure 4.8. FRET experiments of fully assembled structures were carried 
out in a Nanolog fluorometer (Horiba Jobin Yvon) with a 1 cm path length quartz cell 
(Hellma) at room temperature. DNA tweezer concentration was ~ 60 nM. Excitation 
wavelength was set at 514nm. The donor (Cy3) and acceptor (Cy5) emission was 
collected at ~ 570 nm and ~ 670 nm, respectively. The excitation slit was 1 nm and 
emission slit was 6 nm. The interval time for each data point is 1s after the addition of 
fuel strands and 3s after the addition of set strands due to the longer observation period. 
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The addition of fuel or set strands had exactly the same excess percentage as for the 
enzyme activity measurement. 
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Figure 4.8. FRET analysis of DNA tweezers. (A) Schematic illustration of FRET 
analysis of G6pDH/NAD
+
 tweezers. Two fluorophores, Cy3 and Cy5, are labeled at the 
end of the two arms, respectively (5’ modification of strands TP8 and T3). (B) FRET 
signal from the Cy3/Cy5 pair in the open and closed state tweezers. For the open 
tweezers, the distance between the ends of the arms is estimated as ~16 nm, according to 
the length of the fully hybridized regulatory oligomer. For the closed tweezers the FRET 
efficiency is ~ 19% which corresponds to ~ 6.9 nm between the Cy3 and Cy5 dyes, as 
estimated by the equation of  ‘   
 
   
 
  
  
’, given a Förster distance ~ 5.4 nm.27  
4.3.6. Gel Preparation and Characterization. See APPENDIX C. 
4.4. Results and Discussion 
4.4.1. Design and Characterization of Enzyme Nanoreactor. The mechanics of 
the DNA tweezer-regulated enzyme nanoreactor are shown in Figure 4.9A. The design 
and construction of the nanotweezers, with ~14 nm long arms, are based on a previous 
report.
15
 A 25 nucleotide (nt) single stranded DNA (ssDNA) oligomer (5’- 
TTTGCGTAAGACCCACAATCGCTTT-3’) connects the ends of the tweezer arms and 
serves as a structural regulatory element to control the state of the tweezers. In the initial 
closed state the regulatory oligomer is designed to adopt a ‘GCG’ stem-loop hairpin 
structure that holds the two arms of the tweezers close together. The average distance 
between the arms in the closed state is ~ 6.9 nm, according to fluorescence energy 
transfer measurements (FRET)
28,29 
(Figure 4.8). The open state is achieved by disrupting 
the hairpin via hybridization of a complementary set strand to it, thereby generating a 
rigid ~16 nm long double helical domain between the ends of the tweezer arms. To 
switch back to the closed state a fuel strand that is fully complementary to the set strand 
78 
 
is introduced to the system, releasing the regulatory oligomer to a hairpin by a strand 
displacement mechanism.
30
  
Next, G6pDH was conjugated to a ssDNA (5’-TTTTTCCCTCCCTCC-3’) using 
well developed chemical methods.
22
 The complementary anchor strand was displayed 
from one of the tweezer arms to capture the DNA-modified G6pDH via sequence specific 
hybridization. The other arm of the DNA tweezers was functionalized with an amino-
modified NAD
+
 molecule.
31
  
The G6pDH/NAD
+
-assembled tweezer complex was characterized by native 
polyacrylamide electrophoresis (PAGE) as shown in Figure 4.9B. The protein-bound (~ 
100 kD for G6pDH)
32
 DNA tweezers exhibited reduced mobility in the PAGE gel due to 
the relatively higher molecular weight. In addition, the closed state tweezers migrated 
slightly faster than the open state tweezers due to their more compact conformation. The 
identity of each band in the gel was verified by ethidium bromide (EB)
33
 and silver 
staining
34
, where EB preferentially bound to the DNA and the metallic silver solution of 
the protein. The expected band shifts were confirmed by both staining methods. A high 
yield of enzyme-bound tweezers is visible in the gel images, with evidence of successful 
switching between open and closed states. As shown in Figure 4.9C we also 
characterized the conformational state of the fully assembled tweezers using FRET 
between Cy3/Cy5 dye pairs. Here, the end of one of the tweezer arms was labeled with 
Cy3 and the other with Cy5. The closed tweezers exhibited a lower Cy3 signal and a 
higher Cy5 signal due to relatively efficient energy transfer between the fluorophores.   
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Figure 4.9. Design and characterization of G6pDH/NAD
+ 
- assembled DNA tweezers. 
(A)  Schematic illustration of the mechanics of the DNA tweezer-regulated enzyme 
nanoreactor: a regulatory oligomer (shown in red) is designed to adopt a ‘GCG’ stem-
loop hairpin structure that holds the two arms of the tweezers close together. The addition 
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of a set strand (complementary to the regulatory loop shown in red) to the tweezer 
structure results in the formation of a DNA double helix between the tweezer arms that 
separates the G6pDH and NAD
+
 enzyme/cofactor pair (open state). Displacement of the 
set strands from the regulatory loop by fuel strands leads to the active state (closed) in 
which G6pDH and the cofactor NAD
+
 are in close proximity. (B) Characterization of the 
fully assembled tweezers structures: left – EB stained PAGE gel for detecting DNA; right 
– the same gel visualized by silver stain for detecting proteins.  Lane 1: open tweezers 
with NAD
+
 attached by a poly(T)20 linker; lane 2: open tweezers assembled with G6pDH; 
lane 3: closed tweezers assembled with G6pDH. All structures were purified using biotin-
avidin affinity resins. (C) FRET experiment (Cy3/Cy5 dyes) to characterize the open and 
closed states of the tweezers.  
As shown in Figure 4.7, a resazurin-coupled assay was used to evaluate the 
activity of the tweezer bound G6pDH/NAD
+
 pair. The assay involves the phenazine 
methosulfate (PMS) catalyzed reduction of resazurin to resorufin by NADH, as 
evidenced by the production of a strong fluorescence signal (ex. ~544nm/em. ~590nm). 
To remove any unassembled enzymes and minimize the background signal all tweezer 
constructs were purified by biotin-affinity resin treatment. 
4.4.2. Optimization of NAD
+
 Linker Length. In an effort to optimize the 
activity of the G6pDH/NAD
+
-assembled tweezers, the NAD
+
 cofactor was attached to the 
tweezers by a single-stranded poly thymidine (T) linker. As shown in Figure 4.10A and 
B, we investigated the dependence of the length of the poly (T) linker on the activity of 
the G6pDH/NAD
+
-assembled tweezers. Most tweezers were correctly assembled and 
able to open and close as characterized by native PAGE in Figure 4.10C. A small amount 
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of aggregation (< 10 %) of the tweezer constructs was observed due to DNA-DNA 
stacking. The activities of both the open and closed tweezers improved as the length of 
the linker was increased from 0 to 20 nts (~ 30 nm in linear length), presumably due to 
the enhanced flexibility of the longer linkers. Further increasing the linker length from 20 
nts to 40 nts (~ 60 nm in linear length) did not improve the enzyme activity, but rather 
resulted in slight decrease.  
 
Figure 4.10. Optimization of the NAD
+
 linker length for tweezer activity and actuation. 
(A) The activities of open and closed tweezers as a function of poly(T) linker length. (B) 
Enhancement of closed tweezers compared to opened tweezers as a function of poly(T) 
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linker length. (C) Native PAGE characterization of all DNA tweezers with different 
poly(T) linker length. Slight aggregations of tweezers were observed due to DNA-DNA 
stacking. 
We also evaluated the ability of the tweezers to modulate enzymatic activity by 
determining the relative level of enhancement of the closed state compared to the open 
state. As shown in Figure 4.10B, greater than 5.5-fold activity enhancement was 
observed for closed tweezers with no linker, or with a short poly (T)3 linker. As the length 
of the linker increased the enhancement in the activity of the closed tweezers compared 
to the open tweezers gradually decreased. Tweezers with a relatively long poly (T)40 
linker exhibited less than 4-fold activity enhancement. This is likely because longer 
linkers increase the accessibility of NAD
+
 to G6pDH even in the open state, thereby 
reducing the ability of the tweezers structure to modulate enzyme activity. We selected a 
poly (T)20 linker for attachment of the NAD
+
 cofactor to the tweezers, which yielded 
more than 3-fold higher enzymatic activity than tweezers with no linker, and maintained 
greater than 5-fold activity enhancement of closed tweezers compared to open ones. In 
this way were able to sustain adequate enzyme activity while also preserving the 
regulatory capacity of the tweezers.  
4.4.3. Regulatory Cycling of the G6pDH/NAD
+
-assembled Tweezers. We 
further examined the ability of the G6pDH/NAD
+
 tweezers to withstand several cycles of 
ON/OFF enzyme activity.  
To characterize the regulatory cycling of switching, in Figure 4.11A we present a 
native PAGE gel that demonstrates the ability of the assembled tweezers to switch 
between open and closed states nine times while maintaining their structural integrity. 
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Figure 4.11. Characterization of regulatory cycling of the G6pDH/NAD
+
-assembled 
tweezers.  Four cycles of conformational and functional transition were measured and 
analyzed using (A) native PAGE and (B) real-time FRET. Cycles were initiated in the 
open state, and for each conformational change 50% excess fuel or set strands were 
added.  
Additional cycles are limited by the accumulation of large amounts of set and fuel 
strands. We also monitored the real-time opening and closing of the tweezers by labeling 
the tweezer arms with Cy3 and Cy5 FRET dyes, respectively. As shown in Figure 4.11B, 
Cy3 emitted less fluorescence in the closed state due to energy transfer to Cy5, while Cy5 
exhibited higher emission under the same conditions. The gradual decrease in the 
intensity of Cy3 fluorescence over time that was observed can be attributed to photo 
bleaching. Real time kinetic analysis revealed that the tweezers switch from open to 
closed states very quickly, with all tweezers transformed within a few seconds (too fast to 
measure the kinetic constant accurately).  
However, the kinetics of switching from the closed to open state is much slower, 
with a first-order kinetic constant of ~ 0.0025 ± 0.0003 s
-1
. The rate constants 
corresponding to switching from the closed to open state gradually increased as the cycle 
number increased: ~ 0.0051 s
-1
 for the second cycle; ~ 0.0054 s
-1
 for the third cycle; and 
0.0071 s
-1
 for the fourth cycle (Figure 4.12). It is likely that the relatively sluggish 
process of tweezer opening is due to the slow hybridization of the set strand to the self-
folded hairpin structure connecting the tweezer arms and the subsequent disruption of the 
rather stable hairpin structure.  
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Figure 4.12. (A) Fitting of the first-order rate constants for the opening kinetics of the 
tweezers, using the fluorescence signal decrease of Cy5. The equation used for first-order 
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kinetics is described as      −   ∗  
  ∗   , where Y is real-time Cy5 signal, Y0 is 
Cy5 signal at fully closed tweezers state, A is Cy5 signal at fully opened tweezers state, k 
is the first-order rate constant. As the accumulation of extra set strands over cycles, the 
opening kinetics became faster. (B) The rate constants for tweezer-open kinetics vs. 
excess fold of set strands.   
 
Figure 4.13. Enzymatic assay. Cycles were initiated in the open state, and for each 
conformational change 50% excess fuel or set strands were added. All the enzyme 
activities were normalized to the activity of initial open tweezers.  
Figure 4.13 demonstrates the ability of the DNA tweezer structure to regulate 
G6pDH activity by switching between open and closed states. The tweezers were able to 
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actuate the ON/OFF enzyme activity 8 times in 200 minutes, with the closed state 
producing 5-fold higher enzymatic activity on average than the open state. 
4.5. Conclusion 
In conclusion, we have designed and constructed a DNA tweezer-like 
nanostructured enzyme system with the ability to turn on and off the activity of a 
G6pDH/NAD
+
 enzyme/cofactor pair by means of nano-mechanical control. In the open 
state the tweezer conformation inhibits the activity of the G6pDH/NAD
+
 
enzyme/cofactor pair by holding the molecules apart, while in the closed state the close 
proximity of the pair results in greatly enhanced activity. We successfully demonstrated 
several cycles of enzyme inhibition and activation in response to external stimuli 
(regulatory DNA strands). With additional developments in DNA-protein/cofactor 
attachment chemistry it should be possible to regulate other types of enzymes and to 
introduce feedback or feed-forward control loops. In the future it may be feasible to 
develop responsive enzyme nanodevices as highly specific chemical amplifiers in 
diagnostic applications or as biocatalysts in the production of high value chemicals and 
smart materials.  
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Chapter 5 
Summary and Outlook 
Adapted with permission from Fu, J.; Liu, M.; Liu, Y.; Yan, H., Spatially-Interactive 
Biomolecular Networks Organized by Nucleic Acid Nanostructures. Acc. Chem. Res. 
2012, 45, 1215-1226.  Copyright 2012 American Chemical Society. 
5.1. Conclusions 
It has been 30 years since Nadrian Seeman first proposed the idea of using DNA 
as a building block to precisely organize and arrange other biomolecules with nanoscale 
dimensions. The field of DNA nanotechnology has become one of the most successful 
‘bottom-up’ nanofabrication techniques along with the study of lipid vesicles, nanowires 
and quantum dots. People have constructed various DNA nanostructures from one to 
three dimensions, and from a few nanometers to a few micrometers scale that were 
‘glued’ using DNA-DNA hybridization and sticky ends. The reliability of base 
recognition, self-assembling behavior, and attractive structural properties of DNA are 
unparalleled value in systems of this size. DNA nanostructures have been demonstrated 
great scaffolds to direct the self-assembly of functional biomolecules. Supermolecular 
networks that are organized by DNA nanostructures exhibit precisely-controlled 
intercomponent distances and positions.  
In this thesis, we have successfully demonstrated the great ability of DNA 
directed self-assembly of protein networks or enzyme cascades and explained a few 
challenging questions in enzymatic field of study. As described in chapter 2,
1
 we reported 
a strategy of using DNA origami as a scaffold to arrange spherical virus capsids into one-
dimensional arrays with precise nanoscale positioning. In chapter 3,
2
 we organized 
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discrete glucose oxidase (GOx)/ horseradish peroxidase (HRP) enzyme pairs on specific 
DNA origami tiles with controlled interenzyme spacing and position. Then we studied 
the distance-dependent intermediate diffusion and tested the role of limited dimensional 
diffusion along protein surfaces. In chapter 4,
3
 we designed and constructed a tweezer-
like DNA nanostructure to actuate the activity of an enzyme/cofactor pair with reversible 
regulations.  
5.2. Future Perspective 
Self-assembled DNA nanostructures can now be used to organize a variety of 
heterogeneous elements into precise patterns on rationally designed 2D and 3D 
nanoarchitectures. Future challenges include identifying how to harness this power to 
construct functional, spatially interactive biomolecule complexes. Here, we identify 
several potential applications of DNA nanotechnology in constructing artificial 
bionanosystems. 
5.2.1. Bottom-up Engineering of Multicomponent Complexes. Translating 
biochemical reaction pathways to noncellular environments is of great scientific interest. 
Exerting control over these pathways beyond nature's repertoire would enable enzyme-
catalyzed production of novel molecules and energy conversion optimized for ambient 
and extreme environments. Engineering functional multienzyme complexes requires a 
method to reliably organize the individual protein components with control over the 
relative position, orientation, and quantity of the participating molecules. The 
combination of self-assembled DNA nanostructures and common bioconjugation 
strategies make it possible to rationally design and organize multiprotein pathways, as 
well as modulate the local environment and influence the corresponding chemical 
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reactions. For example, the direct transfer of a substrate from one enzyme to a proximal 
enzyme (substrate channeling), is one of the primary ways that natural systems facilitate 
highly efficient enzyme activity.
4
 Similar channeling effects can be replicated in a DNA 
nanostructure system by optimizing the relative position and orientation of the catalytic 
components. Directed diffusion over longer distances can be achieved by modifying the 
environment between two enzymes with specific properties (polarity or hydrophobicity) 
that encourage substrate diffusion. It is also possible to constrain the diffusion between 
two enzymes by constructing DNA cavities or nanotubes. Further, enzyme pathway 
feedback mechanisms may be realized by constructing branched reaction pathways, 
where the catalytic activities are regulated by activation or deactivation of a specific 
pathway.  
5.2.2. In Vivo Delivery and Regulation. Nanotechnology has been applied to 
target-specific drug delivery, in vivo regulation, visualization, and sensing. Structural 
DNA nanotechnology may be used to construct more effective drug delivery vehicles 
through the implementation of complex control mechanisms to sense specific targets, 
respond to environmental conditions, release molecular payloads, and trigger additional 
responses to regulate biological functions that impede disease progression. DNA-based 
nanocontainers, such as DNA boxes with switchable lids that open and close
5
 and 
nanocages with the ability to encapsulate or release nanoparticles,
6
 have demonstrated 
potential as drug-delivery vehicles. An autonomous DNA nanorobot controlled by an 
aptamer-encoded logic gate was recently reported to transport molecular payloads to 
cells, sense cell surface inputs for triggered activation, and transform its structure for 
payload delivery.
7
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Figure 5.1. Engineering enzyme pathways to achieve directional substrate diffusion 
(top), constrained substrate tunneling (middle), and split enzyme pathways as feedback 
mechanisms (bottom). 
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Figure 5.2. Proposed DNA nanocontainer for target-specific drug delivery and in vivo 
regulation.                                                                                                                                                                                                                                                 
In order to realize this nanocontainer application, the resistance of DNA 
nanostructures to the components of serum and cell lysate must be increased so that they 
may withstand in vivo delivery conditions.  A study two years ago showed that certain 
DNA origami structures maintain their structural integrity after incubation with cell 
lysate for up to 12 h, a significant increase in stability compared with natural single- and 
double-stranded DNA.
8
 In addition, it is a challenge to transfer DNA nanostructures 
across cell membranes.  Some recent studies have shown that DNA nanostructures 
modified with CPG
9 
or aptamers
10
 can be taken up by cells. The display of certain ligands 
(amphiphilic molecules, for example) from the surface of a DNA nanostructure may 
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facilitate tissue penetration and cellular uptake of DNA nanodevices. Combining DNA 
nanotechnology with molecular biology may result in the development of novel ways to 
regulate cellular response. It may be feasible to construct artificial intracellular or 
extracellular nanomatrices that are designed to influence gene expression or modulate 
biological pathways. 
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1. Experimental Methods and Materials 
1.1. General 
Unless otherwise noted, all chemicals and solvents were of analytical grade and 
were used as received from commercial sources. Water (ddH2O) used in biological 
procedures or as reaction solvents was deionized using a NANOpure purification system 
(Barnstead, USA). The centrifugations required in spin-concentration steps were 
conducted using a Sorvall Legend Mach 1.6R centrifuge (Thermo Fisher Scientific, 
USA).  
Prior to analysis, biological samples were desalted and separated from small 
molecule contaminants using NAP-5 or NAP-10 gel filtration columns (Amersham 
Biosciences, USA). MS2 capsids elute in the void volume of these columns, while small 
molecules are retained. Additionally, 100,000 Da molecular weight cut-off filters 
(Millipore, USA) were employed as indicated below. 
All oligonucleotides were obtained from Integrated DNA Technologies 
(www.idtdna.com). The origami staple strands were ordered in the format of 96-well 
plates that were normalized to 100μM, and were used without further purification. The 
probe strands were purified by denaturing PAGE. Then concentration of each strand was 
measured and estimated by measuring the OD260 (Eppendorf, USA). Oligonucleotides 
for capsid conjugation were purified by reverse-phase HPLC or NAP-5 gel filtration 
columns (GE Healthcare). Samples were lyophilized using a LAB CONCO Freezone 4.5 
(Lab Conco). Lyophilized oligonucleotides were re-suspended in the appropriate buffer 
and the concentration was determined by measuring the OD260. 
1.2. UV-Vis  
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UV-Vis spectroscopic measurements were conducted on a Cary 50 Scan benchtop 
spectrophotometer (Varian Inc., USA). 
1.3. Protein Gel Analysis 
For protein analysis, sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
(SDS-PAGE) was accomplished on a Mini-Protean apparatus (BioRad, USA), following 
the general protocol of Laemmli.
1
 Commercially-available markers (BioRad, USA) were 
applied to at least one lane of each gel for calculation of apparent molecular weights. 
Visualization of protein bands was accomplished by staining with Coomassie Brilliant 
Blue R-250 (BioRad, USA). Gel imaging was performed on an EpiChem3 Darkroom 
system (UVP, USA). 
1.4. Transmission Electron Microscopy (TEM) 
Part of TEM images were prepared for TEM analysis by applying analyte solution 
to carbon-coated copper grids (400 mesh, Ted Pella, USA) for 3 min, followed by rinsing 
with ddH2O. The grids were then exposed to a solution of uranyl acetate (15 mg/mL in 
ddH2O) for 90 seconds as a negative stain and rinsed with ddH2O. TEM images were 
obtained at the Berkeley Electron Microscope Lab using a FEI Tecnai 12 transmission 
electron microscope with 120 kV accelerating voltage. 
Part of TEM images were prepared by applying the sample solution (2.5 μL) onto 
carbon-coated grids (400 mesh, Ted Pella, USA). Before depositing the sample, the grids 
were glow discharged using an Emitech K100X machine. After deposition, the sample 
was wicked from the grid with a piece of filter paper. The grid was washed with water by 
touching it quickly with a drop of water and wicking away the excess using filter paper. 
The origami-capsid complex sample was stained using 0.7% uranyl formate and imaged 
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using a Philips CM12 transmission electron microscope, operated at 80kV in the bright 
field mode. 
For Tri3 tiles, the capsids were clearly visualized as hollow spherical structures); 
for Tri1 tiles, however, the capsids did not stain as well, and the walls are not as easily 
discerned in some cases. The size of these objects (~30 nm) and the fact that in some of 
them the walls can be distinguished makes us confident that these are indeed the capsids. 
For arrays formed with rectangular tiles and capsids (either using M or DC tiles), the 
arrays adsorb to the grid edge-on, so the tile is visualized as a line connecting the capsids. 
The inter-capsid aggregation on the surface (which is commonly observed with MS2) 
often prevented distinguishing individual arrays as by AFM, but in numerous cases 
individual capsids clearly linked by tiles are visible. We note that the tiles are flexible 
and can curve, as seen in the TEM images, unlike in the AFM images where they adsorb 
flat on the surface.  
1.5. Atomic Force Miscroscopy (AFM) 
For imaging in air, after annealing samples, the tile-capsid conjugates were 
analyzed by tapping-mode AFM. To prepare samples, first 2 μL of 1 mM NiCl2 in ddH2O 
was applied to a freshly cleaved mica surface for 2 min. Next, 2 μL of sample was 
applied for an additional 2 min. The mica was then rinsed by dipping into ddH2O and 
dried using a stream of nitrogen. Images were obtained using a Veeco Nanoscope V 
scanning probe miscroscopy (Veeco, USA) using FM-50 tips with a 75 kHz resonant 
frequency and a force constant of 2.8 N/m (Nano World, USA). 
For imaging in solution, the AFM images were performed under 1x TAE-Mg
2+
 
buffer (40 mM Tris, 20 mM acetic acid, 2 mM EDTA, 12.5 mM Mg(OAc)2, pH 8.0) in a 
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fluid cell in tapping mode, using the tip on the shorter cantilever of the SNL tips (Veeco, 
USA). The sample (2 μL) was first deposited onto the freshly cleaved mica surface and 
left to adsorb for 1min. Then, 35 μL of 1x TAE-Mg2+ buffer was added onto the surface 
before obtaining the image. 
1.6. Design of DNA Origami Tiles 
The position of each probe strand was determined using the software program 
Tiamat (developed by the Yan Lab and collaborators: 
http://yanlab.asu.edu/Resources.html). The design of the rectangular origami tiles was as 
shown in Figure S1.The design of triangular origami was used as previously described by 
Rothemund. 
2
A polyA/T hybridization strategy was chosen over a polyG/C strategy to 
avoid potential problems due to G-quadruplex formation. 
1.7. Formation of Single DNA Origami Tiles 
The origami tiles were formed according to the method of Rothemund.2 A molar 
ratio of 1:5 between the long M13 viral ssDNA and the short unmodified staple strands 
was used. The probe strands for hybridization with the poly-T strands on the capsid were 
used in 10:1 ratio to that of the viral DNA. Origami tiles were assembled in 1x TAE-
Mg
2+
 buffer (40 mM Tris, 20 mM acetic acid, 2 mM EDTA, 12.5 mM Mg(OAc)2, pH 
8.0) by cooling slowly from 90 °C to room temperature. The origami tiles and excess 
staples were then separated by EtBr stained 1.5% agarose gel (running buffer 1x TAE-
Mg
2+
 buffer, 10 V/cm), running in an ice-water bath. The band corresponding to the tiles 
was excised and the probe tiles were extracted from the gel using Freeze N’ Squeeze 
columns (Bio-Rad, USA). After purification, the tiles were then concentrated using 100 
kDa Microcon centrifugal filter devices (Millipore, USA). The final concentration of 
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origami tiles was estimated according to the dsDNA absorbance at 260nm and the 
calculated extinction coefficient (http://biophysics.idtdna.com/). 
1.8. Single Tile Analysis 
Purified origami tiles were verified by both EtBr stained 1.5% agarose gel (the 
same as the purification step) and AFM. Samples (10 μL) were mixed with 1 μL 10x 
native gel loading dye and then loaded into each well. 
1.9. Production of  N87C T19paF MS2 
The unnatural amino acid p-aminophenylalanine (paF) was incorporated into MS2 
as previously described.
3
 The N87C/T19paF mutant plasmid was created by site-directed 
mutagenesis of the pBAD-T19paF MS2 vector using forward primer following the 
Qiagen protocol: 
5’-AGCCGCATGGCGTTCGTACTTATGTATGGAACTAACCATTC-3’ 
and reverse primer: 
5’-GAATGGTTAGTTCCATACATAAGTACGAACGCCATGCGGCT-3’. 
The pBAD-N87C/T19paF was subsequently grown and purified as previously described.
3
 
1.10. Modification of MS2 with Oregon Green (OG) Maleimide 
The modification of capsids with OG maleimide was carried out as previously 
described.
4
 To a solution of N87C T19paF MS2 (80 μM in 10 mM phosphate buffer, pH 
7) was added 20 equivalents of Oregon Green maleimide as a 100 mM solution in DMF. 
The reaction mixture was vortexed briefly, and then incubated at RT for 2 h in the dark. 
The mixture was then passed through a NAP-5 column equilibrated with 10 mM 
phosphate buffer, pH 7, to remove excess chromophore. The capsids were further 
concentrated using a 100,000 Da molecular weight cut-off filter. The conversion of 
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porphyrin was determined by comparing the absorbance of the Oregon Green absorption 
maximum (ε = 80,000 M-1cm-1) to the A260 of the protein (ε = 172,000 M-1cm-1) and 
assuming negligible dye absorbance at 260 nm. All exctinction coefficients were 
determined in 10 mM phosphate, pH 7, the buffer in which the MS2 conjugates were 
stored. 
1.11. DNA attachment via oxidative coupling 
The (T)20 ssDNA sequence was appended to MS2 capsids modified inside with 
Oregon Green (OG) as previously described.
5
 To synthesize the phenylene diamine 
conjugate necessary for the oxidative coupling, DNA strands containing a primary amine 
at the 5’-end were reacted with 4-(4-diethylamino-phenylcarbamoyl)-butyric acid (60-
120 eq.) in a 1:1 solution of DMF and 50 mM phosphate buffer, pH 8. The reaction 
mixture was allowed to react at RT for 2 h, then purified by gel filtration to remove 
excess small molecule. The DNA was then lyophilized and resuspended in the desired 
buffer. The concentration was determined by measuring the absorbance at 260 nm. 
The phenylene diamine-modified DNA strand was next attached to the MS2-OG 
conjugate via the oxidative coupling reaction as previously described. An Eppendorf tube 
was charged with MS2-OG (20 μM), the phenylene diamine-modified oligonucleotide 
(200 μM), and NaIO4 (5 mM). The reaction mixture was vortexed and allowed to react at 
RT for 1 h. The reaction was quenched by the addition of 1/10 volume of 500 mM TCEP, 
then purified by NAP-5 filtration and spin-concentration using 100 kDa molecular weight 
cut-off filters. 
1.12. Procedure for Annealing of Capsids to Tiles 
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For annealing reactions between capsids and tiles, the components were mixed in 
2x TAE-Mg
2+
 buffer (80 mM Tris, 40 mM acetic acid, 4 mM EDTA, 25 mM Mg(OAc)2, 
pH 8.0) and annealed from 37 to 4 °C at a rate of 1 °C/min on a S1000 Thermal Cycler 
PCR machine (Bio-Rad, USA). Typical final tile concentration was ~2 nM, and the 
capsid concentration was scaled accordingly (e.g. ~ 4 nM in capsid for the experiments 
described in the paper). To make the E and M tile arrays, a small aliquot (~1 μL) of a 
concentrated solution of linker strands was added (either 5 or 10 equivalents) to the 
mixture prior to annealing. For the DC tile arrays, 5 equivalents of the edge staples (again 
as a small aliquot of concentrated solution) were added to the mixture prior to annealing. 
All samples were imaged by AFM immediately following annealing in order to prevent 
inter-tile or inter-array aggregation with time. A 2x concentration of buffer was used 
because we found that it gave longer arrays in general, most likely due to the increased 
electrostatic screening of the higher-salt buffer. 
It appears that origami tiles and DNA in general bind to the mica surface with a 
greater efficiency than the MS2-dye-DNA conjugate or capsids alone. Thus, the two-fold 
excess of capsids used in most experiments is not obvious from inspecting the AFM 
images alone. Furthermore, in Figure S19, almost no capsids can be seen in the AFM 
image despite a two-fold excess relative to tiles. This is likely due to the large excess of 
(T)40 ssDNA added, which preferentially binds the mica and passivates it against capsid 
binding. 
Virtually 100% efficiency of capsid-tile association was also observed upon 
incubating the components at 4 °C overnight (without an annealing step), but we used the 
annealing procedure due to the efficacy and speed it afforded. We have also observed that 
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prolonged incubation of capsids and tiles results in lower-quality images for as of yet 
undetermined reasons, so shorter incubation times were preferred. 
The dye modification of the interior of the capsids with OG did not have any 
effect on the hybridization efficiency. Capsids that did not contain the dye associated just 
as effectively with the tiles as capsids with the dye. 
An “on-surface” association of tiles with capsids was also attempted. In this 
experiment, we took tile arrays formed without MS2 and deposited them on the surface 
first. After rinsing and drying the mica surface, a dilute solution of DNA-modified 
capsids was applied for about 5 minutes. Imaging by AFM showed that while a modest 
fraction of binding sites on the tiles contained MS2, there was too much non-specific 
background adsorption of capsids to the surface to make this approach useful. 
Furthermore, this approach may not be optimal because the arrays could bind to the 
surface with the probe strands facing downward, preventing access by the ssDNA on the 
capsids. 
1.13. Array Length Distribution Quantification 
To determine the distribution of array lengths shown in Figures S20-S22, multiple 
AFM images were obtained for each sample calculated (not all images were included in 
the Supporting Information). Manual counting of these images yielded the statistics 
reported in the distributions. For single tiles, visual inspection determined whether a tile 
had a capsid or not, and whether more than one tile was bound to a given capsid. Broken 
or incompletely formed tiles were not counted. 
In counting the E and M tile arrays, only arrays that were completely in the field 
of view of the AFM image were counted. Furthermore, only arrays that were clearly 
116 
 
distinguishable were counted; occasional aggregates that prevented distinguishing 
individual arrays were disregarded. Array lengths are reported based on the number of 
tiles in an array; however, the association efficiency of tiles with capsids remained close 
to 100%, so the tile array length correlates pretty much exactly with the capsid array 
length. 
In counting the DC tile arrays, once again only arrays that were completely in the 
field of view were counted, and large aggregates were disregarded. Due to the presence 
of tile edges without capsids bound, array lengths were reported with respect to the 
number of capsids in a row. The total number of tile edges without capsids was 
determined, as well as the number of branch points (defined as capsids that had more 
than two tiles bound to them). 
1.14. Control Experiments 
Control experiments were first carried out using the three rectangular tiles (E, M, 
and DC) and capsids modified with the dye but not with DNA (Figures S15-S17). Edge 
staples were added in the mixture as well for the case of the DC tiles. No significant 
association of the capsids with the tiles was observed; in addition, the DC tiles show 
significant edge stacking due to the staples added, indicating that this factor was an 
important “pre-organization” effect that aided the array. Control experiments were also 
carried out with E tiles bearing a random 40-nt sequence and capsids modified with the 
(T)20 sequence used in the main experiments (Figure S18). Once again, no significant 
association of the capsids with the tiles was seen. 
In another experiment, MS2-OG-(T)20 was mixed with E tiles (bearing the correct 
(A)40 sequence) and annealed, then in a second step a large excess (~1000-fold) of (T)40 
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ssDNA was added and a second annealing carried out. The competing strand binds to the 
40-nt probe on the tiles with a greater affinity than the 20-nt strands on the MS2; 
combined with the large excess added, this effect results in the displacement of the MS2 
strands from the tile (Figure S19). Fewer tiles are seen on the surface than in other 
experiments, likely due to the passivation of the surface to MS2 binding due to the excess 
(T)40 strand. The removal of the MS2 upon addition of the (T)40 strand not only confirms 
the DNA-specific binding of the capsids, but also suggests a possible way to remove the 
capsids from the tiles if capsid release is required at a later time. 
2. DNA Sequences 
2.1. E-tile Probe Sequences 
Probe-57: 
AACAGGGAAGCGCAGAACAAAGTCAGAGGGTAATTGAGCGCTTATTACGCA
GTATGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA 
Probe-82: 
AGTAATTCTGTCCACGAGCCAGTAATAAGAGAATATAAAGTAATCCAATCGC
AAGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA 
Probe-107: 
TAATGCAGAACGCGATATTTAACAACGCCAACATGTAATTTAATATTTTAGTT
AATAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA 
2.2. M-tile Probe Sequences 
Probe-85: 
GAAGGAGCGGAATTGTTTGAGTAACATTATCATTTTGCGGAATGCAACAGTG
CCACAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA 
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Probe-87: 
GCTGAGAGCCAGCAAGGTGAGGCGGTCAGTATTAACACCGCCCCAGCCATTG
CAACAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA 
Probe-89: 
AGGAAAAACGCTCAGCTGGTAATATCCAGAACAATATTACCGCGCGCTTAAT
GCGCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA 
Probe-110: 
GGCAATTCATCAATACTCGTATTAAATCCTTTGCCCGAACGTTAAAGCATCAC
CTTAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA 
Probe-112: 
GCTGAACCTCAAATCATTAAAAATACCGAACGAACCACCAGCTTTTGACGCT
CAATAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA 
Probe-114: 
CGTCTGAAATGGATAACATCACTTGCCTGAGTAGAAGAACTCTGACGAGCAC
GTATAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA 
2.3. DC-tile Probe Sequences 
Probe-17: 
TATCACCGTCACCGCCATCTTTTCATAATCAAAATCACCGGATCAGAGCCGCC
ACCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA 
Probe-18: 
CTCAGAACCGCCACAGGAGTGTACTGGTAATAAGTTTTAACGTATAAACAGT
TAATAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA 
Probe-19: 
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GCCCCCTGCCTATTGAACCGCCACCCTCAGAGCCACCACCCTAACCCATGTAC
CGTAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA 
Probe-20: 
AACACTGAGTTTCGTCACGTTGAAAATCTCCAAAAAAAAGGCTTATCAGCTT
GCTTAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA 
Probe-21: 
TCGAGGTGAATTTCTGAGGAAGTTTCCATTAAACGGGTAAAACTAAAACGAA
AGAGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA 
Probe-152: 
CGCTATTAATTAATAATAAAGAAATTGCGTAGATTTTCAGGTTATCAAAATTA
TTTAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA 
Probe-160: 
GCACGTAAAACAGAGCACTAACAACTAATAGATTAGAGCCGTAGGAAGGTT
ATCTAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA 
Probe-162: 
AAATATCTTTAGGAAAAGCGTAAGAATACGTGGCACAGACAACCAACAGAG
ATAGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA 
Probe-164: 
ACCCTTCTGACCTGTTTATAATCAGTGAGGCCACCGAGTAAAACGGTACGCC
AGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA 
Probe-166: 
TCCTGAGAAGTGTTCACTAAATCGGAACCCTAAAGGGAGCCCAGTTTTTTGG
GGTCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA 
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2.4. Tri1-tile Probe Sequences 
Probe-A37: 
AGAGAATAACATAAAAACAGGGAAGCGCATTAAAAAAAAAAAAAAAAAAA
AAAAAAAAAAAAAAAAAAAAAA 
Probe-A33: 
CCTTTTTTCATTTAACAATTTCATAGGATTAGAAAAAAAAAAAAAAAAAAAA
AAAAAAAAAAAAAAAAAAAA 
Probe-A10: 
TGTACTGGAAATCCTCATTAAAGCAGAGCCACAAAAAAAAAAAAAAAAAAA
AAAAAAAAAAAAAAAAAAAAA 
Probe-A39: 
TTATCAAACCGGCTTAGGTTGGGTAAGCCTGTAAAAAAAAAAAAAAAAAAA
AAAAAAAAAAAAAAAAAAAAA 
Probe-A35: 
AGTATAAAATATGCGTTATACAAAGCCATCTTAAAAAAAAAAAAAAAAAAA
AAAAAAAAAAAAAAAAAAAAA 
2.5. Tri3-tile Probe Sequences 
Probe-A37: 
AGAGAATAACATAAAAACAGGGAAGCGCATTAAAAAAAAAAAAAAAAAAA
AAAAAAAAAAAAAAAAAAAAAA 
Probe-A33: 
CCTTTTTTCATTTAACAATTTCATAGGATTAGAAAAAAAAAAAAAAAAAAAA
AAAAAAAAAAAAAAAAAAAA 
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Probe-A10: 
TGTACTGGAAATCCTCATTAAAGCAGAGCCACAAAAAAAAAAAAAAAAAAA
AAAAAAAAAAAAAAAAAAAAA 
Probe-A39: 
TTATCAAACCGGCTTAGGTTGGGTAAGCCTGTAAAAAAAAAAAAAAAAAAA
AAAAAAAAAAAAAAAAAAAAA 
Probe-A35: 
AGTATAAAATATGCGTTATACAAAGCCATCTTAAAAAAAAAAAAAAAAAAA
AAAAAAAAAAAAAAAAAAAAA 
Probe-B37: 
ACAGGTAGAAAGATTCATCAGTTGAGATTTAGAAAAAAAAAAAAAAAAAAA
AAAAAAAAAAAAAAAAAAAAA 
Probe-B33: 
AGGGATAGCTCAGAGCCACCACCCCATGTCAAAAAAAAAAAAAAAAAAAAA
AAAAAAAAAAAAAAAAAAAAA 
Probe-B10: 
CAATATGACCCTCATATATTTTAAAGCATTAAAAAAAAAAAAAAAAAAAAA
AAAAAAAAAAAAAAAAAAAAA 
Probe-B39: 
ATTTTCTGTCAGCGGAGTGAGAATACCGATATAAAAAAAAAAAAAAAAAAA
AAAAAAAAAAAAAAAAAAAAA 
Probe-B35: 
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GCCGCTTTGCTGAGGCTTGCAGGGGAAAAGGTAAAAAAAAAAAAAAAAAAA
AAAAAAAAAAAAAAAAAAAAA 
Probe-C37: 
CGAGAAAGGAAGGGAAGCGTACTATGGTTGCTAAAAAAAAAAAAAAAAAAA
AAAAAAAAAAAAAAAAAAAAA 
Probe-C33: 
CGCGTCTGATAGGAACGCCATCAACTTTTACAAAAAAAAAAAAAAAAAAAA
AAAAAAAAAAAAAAAAAAAAA 
Probe-C10: 
TAATCCTGATTATCATTTTGCGGAGAGGAAGGAAAAAAAAAAAAAAAAAAA
AAAAAAAAAAAAAAAAAAAAA 
Probe-C39: 
CAGTTTGACGCACTCCAGCCAGCTAAACGACGAAAAAAAAAAAAAAAAAAA
AAAAAAAAAAAAAAAAAAAAA 
Probe-C35: 
CTCTAGAGCAAGCTTGCATGCCTGGTCAGTTGAAAAAAAAAAAAAAAAAAA
AAAAAAAAAAAAAAAAAAAAA 
2.6. E- and M-tile Array Linker Sequences 
L1: CACCAACTACGTAATGCCACT TCGGCTGTCTTTCC 
L2: GAACCGGCATCAAGAGTAATC AGCCTGTTTAGTAT 
L3: ACTAATGGATTTAGGAATACC TTTCCCTTAGAATC 
L4: AGTCAGAGGTCTTTACCCTGA AATAAAGAAATTGC 
L5: ATTCTGCCCATATAACAGTTG GCACTAACAACTAA 
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L6: GTAGATTTTCAGGTTATCAAAATTATTTGCACGTAAAACAGA CTATTAT 
L7: CTTGAAAACATAGCCTTCTGTAAATCGTCGCTATTAATTAAT ACATTCA 
L8: CATATGCGTTATACAAACACCGGAATCATAATTACTAGAAAA TTGACAA 
L9: TTATCATTCCAAGATTACGAGCATGTAGAAACCAATCAATAA ACGAAGG 
L10: TAGATTAGAGCCGTAGGAAGGTTATCTAAAATATCTTTAGGA ATTCCCA 
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4. Supplemental Figures 
 
Figure S1. Schematic representation of the rectangular tiles used in this study. (A) 
Digram showing the location of the probes in the three designs. Numbers refer to the 
staples holding together the M13 back-bone. (B) Image of rectangular tile showing all the 
helices as well as the protruding probes for the three designs. The 3’ end of each probe is 
protruding from the tile. 
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Figure S2. Schematic representation of the triangular tiles used in this study. (A) 
Diagram showing the location of the probes (red dots) in the two triangle designs. 
Numbers refer to the staples holding together the M13 backbone. (B) Image of the Tri3 
tile showing all the helices as well as the protruding probes. The design of the Tri1 tile 
was identical, but with only one set of probes. The 3’ end of each probe is protruding out 
from the planar. 
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Figure S3. Characterization of the origami tiles. (A) Agarose gel of the tiles used in this 
paper. Lanes: M: 1 kb ladder, 1: M13 genome, 2: E tiles, 3: M tiles, 4: DC tiles (dimer 
due to edge stacking), 5: Tri1 tiles, 6: Tri3 tiles. (B-F): AFM images of single tiles after 
purification. Scale bars: 500 nm. 
 
 
 
 
 
 
127 
 
 
Figure S4. Synthesis and characterization of the MS2 capsids with Oregon Green (OG) 
inside and ssDNA outside. The 5’ end of the ssDNA strand is attached to the capsid. The 
5’ end of the ssDNA strand is attached to the capsid. (A) Synthetic scheme to modify the 
interior of the capsid with Oregon Green maleimide at C87 and the exterior of the capsid 
with (T)20 DNA at the unnatural amino acid paF19 using an oxidative coupling reaction. 
(B) The UV-Vis spectrum of the MS2-OG conjugate shows the chromophore absorbance 
at 500 nm. The conversion was estimated to be nearly quantitative by the comparison of 
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the dye extinction coefficient (ε500 nm = 80,000 M-1cm-1) and the protein’s extinction 
coefficent (ε260 nm = 176,000 M-1cm-1). (C) SDS-PAGE analysis of the MS2-OG-(T)20 
conjugate shows a new band at higher molecular weight corresponding to the protein-
DNA conjugate. The conversion was estimated to at ~11% by densitometry 
(corresponding to ~20 copies/capsid). (D) Transmission electron microscopy images of 
the MS2-OG-(T)20 conjugate indicated that the capsids were intact, assembled, and 27 
nm in diameter as expected. 
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Figure S5. Additional AFM images of E tiles + MS2. Zoom-in scale bars: 200 nm. 
Zoom-out scale bars: 500 nm. 
 
Figure S6. Additional AFM images of M tiles + MS2. Zoom-in scale bars: 200 nm. 
Zoom-out scale bars: 500 nm. 
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Figure S7. Additional AFM images of Tri1 tiles + MS2. Zoom-in scale bars: 200 nm. 
Zoom-out scale bars: 500 nm. 
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Figure S8. Additional AFM images of Tri3 tiles + MS2. Zoom-in scale bars: 200 nm. 
Zoom-out scale bars: 500 nm. 
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Figure S9. Additional AFM images of Tri3 tiles showing the occasional binding of one 
capsid to a single edge of the tile (but not sitting in the hole), two capsids binding to two 
edges of the tile, or three capsids binding to three edges of the tile. Scale bars: 50 nm. 
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Figure S10. Additional AFM images of E tile arrays with MS2. Note the frequent 
occurence of array aggregation due to multiple tiles binding a single capsid. Scale bars: 
200 nm. 
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Figure S11. Additional AFM images of M tile arrays with MS2. Scale bars: 200 nm. 
 
Figure S11 (cont). Additional AFM images of M tile arrays with MS2. Scale bars: 200 
nm. 
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Figure S11 (cont). Additional AFM images of M tile arrays with MS2 . Scale bars: 500 
nm. 
 
Figure S12. AFM images of additional DC tile arrays formed with MS2. Scale bars: 500 
nm. 
 
Figure S12 (cont). AFM images of additional DC tile arrays formed with MS2. Scale 
bars: 500 nm. 
136 
 
 
Figure S13. AFM images of E tile arrays formed without MS2. Scale bars: 500 nm. 
 
Figure S14. AFM images of M tile arrays formed without MS2. Scale bars: 500 nm. 
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Figure S15. AFM images of control experiment: E tiles with MS2-dye (no DNA). No 
significant asso-ciation of the capsids with the tiles is visible. Scale bars: 500 nm. 
 
Figure S16. AFM images of control experiment: M tiles with MS2-dye (no DNA). No 
significant asso-ciation of the capsids with the tiles is visible. Scale bars: 500 nm 
 
Figure S17. AFM images of control experiment: DC tiles with MS2-dye (no DNA) + 
edge staples. No significant association of the capsids with the tiles is visible. Note the 
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prevalent association of the tile short edges due to noncovalent base stacking induced by 
the edge staples. Scale bars: 500 nm. 
 
Figure S18. AFM images of control experiment: E tiles with capsids, but with 
mismatched probes. The capsids contained the 20-bp polyT sequence, but the tiles 
contained probes with a random 40-bp sequence. No association is seen between the 
capsids and the tiles, further indicating that specific DNA hybridization is necessary and 
the association is not a non-specific DNA-based effect. Scale bars: 500 nm. 
 
Figure S19. Control experiments: E tiles with capsids with matched probes, then addition 
of excess (T)40 strand. Very few tiles still have capsids bound to them, indicating both the 
sequence selective nature of the capsid-tile association, as well as suggesting a release 
mechanism for capsids once bound to the tiles. Fewer capsids are seen on the surface 
than usual, likely due to passivation of the mica by the excess ssDNA, thus 
electrostatically occluding the surface to the capsids. Scale bars: 500 nm. 
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Figure S20. E tile array length distributions. An array length of 1 indicates a single tile 
not in an array. For the samples that include MS2, virtually complete association of the 
caspids with tiles was maintained 
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Figure S21. M tile array length distributions. An array length of 1 indicates a single tile 
not in an array. For the samples that include MS2, virtually complete association of the 
caspids with tiles was maintained 
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Figure S21 (cont). M tile array length distributions. 
 
Figure S22. DC tile array length distributions. The arrays are counted in the number of 
capsids in a row, not tiles (as with the E and M tile arrays). An array length of 0 signifies 
a tile with no capsids bound. 
 
 
 
142 
 
 
Figure S23. Additional TEM image of Tri1 tiles and MS2. The triangular tiles are clearly 
visible, as are the caspids adhered to one side. Scale bar: 100 nm. 
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Figure S24. Additional zoom-out TEM images of Tri3 tiles and MS2. The capsids are 
almost exclusively immobilized in the center of the tiles and pull the three sides inwards 
towards the center of the tile, distorting them. Scale bars: 50 nm. 
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Figure S25. TEM images of M tile arrays with MS2. The tiles do not stain well, and 
likely shrink due to the uranyl acetate stain, as well as lying sideways on the grid, but the 
capsids are intact and spaced approximately 100 nm apart. Scale bars: 50 nm. 
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Figure S26. TEM images of DC tile arrays formed with MS2. Scale bars: 50 nm. 
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Figure S27. AFM images of capsids and tiles association using a random, 
complementary sequence (not polyA/T). The probes on the tiles are a random 40-bp 
sequence and the DNA on the caspids is complemen-tary to the last 20 bp of the probe. 
The hybridization efficiency does not surpass ~50%. 
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1. Chemicals 
Glucose oxidase (Aspergillus niger), horseradish peroxidase, and phosphate 
buffered saline (PBS) were purchased from Sigma (St.Louis, MO). β-Gal streptavidin 
conjugates were purchased from Rockland (Gilbertsville, PA). Neutravidin, ABTS (2, 2’-
Azinobis [3-ethylbenzothiazoline-6-sulfonic acid] -diammonium salt) and SPDP (N-
Succinimidyl 3-(2-pyridyldithio)-propionate) were purchased from Pierce (Rockford, IL). 
M13 single-stranded DNA was purchased from Affymetrix (Santa Clara, CA). Single-
stranded oligonucleotides were purchased from IDT (Coralville, Iowa). 
2. AFM Imaging 
~ 2 μL sample was deposited onto a freshly cleaved mica surface (Ted Pella, Inc.) 
and left to adsorb for 1 min. 400 μL of 1 x TAE-Mg2+ buffer was added to the liquid cell 
and the sample was scanned using SNL tips (Veeco, Inc.) in AC acoustic mode using a 
Pico-Plus AFM (Molecular Imaging, Agilent Technologies), or on a Veeco 8 AFM in 
peak-force mode. 
 
Table S1. Detailed annealing program for assembling DNA origami tiles. 
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Figure S1. SDS-PAGE electrophoresis of purified protein-DNA conjugates: lane1, 
ladder; lane 2, wild-type HRP; lane 3, HRP-poly(GGT)6; lane 4, wild-type GOx; lane5, 
GOx-poly(T)22. Conditions: NuPAGE 4%-12% Bis Tris Gel with a constant voltage of 
150 V for 50mins. 
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Figure S2. DNA Origami tile schematics. 
 
Figure S2(cont). DNA Origami tile schematics. 
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Figure S3. Agarose gel electrophoresis of DNA origami tiles after purification. 
Condition: 1.0% agarose (1xTAE-Mg
2+
, 0.5 g/mL ethidium bromide) at 75-80 V for two-
three hours; visualized with UV light. The bright background is a result of the loading 
dye (inverse color). 
 
Figure S4. Titration of enzyme-to-origami ratio to achieve efficient co-assembly yields. 
DNA origami tiles with 45-nm inter-enzyme distance were used for this assay (scale bar 
~ 200 nm). 
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Figure S5. Evaluation of co-assembly yield of GOx and HRP on designed origami tiles. 
Each AFM image is generated by scanning an area of 2 μm× 2 μm. (A) 10-nm GOx/HRP 
interenzyme distance with ~ 44% assembly yield; (B) 20-nm GOx/HRP inter-enzyme 
distance with ~ 77% assembly yield; 
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Figure S5 (cont). (C) 45-nm GOx/HRP inter-enzyme distance with ~ 95% assembly 
yield and (D) 65-nm GOx/HRP inter-enzyme distance with ~ 93% assembly yield. The 
calculated assembly yield is the average of two AFM images. Unclear origami tiles were 
not counted. 
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Figure S6. Height profiles of typical GOx/HRP pairs assembled on DNA origami tiles 
with (a)10-nm inter-enzyme distance, (B) 20-nm inter-enzyme distance, (C) 45-nm inter-
enzyme distance and (D) 65-nm inter-enzyme distance. 
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Figure S7. Enhancement in the calibrated enzyme activity of assembled GOx/HRP tiles 
with six inter-enzyme distances ranging from 10-nm to 65-nm (GOx/HRP co-assembly 
yields are noted above each bar). Note, only two capture probes were used for these 
experiments, with relatively low co-assembly yields compared to experiments utilizing 
four capture probes. 
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Figure S8. Evaluation of co-assembly yield of GOx/HRP pairs with a protein bridge on 
designed origami tiles. Each AFM image is generated by scanning an area of 2.5 μm× 2.5 
μm. (A) 30-nm GOx/HRP tile inter-enzyme distance with ~ 84% assembly yield; (B) 30-
nm GOx-(β-Gal)-HRP- inter-enzyme distance with ~ 38% assembly yield; (C) 30-nm 
GOx-(NTV)-HRP inter-enzyme distance with ~ 50% assembly yield. 
 
Figure S9. Crystal structures generated by PyMOL program. (A) Horseradish peroxidase 
(PDB 1ATJ); (B) Glucose oxidase (Apergillus Niger, PDB 1CF3); (C) Neutravidin; (D) 
β-galactosidase 
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Figure S10. 3D model of GOx/HRP cascade assembled on origami tiles with anchor 
spacing distance ranged from 10-nm to 65-nm. Double-stranded DNA linker for 
anchoring enzymes is 20- 22-bp with ~ 7 nm in length. GOx (yellow sphere) has a 
diameter ~ 10 nm from crystal structure, and HRP (purple sphere) has a diameter ~ 5 nm. 
The yellow dot line indicates the accessible range for GOx, and the purple dot line 
indicates the accessible range for HRP on the origami tiles. For a GOx/HRP pair spaced 
with 10-nm, there is a high possibility that two proteins will connect to each other. The 
crowded space also results in the lower assembly yield for the 10-nm spacing distance. 
 
Figure S11. Statistical analysis of the observed inter-enzyme distances (center-to-center) 
for GOx/HRP assembled origami tiles using the AFM images in Figure S8: (A) 10-nm 
spaced origami tiles, (B) 20-nm spaced origami tiles; (C) 45-nm spaced origami tiles and 
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(D) 65-nm spaced origami tiles. 100 GOx/HRP-assembled tiles were statically analyzed 
for each interenzyme distance. No origami tiles were observed with inter-enzyme 
distance less than 5 nm due to the overlap of protein volume. Nearly 50% of GOx/HRP 
pairs on 10-nm spaced origami tiles exhibited an inter-enzyme distance between 5-10 nm, 
indicating that two enzymes are essentially touched with each other. This connected 
surface will strongly facilitate the H2O2 transfer across the shared hydration shell. 
 
Figure S12. Curve fitting for the activity of assembled GOx/HRP pairs with β-Gal and 
NTV bridges compared to un-bridged GOx/HRP pairs. The velocity of each GOx/HRP 
pair is estimated by the fitting the slope of the curve. The β-Gal bridges result in 42 ± 4 
% higher activity than un-bridged GOx/HRP pairs, while the HRP bridges result in 20 ± 
4 % higher activity than un-bridged GOx/HRP pairs. 
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Name Sequence Name Sequence
13 TGGTTTTTAACGTCAAAGGGCGAAGAACCATC 114 ATCGGCTGCGAGCATGTAGAAACCTATCATAT
14 CTTGCATGCATTAATGAATCGGCCCGCCAGGG 115 CCTAATTTACGCTAACGAGCGTCTAATCAATA
15 TAGATGGGGGGTAACGCCAGGGTTGTGCCAAG 116 AAAAGTAATATCTTACCGAAGCCCTTCCAGAG
16 CATGTCAAGATTCTCCGTGGGAACCGTTGGTG 117 TTATTCATAGGGAAGGTAAATATTCATTCAGT
17 CTGTAATATTGCCTGAGAGTCTGGAAAACTAG 118 GAGCCGCCCCACCACCGGAACCGCGACGGAAA
18 TGCAACTAAGCAATAAAGCCTCAGTTATGACC 119 AATGCCCCGTAACAGTGCCCGTATCTCCCTCA
19 AAACAGTTGATGGCTTAGAGCTTATTTAAATA 120 CAAGCCCAATAGGAACCCATGTACAAACAGTT
20 ACGAACTAGCGTCCAATACTGCGGAATGCTTT 121 CGGCCTTGCTGGTAATATCCAGAACGAACTGA
21 CTTTGAAAAGAACTGGCTCATTATTTAATAAA 122 TAGCCCTACCAGCAGAAGATAAAAACATTTGA
22 ACGGCTACTTACTTAGCCGGAACGCTGACCAA 123 GGATTTAGCGTATTAAATCCTTTGTTTTCAGG
23 GAGAATAGCTTTTGCGGGATCGTCGGGTAGCA 124 TTTAACGTTCGGGAGAAACAATAATTTTCCCT
24 ACGTTAGTAAATGAATTTTCTGTAAGCGGAGT 125 TAGAATCCCTGAGAAGAGTCAATAGGAATCAT
25 ACCCAAATCAAGTTTTTTGGGGTCAAAGAACG 126 AATTACTACAAATTCTTACCAGTAATCCCATC
26 TGGACTCCCTTTTCACCAGTGAGACCTGTCGT 127 CTAATTTATCTTTCCTTATCATTCATCCTGAA
27 GCCAGCTGCCTGCAGGTCGACTCTGCAAGGCG 128 TCTTACCAGCCAGTTACAAAATAAATGAAATA
28 ATTAAGTTCGCATCGTAACCGTGCGAGTAACA 129 GCAATAGCGCAGATAGCCGAACAATTCAACCG
29 ACCCGTCGTCATATGTACCCCGGTAAAGGCTA 130 ATTGAGGGTAAAGGTGAATTATCAATCACCGG
30 TCAGGTCACTTTTGCGGGAGAAGCAGAATTAG 131 AACCAGAGACCCTCAGAACCGCCAGGGGTCAG
31 CAAAATTAAAGTACGGTGTCTGGAAGAGGTCA 132 TGCCTTGACTGCCTATTTCGGAACAGGGATAG
32 TTTTTGCGCAGAAAACGAGAATGAATGTTTAG 133 AGGCGGTCATTAGTCTTTAATGCGCAATATTA
33 ACTGGATAACGGAACAACATTATTACCTTATG 134 TTATTAATGCCGTCAATAGATAATCAGAGGTG
34 CGATTTTAGAGGACAGATGAACGGCGCGACCT 135 CCTGATTGAAAGAAATTGCGTAGACCCGAACG
35 GCTCCATGAGAGGCTTTGAGGACTAGGGAGTT 136 ATCAAAATCGTCGCTATTAATTAACGGATTCG
36 AAAGGCCGAAAGGAACAACTAAAGCTTTCCAG 137 ACGCTCAAAATAAGAATAAACACCGTGAATTT
37 AGCTGATTACAAGAGTCCACTATTGAGGTGCC 138 GGTATTAAGAACAAGAAAAATAATTAAAGCCA
38 CCCGGGTACTTTCCAGTCGGGAAACGGGCAAC 139 ATTATTTAACCCAGCTACAATTTTCAAGAACG
39 GTTTGAGGGAAAGGGGGATGTGCTAGAGGATC 140 GAAGGAAAATAAGAGCAAGAAACAACAGCCAT
40 AGAAAAGCAACATTAAATGTGAGCATCTGCCA 141 GACTTGAGAGACAAAAGGGCGACAAGTTACCA
41 CAACGCAATTTTTGAGAGATCTACTGATAATC 142 GCCACCACTCTTTTCATAATCAAACCGTCACC
42 TCCATATACATACAGGCAAGGCAACTTTATTT 143 CTGAAACAGGTAATAAGTTTTAACCCCTCAGA
43 CAAAAATCATTGCTCCTTTTGATAAGTTTCAT 144 CTCAGAGCCACCACCCTCATTTTCCTATTATT
44 AAAGATTCAGGGGGTAATAGTAAACCATAAAT 145 CCGCCAGCCATTGCAACAGGAAAAATATTTTT
45 CCAGGCGCTTAATCATTGTGAATTACAGGTAG 146 GAATGGCTAGTATTAACACCGCCTCAACTAAT
46 TTTCATGAAAATTGTGTCGAAATCTGTACAGA 147 AGATTAGATTTAAAAGTTTGAGTACACGTAAA
47 AATAATAAGGTCGCTGAGGCTTGCAAAGACTT 148 ACAGAAATCTTTGAATACCAAGTTCCTTGCTT
48 CGTAACGATCTAAAGTTTTGTCGTGAATTGCG 149 CTGTAAATCATAGGTCTGAGAGACGATAAATA
49 GTAAAGCACTAAATCGGAACCCTAGTTGTTCC 150 AGGCGTTACAGTAGGGCTTAATTGACAATAGA
50 AGTTTGGAGCCCTTCACCGCCTGGTTGCGCTC 151 TAAGTCCTACCAAGTACCGCACTCTTAGTTGC
51 ACTGCCCGCCGAGCTCGAATTCGTTATTACGC 152 TATTTTGCTCCCAATCCAAATAAGTGAGTTAA
52 CAGCTGGCGGACGACGACAGTATCGTAGCCAG 153 GCCCAATACCGAGGAAACGCAATAGGTTTACC
53 CTTTCATCCCCAAAAACAGGAAGACCGGAGAG 154 AGCGCCAACCATTTGGGAATTAGATTATTAGC
54 GGTAGCTAGGATAAAAATTTTTAGTTAACATC 155 GTTTGCCACCTCAGAGCCGCCACCGATACAGG
55 CAATAAATACAGTTGATTCCCAATTTAGAGAG 156 AGTGTACTTGAAAGTATTAAGAGGCCGCCACC
56 TACCTTTAAGGTCTTTACCCTGACAAAGAAGT 157 GCCACGCTATACGTGGCACAGACAACGCTCAT
57 TTTGCCAGATCAGTTGAGATTTAGTGGTTTAA 158 ATTTTGCGTCTTTAGGAGCACTAAGCAACAGT
58 TTTCAACTATAGGCTGGCTGACCTTGTATCAT 159 GCGCAGAGATATCAAAATTATTTGACATTATC
59 CGCCTGATGGAAGTTTCCATTAAACATAACCG 160 TAACCTCCATATGTGAGTGAATAAACAAAATC
60 ATATATTCTTTTTTCACGTTGAAAATAGTTAG 161 CATATTTAGAAATACCGACCGTGTTACCTTTT
61 GAGTTGCACGAGATAGGGTTGAGTAAGGGAGC 162 CAAGCAAGACGCGCCTGTTTATCAAGAATCGC
62 TCATAGCTACTCACATTAATTGCGCCCTGAGA 163 TTTTGTTTAAGCCTTAAATCAAGAATCGAGAA
63 GAAGATCGGTGCGGGCCTCTTCGCAATCATGG 164 ATACCCAAGATAACCCACAAGAATAAACGATT
64 GCAAATATCGCGTCTGGCCTTCCTGGCCTCAG 165 AATCACCAAATAGAAAATTCATATATAACGGA
65 TATATTTTAGCTGATAAATTAATGTTGTATAA 166 CACCAGAGTTCGGTCATAGCCCCCGCCAGCAA
66 CGAGTAGAACTAATAGTAGTAGCAAACCCTCA 167 CCTCAAGAATACATGGCTTTTGATAGAACCAC
67 TCAGAAGCCTCCAACAGGTCAGGATCTGCGAA 168 CCCTCAGAACCGCCACCCTCAGAACTGAGACT
68 CATTCAACGCGAGAGGCTTTTGCATATTATAG 169 GGAAATACCTACATTTTGACGCTCACCTGAAA
69 AGTAATCTTAAATTGGGCTTGAGAGAATACCA 170 GCGTAAGAGAGAGCCAGCAGCAAAAAGGTTAT
70 ATACGTAAAAGTACAACGGAGATTTCATCAAG 171 CTAAAATAGAACAAAGAAACCACCAGGGTTAG
71 AAAAAAGGACAACCATCGCCCACGCGGGTAAA 172 AACCTACCGCGAATTATTCATTTCCAGTACAT
72 TGTAGCATTCCACAGACAGCCCTCATCTCCAA 173 AAATCAATGGCTTAGGTTGGGTTACTAAATTT
73 CCCCGATTTAGAGCTTGACGGGGAAATCAAAA 174 AATGGTTTACAACGCCAACATGTAGTTCAGCT
74 GAATAGCCGCAAGCGGTCCACGCTCCTAATGA 175 AATGCAGACCGTTTTTATTTTCATCTTGCGGG
75 GTGAGCTAGTTTCCTGTGTGAAATTTGGGAAG 176 AGGTTTTGAACGTCAA  AAATGAAAGCGCTAAT
76 GGCGATCGCACTCCAGCCAGCTTTGCCATCAA 177 ATCAGAGAAAGAACTG  GCATGATTTTATTTTG
77 AAATAATTTTAAATTGTAAACGTTGATATTCA 178 TCACAATCGTAGCACCATTACCATCGTTTTCA
78 ACCGTTCTAAATGCAATGCCTGAGAGGTGGCA 179 TCGGCATTCCGCCGCCAGCATTGACGTTCCAG
79 TCAATTCTTTTAGTTTGACCATTACCAGACCG 180 TAAGCGTCGAAGGATT  AGGATTAGTACCGCCA
80 GAAGCAAAAAAGCGGATTGCATCAGATAAAAA 181 CTAAAGCAAGATAGAA  CCCTTCTGAATCGTCT
81 CCAAAATATAATGCAGATACATAAACACCAGA 182 CGGAATTATTGAAAGGAATTGAGGTGAAAAAT
82 ACGAGTAGTGACAAGAACCGGATATACCAAGC 183 GAGCAAAAACTTCTGAATAATGGAAGAAGGAG
83 GCGAAACATGCCACTACGAAGGCATGCGCCGA 184 TATGTAAACCTTTTTTAATGGAAAAATTACCT
84 CAATGACACTCCAAAAGGAGCCTTACAACGCC 185 AGAGGCATAATTTCATCTTCTGACTATAACTA
85 CCAGCAGGGGCAAAATCCCTTATAAAGCCGGC 186 TCATTACCCGACAATAAACAACATATTTAGGC
86 GCTCACAATGTAAAGCCTGGGGTGGGTTTGCC 187 CTTTACAGTTAGCGAACCTCCCGACGTAGGAA
87 GCTTCTGGTCAGGCTGCGCAACTGTGTTATCC 188 TTATTACGGTCAGAGG  GTAATTGAATAGCAGC
88 GTTAAAATTTTAACCAATAGGAACCCGGCACC 189 CCGGAAACACACCACG  GAATAAGTAAGACTCC
89 AGGTAAAGAAATCACCATCAATATAATATTTT 190 TGAGGCAGGCGTCAGACTGTAGCGTAGCAAGG
90 TCGCAAATGGGGCGCGAGCTGAAATAATGTGT 191 TGCTCAGTCAGTCTCTGAATTTACCAGGAGGT
91 AAGAGGAACGAGCTTCAAAGCGAAGATACATT 192 TATCACCGTACTCAGGAGGTTTAGCGGGGTTT
92 GGAATTACTCGTTTACCAGACGACAAAAGATT 193 GAAATGGATTATTTACATTGGCAGACATTCTG
93 CCAAATCACTTGCCCTGACGAGAACGCCAAAA 194 GCCAACAGTCACCTTGCTGAACCTGTTGGCAA
94 AAACGAAATGACCCCCAGCGATTATTCATTAC 195 ATCAACAGTCATCATATTCCTGATTGATTGTT
95 TCGGTTTAGCTTGATACCGATAGTCCAACCTA 196 TGGATTATGAAGATGA  TGAAACAAAATTTCAT
96 TGAGTTTCGTCACCAGTACAAACTTAATTGTA 197 TTGAATTATGCTGATG  CAAATCCACAAATATA
97 GAACGTGGCGAGAAAGGAAGGGAACAAACTAT 198 TTTTAGTTTTTCGAGCCAGTAATAAATTCTGT
98 CCGAAATCCGAAAATCCTGTTTGAAGCCGGAA 199 CCAGACGAGCGCCCAATAGCAAGCAAGAACGC
99 GCATAAAGTTCCACACAACATACGAAGCGCCA 200 GAGGCGTTAGAGAATAACATAAAAGAACACCC
100 TTCGCCATTGCCGGAAACCAGGCATTAAATCA 201 TGAACAAACAGTATGTTAGCAAACTAAAAGAA
101 GCTCATTTTCGCATTAAATTTTTGAGCTTAGA 202 ACGCAAAGGTCACCAATGAAACCAATCAAGTT
102 AGACAGTCATTCAAAAGGGTGAGAAGCTATAT 203 TGCCTTTAGTCAGACGATTGGCCTGCCAGAAT
103 TTTCATTTGGTCAATAACCTGTTTATATCGCG 204 GGAAAGCGACCAGGCGGATAAGTGAATAGGTG
104 TTTTAATTGCCCGAAAGACTTCAAAACACTAT 217 AACATCACTTGCCTGAGTAGAAGAACT
105 CATAACCCGAGGCATAGTAAGAGCTTTTTAAG 218 TGTAGCAATACTTCTTTGATTAGTAAT
106 GAATAAGGACGTAACAAAGCTGCTCTAAAACA 219 AGTCTGTCCATCACGCAAATTAACCGT
107 CTCATCTTGAGGCAAAAGAATACAGTGAATTT 220 ATAATCAGTGAGGCCACCGAGTAAAAG
108 CTTAAACATCAGCTTGCTTTCGAGCGTAACAC 221 ACGCCAGAATCCTGAGAAGTGTTTTT
109 ACGAACCAAAACATCGCCATTAAATGGTGGTT 222 TTAAAGGGATTTTAGACAGGAACGGT
110 CGACAACTAAGTATTAGACTTTACAATACCGA 223 AGAGCGGGAGCTAAACAGGAGGCCGA
111 CTTTTACACAGATGAATATACAGTAAACAATT 224 TATAACGTGCTTTCCTCGTTAGAATC
112 TTAAGACGTTGAAAACATAGCGATAACAGTAC 225 GTACTATGGTTGCTTTGACGAGCACG
113 GCGTTATAGAAAAAGCCTGTTTAGAAGGCCGG 226 GCGCTTAATGCGCCGCTACAGGGCGC
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Name Sequence Name Sequence
13 TGGTTTTTAACGTCAAAGGGCGAAGAACCATC 114 ATCGGCTGCGAGCATGTAGAAACCTATCATAT
14 CTTGCATGCATTAATGAATCGGCCCGCCAGGG 115 CCTAATTTACGCTAACGAGCGTCTAATCAATA
15 TAGATGGGGGGTAACGCCAGGGTTGTGCCAAG 116 AAAAGTAATATCTTACCGAAGCCCTTCCAGAG
16 CATGTCAAGATTCTCCGTGGGAACCGTTGGTG 117 TTATTCATAGGGAAGGTAAATATTCATTCAGT
17 CTGTAATATTGCCTGAGAGTCTGGAAAACTAG 118 GAGCCGCCCCACCACCGGAACCGCGACGGAAA
18 TGCAACTAAGCAATAAAGCCTCAGTTATGACC 119 AATGCCCCGTAACAGTGCCCGTATCTCCCTCA
19 AAACAGTTGATGGCTTAGAGCTTATTTAAATA 120 CAAGCCCAATAGGAACCCATGTACAAACAGTT
20 ACGAACTAGCGTCCAATACTGCGGAATGCTTT 121 CGGCCTTGCTGGTAATATCCAGAACGAACTGA
21 CTTTGAAAAGAACTGGCTCATTATTTAATAAA 122 TAGCCCTACCAGCAGAAGATAAAAACATTTGA
22 ACGGCTACTTACTTAGCCGGAACGCTGACCAA 123 GGATTTAGCGTATTAAATCCTTTGTTTTCAGG
23 GAGAATAGCTTTTGCGGGATCGTCGGGTAGCA 124 TTTAACGTTCGGGAGAAACAATAATTTTCCCT
24 ACGTTAGTAAATGAATTTTCTGTAAGCGGAGT 125 TAGAATCCCTGAGAAGAGTCAATAGGAATCAT
25 ACCCAAATCAAGTTTTTTGGGGTCAAAGAACG 126 AATTACTACAAATTCTTACCAGTAATCCCATC
26 TGGACTCCCTTTTCACCAGTGAGACCTGTCGT 127 CTAATTTATCTTTCCTTATCATTCATCCTGAA
27 GCCAGCTGCCTGCAGGTCGACTCTGCAAGGCG 128 TCTTACCAGCCAGTTACAAAATAAATGAAATA
28 ATTAAGTTCGCATCGTAACCGTGCGAGTAACA 129 GCAATAGCGCAGATAGCCGAACAATTCAACCG
29 ACCCGTCGTCATATGTACCCCGGTAAAGGCTA 130 ATTGAGGGTAAAGGTGAATTATCAATCACCGG
30 TCAGGTCACTTTTGCGGGAGAAGCAGAATTAG 131 AACCAGAGACCCTCAGAACCGCCAGGGGTCAG
31 CAAAATTAAAGTACGGTGTCTGGAAGAGGTCA 132 TGCCTTGACTGCCTATTTCGGAACAGGGATAG
32 TTTTTGCGCAGAAAACGAGAATGAATGTTTAG 133 AGGCGGTCATTAGTCTTTAATGCGCAATATTA
33 ACTGGATAACGGAACAACATTATTACCTTATG 134 TTATTAATGCCGTCAATAGATAATCAGAGGTG
34 CGATTTTAGAGGACAGATGAACGGCGCGACCT 135 CCTGATTGAAAGAAATTGCGTAGACCCGAACG
35 GCTCCATGAGAGGCTTTGAGGACTAGGGAGTT 136 ATCAAAATCGTCGCTATTAATTAACGGATTCG
36 AAAGGCCGAAAGGAACAACTAAAGCTTTCCAG 137 ACGCTCAAAATAAGAATAAACACCGTGAATTT
37 AGCTGATTACAAGAGTCCACTATTGAGGTGCC 138 GGTATTAAGAACAAGAAAAATAATTAAAGCCA
38 CCCGGGTACTTTCCAGTCGGGAAACGGGCAAC 139 ATTATTTAACCCAGCTACAATTTTCAAGAACG
39 GTTTGAGGGAAAGGGGGATGTGCTAGAGGATC 140 GAAGGAAAATAAGAGCAAGAAACAACAGCCAT
40 AGAAAAGCAACATTAAATGTGAGCATCTGCCA 141 GACTTGAGAGACAAAAGGGCGACAAGTTACCA
41 CAACGCAATTTTTGAGAGATCTACTGATAATC 142 GCCACCACTCTTTTCATAATCAAACCGTCACC
42 TCCATATACATACAGGCAAGGCAACTTTATTT 143 CTGAAACAGGTAATAAGTTTTAACCCCTCAGA
43 CAAAAATCATTGCTCCTTTTGATAAGTTTCAT 144 CTCAGAGCCACCACCCTCATTTTCCTATTATT
44 AAAGATTCAGGGGGTAATAGTAAACCATAAAT 145 CCGCCAGCCATTGCAACAGGAAAAATATTTTT
45 CCAGGCGCTTAATCATTGTGAATTACAGGTAG 146 GAATGGCTAGTATTAACACCGCCTCAACTAAT
46 TTTCATGAAAATTGTGTCGAAATCTGTACAGA 147 AGATTAGATTTAAAAGTTTGAGTACACGTAAA
47 AATAATAAGGTCGCTGAGGCTTGCAAAGACTT 148 ACAGAAATCTTTGAATACCAAGTTCCTTGCTT
48 CGTAACGATCTAAAGTTTTGTCGTGAATTGCG 149 CTGTAAATCATAGGTCTGAGAGACGATAAATA
49 GTAAAGCACTAAATCGGAACCCTAGTTGTTCC 150 AGGCGTTACAGTAGGGCTTAATTGACAATAGA
50 AGTTTGGAGCCCTTCACCGCCTGGTTGCGCTC 151 TAAGTCCTACCAAGTACCGCACTCTTAGTTGC
51 ACTGCCCGCCGAGCTCGAATTCGTTATTACGC 152 TATTTTGCTCCCAATCCAAATAAGTGAGTTAA
52 CAGCTGGCGGACGACGACAGTATCGTAGCCAG 153 GCCCAATACCGAGGAAACGCAATAGGTTTACC
53 CTTTCATCCCCAAAAACAGGAAGACCGGAGAG 154 AGCGCCAACCATTTGGGAATTAGATTATTAGC
54 GGTAGCTAGGATAAAAATTTTTAGTTAACATC 155 GTTTGCCACCTCAGAGCCGCCACCGATACAGG
55 CAATAAATACAGTTGATTCCCAATTTAGAGAG 156 AGTGTACTTGAAAGTATTAAGAGGCCGCCACC
56 TACCTTTAAGGTCTTTACCCTGACAAAGAAGT 157 GCCACGCTATACGTGGCACAGACAACGCTCAT
57 TTTGCCAGATCAGTTGAGATTTAGTGGTTTAA 158 ATTTTGCGTCTTTAGGAGCACTAAGCAACAGT
58 TTTCAACTATAGGCTGGCTGACCTTGTATCAT 159 GCGCAGAGATATCAAAATTATTTGACATTATC
59 CGCCTGATGGAAGTTTCCATTAAACATAACCG 160 TAACCTCCATATGTGAGTGAATAAACAAAATC
60 ATATATTCTTTTTTCACGTTGAAAATAGTTAG 161 CATATTTAGAAATACCGACCGTGTTACCTTTT
61 GAGTTGCACGAGATAGGGTTGAGTAAGGGAGC 162 CAAGCAAGACGCGCCTGTTTATCAAGAATCGC
62 TCATAGCTACTCACATTAATTGCGCCCTGAGA 163 TTTTGTTTAAGCCTTAAATCAAGAATCGAGAA
63 GAAGATCGGTGCGGGCCTCTTCGCAATCATGG 164 ATACCCAAGATAACCCACAAGAATAAACGATT
64 GCAAATATCGCGTCTGGCCTTCCTGGCCTCAG 165 AATCACCAAATAGAAAATTCATATATAACGGA
65 TATATTTTAGCTGATAAATTAATGTTGTATAA 166 CACCAGAGTTCGGTCATAGCCCCCGCCAGCAA
66 CGAGTAGAACTAATAGTAGTAGCAAACCCTCA 167 CCTCAAGAATACATGGCTTTTGATAGAACCAC
67 TCAGAAGCCTCCAACAGGTCAGGATCTGCGAA 168 CCCTCAGAACCGCCACCCTCAGAACTGAGACT
68 CATTCAACGCGAGAGGCTTTTGCATATTATAG 169 GGAAATACCTACATTTTGACGCTCACCTGAAA
69 AGTAATCTTAAATTGGGCTTGAGAGAATACCA 170 GCGTAAGAGAGAGCCAGCAGCAAAAAGGTTAT
70 ATACGTAAAAGTACAACGGAGATTTCATCAAG 171 CTAAAATAGAACAAAGAAACCACCAGGGTTAG
71 AAAAAAGGACAACCATCGCCCACGCGGGTAAA 172 AACCTACCGCGAATTATTCATTTCCAGTACAT
72 TGTAGCATTCCACAGACAGCCCTCATCTCCAA 173 AAATCAATGGCTTAGGTTGGGTTACTAAATTT
73 CCCCGATTTAGAGCTTGACGGGGAAATCAAAA 174 AATGGTTTACAACGCCAACATGTAGTTCAGCT
74 GAATAGCCGCAAGCGGTCCACGCTCCTAATGA 175 AATGCAGACCGTTTTTATTTTCATCTTGCGGG
75 GTGAGCTAGTTTCCTGTGTGAAATTTGGGAAG 176 AGGTTTTGAACGTCAA  AAATGAAAGCGCTAAT
76 GGCGATCGCACTCCAGCCAGCTTTGCCATCAA 177 ATCAGAGAAAGAACTG  GCATGATTTTATTTTG
77 AAATAATTTTAAATTGTAAACGTTGATATTCA 178 TCACAATCGTAGCACCATTACCATCGTTTTCA
78 ACCGTTCTAAATGCAATGCCTGAGAGGTGGCA 179 TCGGCATTCCGCCGCCAGCATTGACGTTCCAG
79 TCAATTCTTTTAGTTTGACCATTACCAGACCG 180 TAAGCGTCGAAGGATT  AGGATTAGTACCGCCA
80 GAAGCAAAAAAGCGGATTGCATCAGATAAAAA 181 CTAAAGCAAGATAGAA  CCCTTCTGAATCGTCT
81 CCAAAATATAATGCAGATACATAAACACCAGA 182 CGGAATTATTGAAAGGAATTGAGGTGAAAAAT
82 ACGAGTAGTGACAAGAACCGGATATACCAAGC 183 GAGCAAAAACTTCTGAATAATGGAAGAAGGAG
83 GCGAAACATGCCACTACGAAGGCATGCGCCGA 184 TATGTAAACCTTTTTTAATGGAAAAATTACCT
84 CAATGACACTCCAAAAGGAGCCTTACAACGCC 185 AGAGGCATAATTTCATCTTCTGACTATAACTA
85 CCAGCAGGGGCAAAATCCCTTATAAAGCCGGC 186 TCATTACCCGACAATAAACAACATATTTAGGC
86 GCTCACAATGTAAAGCCTGGGGTGGGTTTGCC 187 CTTTACAGTTAGCGAACCTCCCGACGTAGGAA
87 GCTTCTGGTCAGGCTGCGCAACTGTGTTATCC 188 TTATTACGGTCAGAGG  GTAATTGAATAGCAGC
88 GTTAAAATTTTAACCAATAGGAACCCGGCACC 189 CCGGAAACACACCACG  GAATAAGTAAGACTCC
89 AGGTAAAGAAATCACCATCAATATAATATTTT 190 TGAGGCAGGCGTCAGACTGTAGCGTAGCAAGG
90 TCGCAAATGGGGCGCGAGCTGAAATAATGTGT 191 TGCTCAGTCAGTCTCTGAATTTACCAGGAGGT
91 AAGAGGAACGAGCTTCAAAGCGAAGATACATT 192 TATCACCGTACTCAGGAGGTTTAGCGGGGTTT
92 GGAATTACTCGTTTACCAGACGACAAAAGATT 193 GAAATGGATTATTTACATTGGCAGACATTCTG
93 CCAAATCACTTGCCCTGACGAGAACGCCAAAA 194 GCCAACAGTCACCTTGCTGAACCTGTTGGCAA
94 AAACGAAATGACCCCCAGCGATTATTCATTAC 195 ATCAACAGTCATCATATTCCTGATTGATTGTT
95 TCGGTTTAGCTTGATACCGATAGTCCAACCTA 196 TGGATTATGAAGATGA  TGAAACAAAATTTCAT
96 TGAGTTTCGTCACCAGTACAAACTTAATTGTA 197 TTGAATTATGCTGATG  CAAATCCACAAATATA
97 GAACGTGGCGAGAAAGGAAGGGAACAAACTAT 198 TTTTAGTTTTTCGAGCCAGTAATAAATTCTGT
98 CCGAAATCCGAAAATCCTGTTTGAAGCCGGAA 199 CCAGACGAGCGCCCAATAGCAAGCAAGAACGC
99 GCATAAAGTTCCACACAACATACGAAGCGCCA 200 GAGGCGTTAGAGAATAACATAAAAGAACACCC
100 TTCGCCATTGCCGGAAACCAGGCATTAAATCA 201 TGAACAAACAGTATGTTAGCAAACTAAAAGAA
101 GCTCATTTTCGCATTAAATTTTTGAGCTTAGA 202 ACGCAAAGGTCACCAATGAAACCAATCAAGTT
102 AGACAGTCATTCAAAAGGGTGAGAAGCTATAT 203 TGCCTTTAGTCAGACGATTGGCCTGCCAGAAT
103 TTTCATTTGGTCAATAACCTGTTTATATCGCG 204 GGAAAGCGACCAGGCGGATAAGTGAATAGGTG
104 TTTTAATTGCCCGAAAGACTTCAAAACACTAT 217 AACATCACTTGCCTGAGTAGAAGAACT
105 CATAACCCGAGGCATAGTAAGAGCTTTTTAAG 218 TGTAGCAATACTTCTTTGATTAGTAAT
106 GAATAAGGACGTAACAAAGCTGCTCTAAAACA 219 AGTCTGTCCATCACGCAAATTAACCGT
107 CTCATCTTGAGGCAAAAGAATACAGTGAATTT 220 ATAATCAGTGAGGCCACCGAGTAAAAG
108 CTTAAACATCAGCTTGCTTTCGAGCGTAACAC 221 ACGCCAGAATCCTGAGAAGTGTTTTT
109 ACGAACCAAAACATCGCCATTAAATGGTGGTT 222 TTAAAGGGATTTTAGACAGGAACGGT
110 CGACAACTAAGTATTAGACTTTACAATACCGA 223 AGAGCGGGAGCTAAACAGGAGGCCGA
111 CTTTTACACAGATGAATATACAGTAAACAATT 224 TATAACGTGCTTTCCTCGTTAGAATC
112 TTAAGACGTTGAAAACATAGCGATAACAGTAC 225 GTACTATGGTTGCTTTGACGAGCACG
113 GCGTTATAGAAAAAGCCTGTTTAGAAGGCCGG 226 GCGCTTAATGCGCCGCTACAGGGCGC
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Name Sequence Name Sequence
13 TGGTTTTTAACGTCAAAGGGCGAAGAACCATC 114 ATCGGCTGCGAGCATGTAGAAACCTATCATAT
14 CTTGCATGCATTAATGAATCGGCCCGCCAGGG 115 CCTAATTTACGCTAACGAGCGTCTAATCAATA
15 TAGATGGGGGGTAACGCCAGGGTTGTGCCAAG 116 AAAAGTAATATCTTACCGAAGCCCTTCCAGAG
16 CATGTCAAGATTCTCCGTGGGAACCGTTGGTG 117 TTATTCATAGGGAAGGTAAATATTCATTCAGT
17 CTGTAATATTGCCTGAGAGTCTGGAAAACTAG 118 GAGCCGCCCCACCACCGGAACCGCGACGGAAA
18 TGCAACTAAGCAATAAAGCCTCAGTTATGACC 119 AATGCCCCGTAACAGTGCCCGTATCTCCCTCA
19 AAACAGTTGATGGCTTAGAGCTTATTTAAATA 120 CAAGCCCAATAGGAACCCATGTACAAACAGTT
20 ACGAACTAGCGTCCAATACTGCGGAATGCTTT 121 CGGCCTTGCTGGTAATATCCAGAACGAACTGA
21 CTTTGAAAAGAACTGGCTCATTATTTAATAAA 122 TAGCCCTACCAGCAGAAGATAAAAACATTTGA
22 ACGGCTACTTACTTAGCCGGAACGCTGACCAA 123 GGATTTAGCGTATTAAATCCTTTGTTTTCAGG
23 GAGAATAGCTTTTGCGGGATCGTCGGGTAGCA 124 TTTAACGTTCGGGAGAAACAATAATTTTCCCT
24 ACGTTAGTAAATGAATTTTCTGTAAGCGGAGT 125 TAGAATCCCTGAGAAGAGTCAATAGGAATCAT
25 ACCCAAATCAAGTTTTTTGGGGTCAAAGAACG 126 AATTACTACAAATTCTTACCAGTAATCCCATC
26 TGGACTCCCTTTTCACCAGTGAGACCTGTCGT 127 CTAATTTATCTTTCCTTATCATTCATCCTGAA
27 GCCAGCTGCCTGCAGGTCGACTCTGCAAGGCG 128 TCTTACCAGCCAGTTACAAAATAAATGAAATA
28 ATTAAGTTCGCATCGTAACCGTGCGAGTAACA 129 GCAATAGCGCAGATAGCCGAACAATTCAACCG
29 ACCCGTCGTCATATGTACCCCGGTAAAGGCTA 130 ATTGAGGGTAAAGGTGAATTATCAATCACCGG
30 TCAGGTCACTTTTGCGGGAGAAGCAGAATTAG 131 AACCAGAGACCCTCAGAACCGCCAGGGGTCAG
31 CAAAATTAAAGTACGGTGTCTGGAAGAGGTCA 132 TGCCTTGACTGCCTATTTCGGAACAGGGATAG
32 TTTTTGCGCAGAAAACGAGAATGAATGTTTAG 133 AGGCGGTCATTAGTCTTTAATGCGCAATATTA
33 ACTGGATAACGGAACAACATTATTACCTTATG 134 TTATTAATGCCGTCAATAGATAATCAGAGGTG
34 CGATTTTAGAGGACAGATGAACGGCGCGACCT 135 CCTGATTGAAAGAAATTGCGTAGACCCGAACG
35 GCTCCATGAGAGGCTTTGAGGACTAGGGAGTT 136 ATCAAAATCGTCGCTATTAATTAACGGATTCG
36 AAAGGCCGAAAGGAACAACTAAAGCTTTCCAG 137 ACGCTCAAAATAAGAATAAACACCGTGAATTT
37 AGCTGATTACAAGAGTCCACTATTGAGGTGCC 138 GGTATTAAGAACAAGAAAAATAATTAAAGCCA
38 CCCGGGTACTTTCCAGTCGGGAAACGGGCAAC 139 ATTATTTAACCCAGCTACAATTTTCAAGAACG
39 GTTTGAGGGAAAGGGGGATGTGCTAGAGGATC 140 GAAGGAAAATAAGAGCAAGAAACAACAGCCAT
40 AGAAAAGCAACATTAAATGTGAGCATCTGCCA 141 GACTTGAGAGACAAAAGGGCGACAAGTTACCA
41 CAACGCAATTTTTGAGAGATCTACTGATAATC 142 GCCACCACTCTTTTCATAATCAAACCGTCACC
42 TCCATATACATACAGGCAAGGCAACTTTATTT 143 CTGAAACAGGTAATAAGTTTTAACCCCTCAGA
43 CAAAAATCATTGCTCCTTTTGATAAGTTTCAT 144 CTCAGAGCCACCACCCTCATTTTCCTATTATT
44 AAAGATTCAGGGGGTAATAGTAAACCATAAAT 145 CCGCCAGCCATTGCAACAGGAAAAATATTTTT
45 CCAGGCGCTTAATCATTGTGAATTACAGGTAG 146 GAATGGCTAGTATTAACACCGCCTCAACTAAT
46 TTTCATGAAAATTGTGTCGAAATCTGTACAGA 147 AGATTAGATTTAAAAGTTTGAGTACACGTAAA
47 AATAATAAGGTCGCTGAGGCTTGCAAAGACTT 148 ACAGAAATCTTTGAATACCAAGTTCCTTGCTT
48 CGTAACGATCTAAAGTTTTGTCGTGAATTGCG 149 CTGTAAATCATAGGTCTGAGAGACGATAAATA
49 GTAAAGCACTAAATCGGAACCCTAGTTGTTCC 150 AGGCGTTACAGTAGGGCTTAATTGACAATAGA
50 AGTTTGGAGCCCTTCACCGCCTGGTTGCGCTC 151 TAAGTCCTACCAAGTACCGCACTCTTAGTTGC
51 ACTGCCCGCCGAGCTCGAATTCGTTATTACGC 152 TATTTTGCTCCCAATCCAAATAAGTGAGTTAA
52 CAGCTGGCGGACGACGACAGTATCGTAGCCAG 153 GCCCAATACCGAGGAAACGCAATAGGTTTACC
53 CTTTCATCCCCAAAAACAGGAAGACCGGAGAG 154 AGCGCCAACCATTTGGGAATTAGATTATTAGC
54 GGTAGCTAGGATAAAAATTTTTAGTTAACATC 155 GTTTGCCACCTCAGAGCCGCCACCGATACAGG
55 CAATAAATACAGTTGATTCCCAATTTAGAGAG 156 AGTGTACTTGAAAGTATTAAGAGGCCGCCACC
56 TACCTTTAAGGTCTTTACCCTGACAAAGAAGT 157 GCCACGCTATACGTGGCACAGACAACGCTCAT
57 TTTGCCAGATCAGTTGAGATTTAGTGGTTTAA 158 ATTTTGCGTCTTTAGGAGCACTAAGCAACAGT
58 TTTCAACTATAGGCTGGCTGACCTTGTATCAT 159 GCGCAGAGATATCAAAATTATTTGACATTATC
59 CGCCTGATGGAAGTTTCCATTAAACATAACCG 160 TAACCTCCATATGTGAGTGAATAAACAAAATC
60 ATATATTCTTTTTTCACGTTGAAAATAGTTAG 161 CATATTTAGAAATACCGACCGTGTTACCTTTT
61 GAGTTGCACGAGATAGGGTTGAGTAAGGGAGC 162 CAAGCAAGACGCGCCTGTTTATCAAGAATCGC
62 TCATAGCTACTCACATTAATTGCGCCCTGAGA 163 TTTTGTTTAAGCCTTAAATCAAGAATCGAGAA
63 GAAGATCGGTGCGGGCCTCTTCGCAATCATGG 164 ATACCCAAGATAACCCACAAGAATAAACGATT
64 GCAAATATCGCGTCTGGCCTTCCTGGCCTCAG 165 AATCACCAAATAGAAAATTCATATATAACGGA
65 TATATTTTAGCTGATAAATTAATGTTGTATAA 166 CACCAGAGTTCGGTCATAGCCCCCGCCAGCAA
66 CGAGTAGAACTAATAGTAGTAGCAAACCCTCA 167 CCTCAAGAATACATGGCTTTTGATAGAACCAC
67 TCAGAAGCCTCCAACAGGTCAGGATCTGCGAA 168 CCCTCAGAACCGCCACCCTCAGAACTGAGACT
68 CATTCAACGCGAGAGGCTTTTGCATATTATAG 169 GGAAATACCTACATTTTGACGCTCACCTGAAA
69 AGTAATCTTAAATTGGGCTTGAGAGAATACCA 170 GCGTAAGAGAGAGCCAGCAGCAAAAAGGTTAT
70 ATACGTAAAAGTACAACGGAGATTTCATCAAG 171 CTAAAATAGAACAAAGAAACCACCAGGGTTAG
71 AAAAAAGGACAACCATCGCCCACGCGGGTAAA 172 AACCTACCGCGAATTATTCATTTCCAGTACAT
72 TGTAGCATTCCACAGACAGCCCTCATCTCCAA 173 AAATCAATGGCTTAGGTTGGGTTACTAAATTT
73 CCCCGATTTAGAGCTTGACGGGGAAATCAAAA 174 AATGGTTTACAACGCCAACATGTAGTTCAGCT
74 GAATAGCCGCAAGCGGTCCACGCTCCTAATGA 175 AATGCAGACCGTTTTTATTTTCATCTTGCGGG
75 GTGAGCTAGTTTCCTGTGTGAAATTTGGGAAG 176 AGGTTTTGAACGTCAA  AAATGAAAGCGCTAAT
76 GGCGATCGCACTCCAGCCAGCTTTGCCATCAA 177 ATCAGAGAAAGAACTG  GCATGATTTTATTTTG
77 AAATAATTTTAAATTGTAAACGTTGATATTCA 178 TCACAATCGTAGCACCATTACCATCGTTTTCA
78 ACCGTTCTAAATGCAATGCCTGAGAGGTGGCA 179 TCGGCATTCCGCCGCCAGCATTGACGTTCCAG
79 TCAATTCTTTTAGTTTGACCATTACCAGACCG 180 TAAGCGTCGAAGGATT  AGGATTAGTACCGCCA
80 GAAGCAAAAAAGCGGATTGCATCAGATAAAAA 181 CTAAAGCAAGATAGAA  CCCTTCTGAATCGTCT
81 CCAAAATATAATGCAGATACATAAACACCAGA 182 CGGAATTATTGAAAGGAATTGAGGTGAAAAAT
82 ACGAGTAGTGACAAGAACCGGATATACCAAGC 183 GAGCAAAAACTTCTGAATAATGGAAGAAGGAG
83 GCGAAACATGCCACTACGAAGGCATGCGCCGA 184 TATGTAAACCTTTTTTAATGGAAAAATTACCT
84 CAATGACACTCCAAAAGGAGCCTTACAACGCC 185 AGAGGCATAATTTCATCTTCTGACTATAACTA
85 CCAGCAGGGGCAAAATCCCTTATAAAGCCGGC 186 TCATTACCCGACAATAAACAACATATTTAGGC
86 GCTCACAATGTAAAGCCTGGGGTGGGTTTGCC 187 CTTTACAGTTAGCGAACCTCCCGACGTAGGAA
87 GCTTCTGGTCAGGCTGCGCAACTGTGTTATCC 188 TTATTACGGTCAGAGG  GTAATTGAATAGCAGC
88 GTTAAAATTTTAACCAATAGGAACCCGGCACC 189 CCGGAAACACACCACG  GAATAAGTAAGACTCC
89 AGGTAAAGAAATCACCATCAATATAATATTTT 190 TGAGGCAGGCGTCAGACTGTAGCGTAGCAAGG
90 TCGCAAATGGGGCGCGAGCTGAAATAATGTGT 191 TGCTCAGTCAGTCTCTGAATTTACCAGGAGGT
91 AAGAGGAACGAGCTTCAAAGCGAAGATACATT 192 TATCACCGTACTCAGGAGGTTTAGCGGGGTTT
92 GGAATTACTCGTTTACCAGACGACAAAAGATT 193 GAAATGGATTATTTACATTGGCAGACATTCTG
93 CCAAATCACTTGCCCTGACGAGAACGCCAAAA 194 GCCAACAGTCACCTTGCTGAACCTGTTGGCAA
94 AAACGAAATGACCCCCAGCGATTATTCATTAC 195 ATCAACAGTCATCATATTCCTGATTGATTGTT
95 TCGGTTTAGCTTGATACCGATAGTCCAACCTA 196 TGGATTATGAAGATGA  TGAAACAAAATTTCAT
96 TGAGTTTCGTCACCAGTACAAACTTAATTGTA 197 TTGAATTATGCTGATG  CAAATCCACAAATATA
97 GAACGTGGCGAGAAAGGAAGGGAACAAACTAT 198 TTTTAGTTTTTCGAGCCAGTAATAAATTCTGT
98 CCGAAATCCGAAAATCCTGTTTGAAGCCGGAA 199 CCAGACGAGCGCCCAATAGCAAGCAAGAACGC
99 GCATAAAGTTCCACACAACATACGAAGCGCCA 200 GAGGCGTTAGAGAATAACATAAAAGAACACCC
100 TTCGCCATTGCCGGAAACCAGGCATTAAATCA 201 TGAACAAACAGTATGTTAGCAAACTAAAAGAA
101 GCTCATTTTCGCATTAAATTTTTGAGCTTAGA 202 ACGCAAAGGTCACCAATGAAACCAATCAAGTT
102 AGACAGTCATTCAAAAGGGTGAGAAGCTATAT 203 TGCCTTTAGTCAGACGATTGGCCTGCCAGAAT
103 TTTCATTTGGTCAATAACCTGTTTATATCGCG 204 GGAAAGCGACCAGGCGGATAAGTGAATAGGTG
104 TTTTAATTGCCCGAAAGACTTCAAAACACTAT 217 AACATCACTTGCCTGAGTAGAAGAACT
105 CATAACCCGAGGCATAGTAAGAGCTTTTTAAG 218 TGTAGCAATACTTCTTTGATTAGTAAT
106 GAATAAGGACGTAACAAAGCTGCTCTAAAACA 219 AGTCTGTCCATCACGCAAATTAACCGT
107 CTCATCTTGAGGCAAAAGAATACAGTGAATTT 220 ATAATCAGTGAGGCCACCGAGTAAAAG
108 CTTAAACATCAGCTTGCTTTCGAGCGTAACAC 221 ACGCCAGAATCCTGAGAAGTGTTTTT
109 ACGAACCAAAACATCGCCATTAAATGGTGGTT 222 TTAAAGGGATTTTAGACAGGAACGGT
110 CGACAACTAAGTATTAGACTTTACAATACCGA 223 AGAGCGGGAGCTAAACAGGAGGCCGA
111 CTTTTACACAGATGAATATACAGTAAACAATT 224 TATAACGTGCTTTCCTCGTTAGAATC
112 TTAAGACGTTGAAAACATAGCGATAACAGTAC 225 GTACTATGGTTGCTTTGACGAGCACG
113 GCGTTATAGAAAAAGCCTGTTTAGAAGGCCGG 226 GCGCTTAATGCGCCGCTACAGGGCGC
Name Sequence Name Sequence
13 TGGTTTTTAACGTCAAAGGGCGAAGAACCATC 114 ATCGGCTGCGAGCATGTAGAAACCTATCATAT
14 CTTGCATGCATTAATGAATCGGCCCGCCAGGG 115 CCTAATTTACGCTAACGAGCGTCTAATCAATA
15 TAGATGGGGGGTAACGCCAGGGTTGTGCCAAG 116 AAAAGTAATATCTTACCGAAGCCCTTCCAGAG
16 CATGTCAAGATTCTCCGTGGGAACCGTTGGTG 117 TTATTCATAGGGAAGGTAAATATTCATTCAGT
17 CTGTAATATTGCCTGAGAGTCTGGAAAACTAG 118 GAGCCGCCCCACCACCGGAACCGCGACGGAAA
18 TGCAACTAAGCAATAAAGCCTCAGTTATGACC 119 AATGCCCCGTAACAGTGCCCGTATCTCCCTCA
19 AAACAGTTGATGGCTTAGAGCTTATTTAAATA 120 CAAGCCCAATAGGAACCCATGTACAAACAGTT
20 ACGAACTAGCGTCCAATACTGCGGAATGCTTT 121 CGGCCTTGCTGGTAATATCCAGAACGAACTGA
21 CTTTGAAAAGAACTGGCTCATTATTTAATAAA 122 TAGCCCTACCAGCAGAAGATAAAAACATTTGA
22 ACGGCTACTTACTTAGCCGGAACGCTGACCAA 123 GGATTTAGCGTATTAAATCCTTTGTTTTCAGG
23 GAGAATAGCTTTTGCGGGATCGTCGGGTAGCA 124 TTTAACGTTCGGGAGAAACAATAATTTTCCCT
24 ACGTTAGTAAATGAATTTTCTGTAAGCGGAGT 125 TAGAATCCCTGAGAAGAGTCAATAGGAATCAT
25 ACCCAAATCAAGTTTTTTGGGGTCAAAGAACG 126 AATTACTACAAATTCTTACCAGTAATCCCATC
26 TGGACTCCCTTTTCACCAGTGAGACCTGTCGT 127 CTAATTTATCTTTCCTTATCATTCATCCTGAA
27 GCCAGCTGCCTGCAGGTCGACTCTGCAAGGCG 128 TCTTACCAGCCAGTTACAAAATAAATGAAATA
28 ATTAAGTTCGCATCGTAACCGTGCGAGTAACA 129 GCAATAGCGCAGATAGCCGAACAATTCAACCG
29 ACCCGTCGTCATATGTACCCCGGTAAAGGCTA 130 ATTGAGGGTAAAGGTGAATTATCAATCACCGG
30 TCAGGTCACTTTTGCGGGAGAAGCAGAATTAG 131 AACCAGAGACCCTCAGAACCGCCAGGGGTCAG
31 CAAAATTAAAGTACGGTGTCTGGAAGAGGTCA 132 TGCCTTGACTGCCTATTTCGGAACAGGGATAG
32 TTTTTGCGCAGAAAACGAGAATGAATGTTTAG 133 AGGCGGTCATTAGTCTTTAATGCGCAATATTA
33 ACTGGATAACGGAACAACATTATTACCTTATG 134 TTATTAATGCCGTCAATAGATAATCAGAGGTG
34 CGATTTTAGAGGACAGATGAACGGCGCGACCT 135 CCTGATTGAAAGAAATTGCGTAGACCCGAACG
35 GCTCCATGAGAGGCTTTGAGGACTAGGGAGTT 136 ATCAAAATCGTCGCTATTAATTAACGGATTCG
36 AAAGGCCGAAAGGAACAACTAAAGCTTTCCAG 137 ACGCTCAAAATAAGAATAAACACCGTGAATTT
37 AGCTGATTACAAGAGTCCACTATTGAGGTGCC 138 GGTATTAAGAACAAGAAAAATAATTAAAGCCA
38 CCCGGGTACTTTCCAGTCGGGAAACGGGCAAC 139 ATTATTTAACCCAGCTACAATTTTCAAGAACG
39 GTTTGAGGGAAAGGGGGATGTGCTAGAGGATC 140 GAAGGAAAATAAGAGCAAGAAACAACAGCCAT
40 AGAAAAGCAACATTAAATGTGAGCATCTGCCA 141 GACTTGAGAGACAAAAGGGCGACAAGTTACCA
41 CAACGCAATTTTTGAGAGATCTACTGATAATC 142 GCCACCACTCTTTTCATAATCAAACCGTCACC
42 TCCATATACATACAGGCAAGGCAACTTTATTT 143 CTGAAACAGGTAATAAGTTTTAACCCCTCAGA
43 CAAAAATCATTGCTCCTTTTGATAAGTTTCAT 144 CTCAGAGCCACCACCCTCATTTTCCTATTATT
44 AAAGATTCAGGGGGTAATAGTAAACCATAAAT 145 CCGCCAGCCATTGCAACAGGAAAAATATTTTT
45 CCAGGCGCTTAATCATTGTGAATTACAGGTAG 146 GAATGGCTAGTATTAACACCGCCTCAACTAAT
46 TTTCATGAAAATTGTGTCGAAATCTGTACAGA 147 AGATTAGATTTAAAAGTTTGAGTACACGTAAA
47 AATAATAAGGTCGCTGAGGCTTGCAAAGACTT 148 ACAGAAATCTTTGAATACCAAGTTCCTTGCTT
48 CGTAACGATCTAAAGTTTTGTCGTGAATTGCG 149 CTGTAAATCATAGGTCTGAGAGACGATAAATA
49 GTAAAGCACTAAATCGGAACCCTAGTTGTTCC 150 AGGCGTTACAGTAGGGCTTAATTGACAATAGA
50 AGTTTGGAGCCCTTCACCGCCTGGTTGCGCTC 151 TAAGTCCTACCAAGTACCGCACTCTTAGTTGC
51 ACTGCCCGCCGAGCTCGAATTCGTTATTACGC 152 TATTTTGCTCCCAATCCAAATAAGTGAGTTAA
52 CAGCTGGCGGACGACGACAGTATCGTAGCCAG 153 GCCCAATACCGAGGAAACGCAATAGGTTTACC
53 CTTTCATCCCCAAAAACAGGAAGACCGGAGAG 154 AGCGCCAACCATTTGGGAATTAGATTATTAGC
54 GGTAGCTAGGATAAAAATTTTTAGTTAACATC 155 GTTTGCCACCTCAGAGCCGCCACCGATACAGG
55 CAATAAATACAGTTGATTCCCAATTTAGAGAG 156 AGTGTACTTGAAAGTATTAAGAGGCCGCCACC
56 TACCTTTAAGGTCTTTACCCTGACAAAGAAGT 157 GCCACGCTATACGTGGCACAGACAACGCTCAT
57 TTTGCCAGATCAGTTGAGATTTAGTGGTTTAA 158 ATTTTGCGTCTTTAGGAGCACTAAGCAACAGT
58 TTTCAACTATAGGCTGGCTGACCTTGTATCAT 159 GCGCAGAGATATCAAAATTATTTGACATTATC
59 CGCCTGATGGAAGTTTCCATTAAACATAACCG 160 TAACCTCCATATGTGAGTGAATAAACAAAATC
60 ATATATTCTTTTTTCACGTTGAAAATAGTTAG 161 CATATTTAGAAATACCGACCGTGTTACCTTTT
61 GAGTTGCACGAGATAGGGTTGAGTAAGGGAGC 162 CAAGCAAGACGCGCCTGTTTATCAAGAATCGC
62 TCATAGCTACTCACATTAATTGCGCCCTGAGA 163 TTTTGTTTAAGCCTTAAATCAAGAATCGAGAA
63 GAAGATCGGTGCGGGCCTCTTCGCAATCATGG 164 ATACCCAAGATAACCCACAAGAATAAACGATT
64 GCAAATATCGCGTCTGGCCTTCCTGGCCTCAG 165 AATCACCAAATAGAAAATTCATATATAACGGA
65 TATATTTTAGCTGATAAATTAATGTTGTATAA 166 CACCAGAGTTCGGTCATAGCCCCCGCCAGCAA
66 CGAGTAGAACTAATAGTAGTAGCAAACCCTCA 167 CCTCAAGAATACATGGCTTTTGATAGAACCAC
67 TCAGAAGCCTCCAACAGGTCAGGATCTGCGAA 168 CCCTCAGAACCGCCACCCTCAGAACTGAGACT
68 CATTCAACGCGAGAGGCTTTTGCATATTATAG 169 GGAAATACCTACATTTTGACGCTCACCTGAAA
69 AGTAATCTTAAATTGGGCTTGAGAGAATACCA 170 GCGTAAGAGAGAGCCAGCAGCAAAAAGGTTAT
70 ATACGTAAAAGTACAACGGAGATTTCATCAAG 171 CTAAAATAGAACAAAGAAACCACCAGGGTTAG
71 AAAAAAGGACAACCATCGCCCACGCGGGTAAA 172 AACCTACCGCGAATTATTCATTTCCAGTACAT
72 TGTAGCATTCCACAGACAGCCCTCATCTCCAA 173 AAATCAATGGCTTAGGTTGGGTTACTAAATTT
73 CCCCGATTTAGAGCTTGACGGGGAAATCAAAA 174 AATGGTTTACAACGCCAACATGTAGTTCAGCT
74 GAATAGCCGCAAGCGGTCCACGCTCCTAATGA 175 AATGCAGACCGTTTTTATTTTCATCTTGCGGG
75 GTGAGCTAGTTTCCTGTGTGAAATTTGGGAAG 176 AGGTTTTGAACGTCAA  AAATGAAAGCGCTAAT
76 GGCGATCGCACTCCAGCCAGCTTTGCCATCAA 177 ATCAGAGAAAGAACTG  GCATGATTTTATTTTG
77 AAATAATTTTAAATTGTAAACGTTGATATTCA 178 TCACAATCGTAGCACCATTACCATCGTTTTCA
78 ACCGTTCTAAATGCAATGCCTGAGAGGTGGCA 179 TCGGCATTCCGCCGCCAGCATTGACGTTCCAG
79 TCAATTCTTTTAGTTTGACCATTACCAGACCG 180 TAAGCGTCGAAGGATT  AGGATTAGTACCGCCA
80 GAAGCAAAAAAGCGGATTGCATCAGATAAAAA 181 CTAAAGCAAGATAGAA  CCCTTCTGAATCGTCT
81 CCAAAATATAATGCAGATACATAAACACCAGA 182 CGGAATTATTGAAAGGAATTGAGGTGAAAAAT
82 ACGAGTAGTGACAAGAACCGGATATACCAAGC 183 GAGCAAAAACTTCTGAATAATGGAAGAAGGAG
83 GCGAAACATGCCACTACGAAGGCATGCGCCGA 184 TATGTAAACCTTTTTTAATGGAAAAATTACCT
84 CAATGACACTCCAAAAGGAGCCTTACAACGCC 185 AGAGGCATAATTTCATCTTCTGACTATAACTA
85 CCAGCAGGGGCAAAATCCCTTATAAAGCCGGC 186 TCATTACCCGACAATAAACAACATATTTAGGC
86 GCTCACAATGTAAAGCCTGGGGTGGGTTTGCC 187 CTTTACAGTTAGCGAACCTCCCGACGTAGGAA
87 GCTTCTGGTCAGGCTGCGCAACTGTGTTATCC 188 TTATTACGGTCAGAGG  GTAATTGAATAGCAGC
88 GTTAAAATTTTAACCAATAGGAACCCGGCACC 189 CCGGAAACACACCACG  GAATAAGTAAGACTCC
89 AGGTAAAGAAATCACCATCAATATAATATTTT 190 TGAGGCAGGCGTCAGACTGTAGCGTAGCAAGG
90 TCGCAAATGGGGCGCGAGCTGAAATAATGTGT 191 TGCTCAGTCAGTCTCTGAATTTACCAGGAGGT
91 AAGAGGAACGAGCTTCAAAGCGAAGATACATT 192 TATCACCGTACTCAGGAGGTTTAGCGGGGTTT
92 GGAATTACTCGTTTACCAGACGACAAAAGATT 193 GAAATGGATTATTTACATTGGCAGACATTCTG
93 CCAAATCACTTGCCCTGACGAGAACGCCAAAA 194 GCCAACAGTCACCTTGCTGAACCTGTTGGCAA
94 AAACGAAATGACCCCCAGCGATTATTCATTAC 195 ATCAACAGTCATCATATTCCTGATTGATTGTT
95 TCGGTTTAGCTTGATACCGATAGTCCAACCTA 196 TGGATTATGAAGATGA  TGAAACAAAATTTCAT
96 TGAGTTTCGTCACCAGTACAAACTTAATTGTA 197 TTGAATTATGCTGATG  CAAATCCACAAATATA
97 GAACGTGGCGAGAAAGGAAGGGAACAAACTAT 198 TTTTAGTTTTTCGAGCCAGTAATAAATTCTGT
98 CCGAAATCCGAAAATCCTGTTTGAAGCCGGAA 199 CCAGACGAGCGCCCAATAGCAAGCAAGAACGC
99 GCATAAAGTTCCACACAACATACGAAGCGCCA 200 GAGGCGTTAGAGAATAACATAAAAGAACACCC
100 TTCGCCATTGCCGGAAACCAGGCATTAAATCA 201 TGAACAAACAGTATGTTAGCAAACTAAAAGAA
101 GCTCATTTTCGCATTAAATTTTTGAGCTTAGA 202 ACGCAAAGGTCACCAATGAAACCAATCAAGTT
102 AGACAGTCATTCAAAAGGGTGAGAAGCTATAT 203 TGCCTTTAGTCAGACGATTGGCCTGCCAGAAT
103 TTTCATTTGGTCAATAACCTGTTTATATCGCG 204 GGAAAGCGACCAGGCGGATAAGTGAATAGGTG
104 TTTTAATTGCCCGAAAGACTTCAAAACACTAT 217 AACATCACTTGCCTGAGTAGAAGAACT
105 CATAACCCGAGGCATAGTAAGAGCTTTTTAAG 218 TGTAGCAATACTTCTTTGATTAGTAAT
106 GAATAAGGACGTAACAAAGCTGCTCTAAAACA 219 AGTCTGTCCATCACGCAAATTAACCGT
107 CTCATCTTGAGGCAAAAGAATACAGTGAATTT 220 ATAATCAGTGAGGCCACCGAGTAAAAG
108 CTTAAACATCAGCTTGCTTTCGAGCGTAACAC 221 ACGCCAGAATCCTGAGAAGTGTTTTT
109 ACGAACCAAAACATCGCCATTAAATGGTGGTT 222 TTAAAGGGATTTTAGACAGGAACGGT
110 CGACAACTAAGTATTAGACTTTACAATACCGA 223 AGAGCGGGAGCTAAACAGGAGGCCGA
111 CTTTTACACAGATGAATATACAGTAAACAATT 224 TATAACGTGCTTTCCTCGTTAGAATC
112 TTAAGACGTTGAAAACATAGCGATAACAGTAC 225 GTACTATGGTTGCTTTGACGAGCACG
113 GCGTTATAGAAAAAGCCTGTTTAGAAGGCCGG 226 GCGCTTAATGCGCCGCTACAGGGCGC
165 
 
 
Figure S13. Rectangular DNA origami tile (C1 tile) and the corresponding staple strands. 
Name Sequence Name Sequence
13 TGGTTTTTAACGTCAAAGGGCGAAGAACCATC 114 ATCGGCTGCGAGCATGTAGAAACCTATCATAT
14 CTTGCATGCATTAATGAATCGGCCCGCCAGGG 115 CCTAATTTACGCTAACGAGCGTCTAATCAATA
15 TAGATGGGGGGTAACGCCAGGGTTGTGCCAAG 116 AAAAGTAATATCTTACCGAAGCCCTTCCAGAG
16 CATGTCAAGATTCTCCGTGGGAACCGTTGGTG 117 TTATTCATAGGGAAGGTAAATATTCATTCAGT
17 CTGTAATATTGCCTGAGAGTCTGGAAAACTAG 118 GAGCCGCCCCACCACCGGAACCGCGACGGAAA
18 TGCAACTAAGCAATAAAGCCTCAGTTATGACC 119 AATGCCCCGTAACAGTGCCCGTATCTCCCTCA
19 AAACAGTTGATGGCTTAGAGCTTATTTAAATA 120 CAAGCCCAATAGGAACCCATGTACAAACAGTT
20 ACGAACTAGCGTCCAATACTGCGGAATGCTTT 121 CGGCCTTGCTGGTAATATCCAGAACGAACTGA
21 CTTTGAAAAGAACTGGCTCATTATTTAATAAA 122 TAGCCCTACCAGCAGAAGATAAAAACATTTGA
22 ACGGCTACTTACTTAGCCGGAACGCTGACCAA 123 GGATTTAGCGTATTAAATCCTTTGTTTTCAGG
23 GAGAATAGCTTTTGCGGGATCGTCGGGTAGCA 124 TTTAACGTTCGGGAGAAACAATAATTTTCCCT
24 ACGTTAGTAAATGAATTTTCTGTAAGCGGAGT 125 TAGAATCCCTGAGAAGAGTCAATAGGAATCAT
25 ACCCAAATCAAGTTTTTTGGGGTCAAAGAACG 126 AATTACTACAAATTCTTACCAGTAATCCCATC
26 TGGACTCCCTTTTCACCAGTGAGACCTGTCGT 127 CTAATTTATCTTTCCTTATCATTCATCCTGAA
27 GCCAGCTGCCTGCAGGTCGACTCTGCAAGGCG 128 TCTTACCAGCCAGTTACAAAATAAATGAAATA
28 ATTAAGTTCGCATCGTAACCGTGCGAGTAACA 129 GCAATAGCGCAGATAGCCGAACAATTCAACCG
29 ACCCGTCGTCATATGTACCCCGGTAAAGGCTA 130 ATTGAGGGTAAAGGTGAATTATCAATCACCGG
30 TCAGGTCACTTTTGCGGGAGAAGCAGAATTAG 131 AACCAGAGACCCTCAGAACCGCCAGGGGTCAG
31 CAAAATTAAAGTACGGTGTCTGGAAGAGGTCA 132 TGCCTTGACTGCCTATTTCGGAACAGGGATAG
32 TTTTTGCGCAGAAAACGAGAATGAATGTTTAG 133 AGGCGGTCATTAGTCTTTAATGCGCAATATTA
33 ACTGGATAACGGAACAACATTATTACCTTATG 134 TTATTAATGCCGTCAATAGATAATCAGAGGTG
34 CGATTTTAGAGGACAGATGAACGGCGCGACCT 135 CCTGATTGAAAGAAATTGCGTAGACCCGAACG
35 GCTCCATGAGAGGCTTTGAGGACTAGGGAGTT 136 ATCAAAATCGTCGCTATTAATTAACGGATTCG
36 AAAGGCCGAAAGGAACAACTAAAGCTTTCCAG 137 ACGCTCAAAATAAGAATAAACACCGTGAATTT
37 AGCTGATTACAAGAGTCCACTATTGAGGTGCC 138 GGTATTAAGAACAAGAAAAATAATTAAAGCCA
38 CCCGGGTACTTTCCAGTCGGGAAACGGGCAAC 139 ATTATTTAACCCAGCTACAATTTTCAAGAACG
39 GTTTGAGGGAAAGGGGGATGTGCTAGAGGATC 140 GAAGGAAAATAAGAGCAAGAAACAACAGCCAT
40 AGAAAAGCAACATTAAATGTGAGCATCTGCCA 141 GACTTGAGAGACAAAAGGGCGACAAGTTACCA
41 CAACGCAATTTTTGAGAGATCTACTGATAATC 142 GCCACCACTCTTTTCATAATCAAACCGTCACC
42 TCCATATACATACAGGCAAGGCAACTTTATTT 143 CTGAAACAGGTAATAAGTTTTAACCCCTCAGA
43 CAAAAATCATTGCTCCTTTTGATAAGTTTCAT 144 CTCAGAGCCACCACCCTCATTTTCCTATTATT
44 AAAGATTCAGGGGGTAATAGTAAACCATAAAT 145 CCGCCAGCCATTGCAACAGGAAAAATATTTTT
45 CCAGGCGCTTAATCATTGTGAATTACAGGTAG 146 GAATGGCTAGTATTAACACCGCCTCAACTAAT
46 TTTCATGAAAATTGTGTCGAAATCTGTACAGA 147 AGATTAGATTTAAAAGTTTGAGTACACGTAAA
47 AATAATAAGGTCGCTGAGGCTTGCAAAGACTT 148 ACAGAAATCTTTGAATACCAAGTTCCTTGCTT
48 CGTAACGATCTAAAGTTTTGTCGTGAATTGCG 149 CTGTAAATCATAGGTCTGAGAGACGATAAATA
49 GTAAAGCACTAAATCGGAACCCTAGTTGTTCC 150 AGGCGTTACAGTAGGGCTTAATTGACAATAGA
50 AGTTTGGAGCCCTTCACCGCCTGGTTGCGCTC 151 TAAGTCCTACCAAGTACCGCACTCTTAGTTGC
51 ACTGCCCGCCGAGCTCGAATTCGTTATTACGC 152 TATTTTGCTCCCAATCCAAATAAGTGAGTTAA
52 CAGCTGGCGGACGACGACAGTATCGTAGCCAG 153 GCCCAATACCGAGGAAACGCAATAGGTTTACC
53 CTTTCATCCCCAAAAACAGGAAGACCGGAGAG 154 AGCGCCAACCATTTGGGAATTAGATTATTAGC
54 GGTAGCTAGGATAAAAATTTTTAGTTAACATC 155 GTTTGCCACCTCAGAGCCGCCACCGATACAGG
55 CAATAAATACAGTTGATTCCCAATTTAGAGAG 156 AGTGTACTTGAAAGTATTAAGAGGCCGCCACC
56 TACCTTTAAGGTCTTTACCCTGACAAAGAAGT 157 GCCACGCTATACGTGGCACAGACAACGCTCAT
57 TTTGCCAGATCAGTTGAGATTTAGTGGTTTAA 158 ATTTTGCGTCTTTAGGAGCACTAAGCAACAGT
58 TTTCAACTATAGGCTGGCTGACCTTGTATCAT 159 GCGCAGAGATATCAAAATTATTTGACATTATC
59 CGCCTGATGGAAGTTTCCATTAAACATAACCG 160 TAACCTCCATATGTGAGTGAATAAACAAAATC
60 ATATATTCTTTTTTCACGTTGAAAATAGTTAG 161 CATATTTAGAAATACCGACCGTGTTACCTTTT
61 GAGTTGCACGAGATAGGGTTGAGTAAGGGAGC 162 CAAGCAAGACGCGCCTGTTTATCAAGAATCGC
62 TCATAGCTACTCACATTAATTGCGCCCTGAGA 163 TTTTGTTTAAGCCTTAAATCAAGAATCGAGAA
63 GAAGATCGGTGCGGGCCTCTTCGCAATCATGG 164 ATACCCAAGATAACCCACAAGAATAAACGATT
64 GCAAATATCGCGTCTGGCCTTCCTGGCCTCAG 165 AATCACCAAATAGAAAATTCATATATAACGGA
65 TATATTTTAGCTGATAAATTAATGTTGTATAA 166 CACCAGAGTTCGGTCATAGCCCCCGCCAGCAA
66 CGAGTAGAACTAATAGTAGTAGCAAACCCTCA 167 CCTCAAGAATACATGGCTTTTGATAGAACCAC
67 TCAGAAGCCTCCAACAGGTCAGGATCTGCGAA 168 CCCTCAGAACCGCCACCCTCAGAACTGAGACT
68 CATTCAACGCGAGAGGCTTTTGCATATTATAG 169 GGAAATACCTACATTTTGACGCTCACCTGAAA
69 AGTAATCTTAAATTGGGCTTGAGAGAATACCA 170 GCGTAAGAGAGAGCCAGCAGCAAAAAGGTTAT
70 ATACGTAAAAGTACAACGGAGATTTCATCAAG 171 CTAAAATAGAACAAAGAAACCACCAGGGTTAG
71 AAAAAAGGACAACCATCGCCCACGCGGGTAAA 172 AACCTACCGCGAATTATTCATTTCCAGTACAT
72 TGTAGCATTCCACAGACAGCCCTCATCTCCAA 173 AAATCAATGGCTTAGGTTGGGTTACTAAATTT
73 CCCCGATTTAGAGCTTGACGGGGAAATCAAAA 174 AATGGTTTACAACGCCAACATGTAGTTCAGCT
74 GAATAGCCGCAAGCGGTCCACGCTCCTAATGA 175 AATGCAGACCGTTTTTATTTTCATCTTGCGGG
75 GTGAGCTAGTTTCCTGTGTGAAATTTGGGAAG 176 AGGTTTTGAACGTCAA  AAATGAAAGCGCTAAT
76 GGCGATCGCACTCCAGCCAGCTTTGCCATCAA 177 ATCAGAGAAAGAACTG  GCATGATTTTATTTTG
77 AAATAATTTTAAATTGTAAACGTTGATATTCA 178 TCACAATCGTAGCACCATTACCATCGTTTTCA
78 ACCGTTCTAAATGCAATGCCTGAGAGGTGGCA 179 TCGGCATTCCGCCGCCAGCATTGACGTTCCAG
79 TCAATTCTTTTAGTTTGACCATTACCAGACCG 180 TAAGCGTCGAAGGATT  AGGATTAGTACCGCCA
80 GAAGCAAAAAAGCGGATTGCATCAGATAAAAA 181 CTAAAGCAAGATAGAA  CCCTTCTGAATCGTCT
81 CCAAAATATAATGCAGATACATAAACACCAGA 182 CGGAATTATTGAAAGGAATTGAGGTGAAAAAT
82 ACGAGTAGTGACAAGAACCGGATATACCAAGC 183 GAGCAAAAACTTCTGAATAATGGAAGAAGGAG
83 GCGAAACATGCCACTACGAAGGCATGCGCCGA 184 TATGTAAACCTTTTTTAATGGAAAAATTACCT
84 CAATGACACTCCAAAAGGAGCCTTACAACGCC 185 AGAGGCATAATTTCATCTTCTGACTATAACTA
85 CCAGCAGGGGCAAAATCCCTTATAAAGCCGGC 186 TCATTACCCGACAATAAACAACATATTTAGGC
86 GCTCACAATGTAAAGCCTGGGGTGGGTTTGCC 187 CTTTACAGTTAGCGAACCTCCCGACGTAGGAA
87 GCTTCTGGTCAGGCTGCGCAACTGTGTTATCC 188 TTATTACGGTCAGAGG  GTAATTGAATAGCAGC
88 GTTAAAATTTTAACCAATAGGAACCCGGCACC 189 CCGGAAACACACCACG  GAATAAGTAAGACTCC
89 AGGTAAAGAAATCACCATCAATATAATATTTT 190 TGAGGCAGGCGTCAGACTGTAGCGTAGCAAGG
90 TCGCAAATGGGGCGCGAGCTGAAATAATGTGT 191 TGCTCAGTCAGTCTCTGAATTTACCAGGAGGT
91 AAGAGGAACGAGCTTCAAAGCGAAGATACATT 192 TATCACCGTACTCAGGAGGTTTAGCGGGGTTT
92 GGAATTACTCGTTTACCAGACGACAAAAGATT 193 GAAATGGATTATTTACATTGGCAGACATTCTG
93 CCAAATCACTTGCCCTGACGAGAACGCCAAAA 194 GCCAACAGTCACCTTGCTGAACCTGTTGGCAA
94 AAACGAAATGACCCCCAGCGATTATTCATTAC 195 ATCAACAGTCATCATATTCCTGATTGATTGTT
95 TCGGTTTAGCTTGATACCGATAGTCCAACCTA 196 TGGATTATGAAGATGA  TGAAACAAAATTTCAT
96 TGAGTTTCGTCACCAGTACAAACTTAATTGTA 197 TTGAATTATGCTGATG  CAAATCCACAAATATA
97 GAACGTGGCGAGAAAGGAAGGGAACAAACTAT 198 TTTTAGTTTTTCGAGCCAGTAATAAATTCTGT
98 CCGAAATCCGAAAATCCTGTTTGAAGCCGGAA 199 CCAGACGAGCGCCCAATAGCAAGCAAGAACGC
99 GCATAAAGTTCCACACAACATACGAAGCGCCA 200 GAGGCGTTAGAGAATAACATAAAAGAACACCC
100 TTCGCCATTGCCGGAAACCAGGCATTAAATCA 201 TGAACAAACAGTATGTTAGCAAACTAAAAGAA
101 GCTCATTTTCGCATTAAATTTTTGAGCTTAGA 202 ACGCAAAGGTCACCAATGAAACCAATCAAGTT
102 AGACAGTCATTCAAAAGGGTGAGAAGCTATAT 203 TGCCTTTAGTCAGACGATTGGCCTGCCAGAAT
103 TTTCATTTGGTCAATAACCTGTTTATATCGCG 204 GGAAAGCGACCAGGCGGATAAGTGAATAGGTG
104 TTTTAATTGCCCGAAAGACTTCAAAACACTAT 217 AACATCACTTGCCTGAGTAGAAGAACT
105 CATAACCCGAGGCATAGTAAGAGCTTTTTAAG 218 TGTAGCAATACTTCTTTGATTAGTAAT
106 GAATAAGGACGTAACAAAGCTGCTCTAAAACA 219 AGTCTGTCCATCACGCAAATTAACCGT
107 CTCATCTTGAGGCAAAAGAATACAGTGAATTT 220 ATAATCAGTGAGGCCACCGAGTAAAAG
108 CTTAAACATCAGCTTGCTTTCGAGCGTAACAC 221 ACGCCAGAATCCTGAGAAGTGTTTTT
109 ACGAACCAAAACATCGCCATTAAATGGTGGTT 222 TTAAAGGGATTTTAGACAGGAACGGT
110 CGACAACTAAGTATTAGACTTTACAATACCGA 223 AGAGCGGGAGCTAAACAGGAGGCCGA
111 CTTTTACACAGATGAATATACAGTAAACAATT 224 TATAACGTGCTTTCCTCGTTAGAATC
112 TTAAGACGTTGAAAACATAGCGATAACAGTAC 225 GTACTATGGTTGCTTTGACGAGCACG
113 GCGTTATAGAAAAAGCCTGTTTAGAAGGCCGG 226 GCGCTTAATGCGCCGCTACAGGGCGC
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Figure S14. S1 origami tile schematic with 10-nm distance between probes. 
 
 
 
 
Name Sequence
A-174 AATGGTTTACAACGCCAACATGTAGTTCAGCTAAAAAAAAAAAAAAAAAAAAAAAAAAAA
A-175 AATGCAGACCGTTTTTATTTTCATCTTGCGGGAAAAAAAAAAAAAAAAAAAAAAAAAAAA
A-186 TCATTACCCGACAATAAACAACATATTTAGGCAAAAAAAAAAAAAAAAAAAAAAAAAAAA
A-187 CTTTACAGTTAGCGAACCTCCCGACGTAGGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
ACC10-150 AGGCGTTACAGTAGGGCTTAATTGACAATAGAACCACCACCACCACCACCACCACCACC
ACC10-151 TAAGTCCTACCAAGTACCGCACTCTTAGTTGCACCACCACCACCACCACCACCACCACC
ACC10-162 CAAGCAAGACGCGCCTGTTTATCAAGAATCGCACCACCACCACCACCACCACCACCACC
ACC10-163 TTTTGTTTAAGCCTTAAATCAAGAATCGAGAAACCACCACCACCACCACCACCACCACC
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Figure S15. S2 origami tile schematic with 20-nm distance between probes. 
 
 
 
 
Name Sequence
A-174 AATGGTTTACAACGCCAACATGTAGTTCAGCTAAAAAAAAAAAAAAAAAAAAAAAAAAAA
A-175 AATGCAGACCGTTTTTATTTTCATCTTGCGGGAAAAAAAAAAAAAAAAAAAAAAAAAAAA
A-186 TCATTACCCGACAATAAACAACATATTTAGGCAAAAAAAAAAAAAAAAAAAAAAAAAAAA
A-187 CTTTACAGTTAGCGAACCTCCCGACGTAGGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
ACC20-126 AATTACTACAAATTCTTACCAGTAATCCCATCACCACCACCACCACCACCACCACCACC
ACC20-127 CTAATTTATCTTTCCTTATCATTCATCCTGAAACCACCACCACCACCACCACCACCACC
ACC20-138 GGTATTAAGAACAAGAAAAATAATTAAAGCCAACCACCACCACCACCACCACCACCACC
ACC20-139 ATTATTTAACCCAGCTACAATTTTCAAGAACGACCACCACCACCACCACCACCACCACC
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Figure S16. S3 origami tile schematic with 45-nm distance between probes. 
 
 
 
 
Name Sequence
A-174 AATGGTTTACAACGCCAACATGTAGTTCAGCTAAAAAAAAAAAAAAAAAAAAAAAAAAAA
A-175 AATGCAGACCGTTTTTATTTTCATCTTGCGGGAAAAAAAAAAAAAAAAAAAAAAAAAAAA
A-186 TCATTACCCGACAATAAACAACATATTTAGGCAAAAAAAAAAAAAAAAAAAAAAAAAAAA
A-187 CTTTACAGTTAGCGAACCTCCCGACGTAGGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
ACC45-66 CGAGTAGAACTAATAGTAGTAGCAAACCCTCAACCACCACCACCACCACCACCACCACC
ACC45-67 TCAGAAGCCTCCAACAGGTCAGGATCTGCGAAACCACCACCACCACCACCACCACCACC
ACC45-78 ACCGTTCTAAATGCAATGCCTGAGAGGTGGCAACCACCACCACCACCACCACCACCACC
ACC45-79 TCAATTCTTTTAGTTTGACCATTACCAGACCGACCACCACCACCACCACCACCACCACC
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Figure S17. S4 origami tile schematic with 65-nm distance between probes. 
 
 
 
 
Name Sequence
A-174 AATGGTTTACAACGCCAACATGTAGTTCAGCTAAAAAAAAAAAAAAAAAAAAAAAAAAAA
A-175 AATGCAGACCGTTTTTATTTTCATCTTGCGGGAAAAAAAAAAAAAAAAAAAAAAAAAAAA
A-186 TCATTACCCGACAATAAACAACATATTTAGGCAAAAAAAAAAAAAAAAAAAAAAAAAAAA
A-187 CTTTACAGTTAGCGAACCTCCCGACGTAGGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
ACC65-30 TCAGGTCACTTTTGCGGGAGAAGCAGAATTAGACCACCACCACCACCACCACCACCACC
ACC65-31 CAAAATTAAAGTACGGTGTCTGGAAGAGGTCAACCACCACCACCACCACCACCACCACC
ACC65-42 TCCATATACATACAGGCAAGGCAACTTTATTTACCACCACCACCACCACCACCACCACC
ACC65-43 CAAAAATCATTGCTCCTTTTGATAAGTTTCATACCACCACCACCACCACCACCACCACC
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Figure S18. Schematic of the origami tile used for capturing NTV or β-Gal protein 
bridges.  
 
Name Sequence
A-174 AATGGTTTACAACGCCAACATGTAGTTCAGCTAAAAAAAAAAAAAAAAAAAAAAAAAAAA
A-175 AATGCAGACCGTTTTTATTTTCATCTTGCGGGAAAAAAAAAAAAAAAAAAAAAAAAAAAA
A-186 TCATTACCCGACAATAAACAACATATTTAGGCAAAAAAAAAAAAAAAAAAAAAAAAAAAA
A-187 CTTTACAGTTAGCGAACCTCCCGACGTAGGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
ACC30-102 AGACAGTCATTCAAAAGGGTGAGAAGCTATATACCACCACCACCACCACCACCACCACC
ACC30-102 TTTCATTTGGTCAATAACCTGTTTATATCGCGACCACCACCACCACCACCACCACCACC
ACC30-114 ATCGGCTGCGAGCATGTAGAAACCTATCATATACCACCACCACCACCACCACCACCACC
ACC30-115 CCTAATTTACGCTAACGAGCGTCTAATCAATAACCACCACCACCACCACCACCACCACC
bio138 GGTATTAAGAACAAGAAAAATAATTAAAGCCATCCAAATCCAATCCAAATCCAA/3BioTEG/
bio139 ATTATTTAACCCAGCTACAATTTTCAAGAACGTCCAAATCCAATCCAAATCCAA/3BioTEG/
bio150 AGGCGTTACAGTAGGGCTTAATTGACAATAGATCCAAATCCAATCCAAATCCAA/3BioTEG/
bio151 TAAGTCCTACCAAGTACCGCACTCTTAGTTGCTCCAAATCCAATCCAAATCCAA/3BioTEG/
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Figure S19. X-ray crystal structures of GOx and HRP with cofactors and potential 
surface lysines. Figures are generated by PyMOL program. (A) GOx (1CF3) structure 
with FAD cofactor (red); (B) (blue) potential surface lysines of GOx for DNA 
conjugation; (C) HRP (1ATJ) structure with heme cofactor (red); (D) (blue) potential 
surface lysines of HRP for DNA conjugation. 
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1. Chemicals 
Glucose-6 phosphate dehydrogenase, G6pDH (Leuconostoc mesenteroides), 
glucose-6 phosphate (G6p), resazurin, phenazine methosulfate (PMS), N-Succinimidyl 3-
(2-pyridyldithio)-propionate (SPDP), disuccinimidyl suberate (DSS), N,N-
Diisopropylethylamine (DIPEA), phosphate buffered saline (PBS), sodium HEPES salt, 
tris buffered saline (TBS) and DEAE-Sepharose resin were purchased from Sigma 
(St.Louis, MO). β-Nicotinamide-N6-(2-aminoethyl) adenine dinucleotide (6AE-NAD+) 
was ordered from BIOLOG (Bremen, Germany). Single-stranded oligonucleotides were 
purchased from IDT (Coralville, Iowa). 
2. Gel Preparation and Characterization 
3% Native PAGE gels were prepared at room temperature and run for 2.5 to 3 
hours at constant 200V and subsequently stained with ethidium bromide. To verify the 
assembled proteins, the same gel was then washed and stained using Pierce Silver Stain 
Kit (Thermo Fisher Scientific Inc.).  
 
 
 
 
 
 
 
 
175 
 
 
Table S1. Thermal annealing program for DNA tweezers.  
 
 
 
 
 
 
 
 
Temperature Time 
90 ℃ 1 min
88 ℃ 1 min
86 ℃ 1 min
84 ℃ 1 min
82 ℃ 1 min
80 ℃ 1 min
78 ℃ 1 min
76 ℃ 2 min
72 ℃ 2 min
68 ℃ 5 min
64 ℃ 5 min
60 ℃ 5 min
56 ℃ 5 min
52 ℃ 5 min
48 ℃ 5 min
44 ℃ 5 min
40 ℃ 5 min
36 ℃ 5 min
32 ℃ 5 min
28 ℃ 5 min
24 ℃ 5 min
4 ℃ hold
176 
 
 
 
 
Figure S1. Mass spectrometry characterization of HPLC purified NAD-DNA conjugates: 
(a) NAD-T9 (0T); (b) NAD-T9 (3T). 
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Figure S1 (cont). (c) NAD-T9 (13T); (d) NAD-T9 (20T). 
 
 
178 
 
 
 
 
Figure S1 (cont).  (e) NAD-T9 (30T); (f) NAD-T9 (40T).  
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Figure S3. Evaluating the effect of the double-stranded DNA/Mg
2+
 complex in 
quenching resorufin fluorescence. After 4 cycles of opening and closing the tweezer 
structures, and in the presence of 1 mM Mg
2+
, the enzyme activity was reduced due to 
accumulation of excess fuel and set strands bound to Mg
2+
 and the formation of 
DNA/Mg
2+
 complexes
 
 that quench resorufin fluorescence. By removing Mg
2+
 from the 
assay solution, no fluorescence quenching was observed, as shown in Figure 4.13.  
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Figure S4. AFM characterization of DNA tweezers. (A) Open tweezers: design (top); 
zoom-ins (middle); zoom-out image (bottom). A wider distance between two arms was 
observed (20-25 nm). (B) Close tweezers: design (top); zoom-ins (middle); zoom-out 
image (bottom). Due to the flexibility of two arms, the actual distance between two arms 
was observed ~5-7 nm which correlates to FRET measurement. 
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Figure S5. 3D crystal structure of G6pDH (Leuconostoc Mesenteroides, PDB 1DPG) 
generated by PyMOL program with cofactor NADP (red) and potential surface lysines 
(blue) for DNA conjugation. 
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